PEST CONTROL AGENT

Abstract
Provided is a novel pest control agent using at least one imino derivative represented by the following chemical formula (I):
Description
TECHNICAL FIELD

The present invention relates to a novel pest control agent using an imino derivative.


BACKGROUND ART

Although many pest control agents have been developed so far, novel drugs are still sought because of problems associated with decreased drug susceptibility, persistence of the effects of drugs, safety of drugs during the use, and the like.


As for the use of imino derivatives for controlling pests, the uses of imino derivatives as pesticides in the agricultural field have been reported (Patent Documents 1 to 3 and Non-Patent Document 1).


However, these Documents do not specifically describe the use of imino derivatives for controlling animal-parasitic pests or public health pests.


CITATION LIST
Patent Literature



  • [PTL 1] Japanese Unexamined Patent Application Publication No. Sho 63-150275

  • [PTL 2] International Application Japanese-Phase Publication No. 2007-506674

  • [PTL 3] International Publication No. WO2010/001922



Non Patent Literature



  • [NPL 1] Chemical Research in Toxicology, 2009, 22(3), 476-482



SUMMARY OF INVENTION
Technical Problem

An object of the present invention is to provide a novel pest control agent.


Solution to Problem

To achieve the above-described object, the present inventors provide a pest control agent using at least one imino derivative represented by the following chemical formula (I):




embedded image


Specifically, the present invention provides a pest control agent using at least one imino derivative represented by the chemical formula (I) (where Ar represents a heterocyclic group which may have a substituent on a ring thereof, X represents a sulfur atom, CH2, or NR, Y represents COR1, CONR3R4, CONHCOR5, or CO2R9, and R represents a hydrogen atom or an alkyl group,


when Y is COR1, R1 represents a hydrogen atom, a C1-C18 alkyl group, a C1-C18 halogenated alkyl group, a C2-C18 alkenyl group, a C2-C18 halogenated alkenyl group, a C2-C18 alkynyl group, a C2-C18 halogenated alkynyl group, a substituted or unsubstituted C6-C10 aryl group, a substituted or unsubstituted (C6-C10)aryl(C1-C8)alkyl group, a substituted or unsubstituted (C6-C10)aryl(C2-C8)alkenyl group, a substituted or unsubstituted (C6-C10)aryl(C2-C8)alkynyl group, a substituted or unsubstituted (C1-C4)alkoxy(C1-C5)alkyl group, a substituted or unsubstituted (C1-C4)alkoxy(C2-C5)alkenyl group, a substituted or unsubstituted (C1-C4)alkoxy(C2-C5)alkynyl group, a C1-C3 alkoxycarbonyl group, a (C1-C3)alkylsulfonyl(C1-C3)alkyl group, a (C1-C4)alkylthio(C1-C5)alkyl group, a C3-C12 substituted or unsubstituted cycloalkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C1-C8)alkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C8)alkenyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C8)alkynyl group, a cyano(C1-C3)alkyl group, a substituted or unsubstituted phenoxy(C1-C8)alkyl group, a substituted or unsubstituted phenoxy(C2-C8)alkenyl group, a substituted or unsubstituted phenoxy(C2-C8)alkynyl group, a substituted or unsubstituted heterocyclyl(C1-C8)alkyl group, a substituted or unsubstituted heterocyclyl(C2-C8)alkenyl group, a substituted or unsubstituted heterocyclyl(C2-C8)alkynyl group, a substituted or unsubstituted heterocyclyloxy(C1-C8)alkyl group, a substituted or unsubstituted heterocyclyloxy(C2-C8)alkenyl group, a substituted or unsubstituted heterocyclyloxy(C2-C8)alkynyl group, a furanyl group, a morpholinyl group, a norbornenyl group, an adamantyl group, an isothiocyanatomethyl group, a rhodanine group, a substituted or unsubstituted heterocyclic or aromatic ring, a (C1-C5)alkylcarbonylamino(C1-C3)alkyl group, a (C1-C5)alkyloxycarbonylaminooxymethyl group, a (C1-C5)alkyloxycarbonylaminomethyl group, or a (C1-C5)alkylcarbonyloxymethyl group,


when Y is CONR3R4, R3 and R4 each represent a hydrogen atom, a C1-C5 alkyl group, a C1-C5 halogenated alkyl group, a C2-C5 alkenyl group, a C2-C5 halogenated alkenyl group, a C2-C5 alkynyl group, a C2-C5 halogenated alkynyl group, a C1-C3 alkoxy group, an alkenyloxy group, a substituted or unsubstituted C6-C10 aryl group, a substituted or unsubstituted (C6-C10)aryl(C1-C8)alkyl group, a substituted or unsubstituted (C6-C10)aryl(C2-C8)alkenyl group, a substituted or unsubstituted (C6-C10)aryl(C2-C8)alkynyl group, a (C1-C4)alkoxy(C1-C5)alkyl group, a (C1-C4)alkoxy(C2-C5)alkenyl group, a (C1-C4)alkoxy(C2-C5)alkynyl group, a C1-C3 alkoxycarbonylmethyl group, a (C1-C4)alkylthio(C1-C5)alkyl group, a C3-C12 substituted or unsubstituted cycloalkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl group, a substituted or unsubstituted pyridylmethyl group, a substituted or unsubstituted benzenesulfonyl group, a (C1-C5)alkylamino group, a substituted or unsubstituted phenylamino group, a (C1-C5)alkylcarbonylamino group, or a substituted or unsubstituted benzoylamino group, and NR3R4 may form a ring,


when Y is CONHCOR5, R5 represents a hydrogen atom, a C1-C5 alkyl group, a C1-C5 halogenated alkyl group, a C2-C5 alkenyl group, a C2-C5 halogenated alkenyl group, a substituted or unsubstituted C6-C10 aryl group, or a substituted or unsubstituted (C6-C10)aryl(C1-C5)alkyl group, and


when Y is CO2R9, R9 represents a hydrogen atom, a C1-C18 alkyl group, a C1-C18 halogenated alkyl group, a C2-C18 alkenyl group, a C2-C18 halogenated alkenyl group, a C2-C18 alkynyl group, a C2-C18 halogenated alkynyl group, a substituted or unsubstituted C6-C10 aryl group, a substituted or unsubstituted (C6-C10)aryl(C1-C8)alkyl group, a substituted or unsubstituted (C6-C10)aryl(C2-C8)alkenyl group, a substituted or unsubstituted (C6-C10)aryl(C2-C8)alkynyl group, a substituted or unsubstituted (C1-C4)alkoxy(C1-C5)alkyl group, a substituted or unsubstituted (C1-C4)alkoxy(C2-C5)alkenyl group, a substituted or unsubstituted (C1-C4)alkoxy(C2-C5)alkynyl group, a (C1-C4)alkylthio(C1-C5)alkyl group, a tri(C1-C3 alkyl)silyl(C1-C3)alkyl group, a C3-C12 substituted or unsubstituted cycloalkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C1-C8)alkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C8)alkenyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C8)alkynyl group, a (C1-C4)alkylthio(C1-C5)alkyl group, a (C1-C3)alkylsulfonyl(C1-C3)alkyl group, a substituted or unsubstituted phenoxy(C1-C8)alkyl group, a substituted or unsubstituted phenoxy(C2-C8)alkenyl group, a substituted or unsubstituted phenoxy(C2-C8)alkynyl group, a substituted or unsubstituted heterocyclyl(C1-C8)alkyl group, a substituted or unsubstituted heterocyclyl(C2-C8)alkenyl group, a substituted or unsubstituted heterocyclyl(C2-C8)alkynyl group, a substituted or unsubstituted heterocyclyloxy(C1-C8)alkyl group, a substituted or unsubstituted heterocyclyloxy(C2-C8)alkenyl group, a substituted or unsubstituted heterocyclyloxy(C2-C8)alkynyl group, a succinimide group, or a 18-crown-6-methyl group, and


carbon chains thereof may be substituted with halogens).


In a preferred mode, provided is the pest control agent comprising at least one compound represented by the chemical formula (I) (where Ar is represented by the following chemical formula (II) or (III), and X and Y have the same meanings as described above:




embedded image


In another preferred mode, provided is the pest control agent, wherein the imino derivative represented by the chemical formula (I) is any one of the compounds shown in the following Table 1.












TABLE 1





Compound No.
Y
X
Ar


















6
CO-phenyl
S
(II)


42
COOMe
S
(II)


43
COOC3H7-n
S
(II)


44
COOC3H7-i
S
(II)


45
COOCH2CH2Cl
S
(II)


57
COPh
S
(III)


61
CHO
S
(III)


72
COMe
S
(II)


76
COOHF2
S
(II)


81
COCH2CH2OMe
S
(II)


83
COCH═CH2
S
(II)


106
CONHOMe
S
(II)


107
CONHOEt
S
(II)


113
COOEt
S
(II)


114
COOCH2CH2F
S
(II)


115
COOCH2CHF2
S
(II)


122
COOCH2CH2CH2F
S
(II)


123
COOCH(CH2F)2
S
(II)


124
COOCH(Me)CF3
S
(II)


125
COOCH(CF3)2
S
(II)


128
COO-n-butyl
S
(II)


132
COOCH2CH2CH2CH2F
S
(II)


134
COOCH2CF2CF2CF3
S
(II)


135
COOCH2CH═CMe2
S
(II)


139
COO—CH2-cyclopropyl
S
(II)


140
COOCH2-2-oxiranyl
S
(II)


141
COO-cyclobutyl
S
(II)


144
COOCH2-3-tetrahydrofuranyl
S
(II)


145
COOCH2-(2,2-dimethyl-1,3-
S
(II)



dioxolan-4-yl)




155
COCH2-3-thienyl
S
(II)


167
COO-iso-propyl
S
(III)


171
COOCH2C≡CH
S
(II)


198
CO-4-t-butylphenyl
S
(III)


211
COO-n-pentyl
S
(II)


213
CO-2,2-difluorocyclopropyl
S
(II)


216
COCH2CH2CF3
S
(II)


226
COO-n-hexyl
S
(II)


227
COOCH2t-Bu
S
(II)


228
COO—CH2-Crownether(18-C-6)
S
(II)


230
COCH2OCOMe
S
(II)


233
COCH2ONHCOOEt
S
(II)


240
COCF3
S
(II)


241
COCF3
S
(III)


244
COO-3-methoxyphenyl
S
(II)


251
COOCH2CH2CH2NO2
S
(II)


255
COOCH2CH2morpholinyl
S
(II)


267
CO-3-methylphenyl
S
(II)


268
CO-2-fluorophenyl
S
(II)


292
CO-2-fluorophenyl
S
(III)


299
CO-phenyl
S
4,5-dichloro-





3-pyridyl


302
CO-phenyl
S
4-bromo-





3-pyridyl


303
COOCH2CH2C≡CH
S
(II)


308
COCH2CH2C≡CH
S
(II)


309
COCH2CH2CH2C≡CH
S
(II)


313
COCH2CH2CH2CH2C≡CH
S
(III)


326
COCH2-(2-tetrahydrofuranyl)
S
(II)


328
COCH2CH2-(2-thienyl)
S
(II)


329
COOCH2CH2-(2-
S
(II)



tetrahydrofuranyl)




336
COCH2CH2-(2-
S
(II)



tetrahydrofuranyl)




337
COOCH2CH2CH2-(2-furanyl)
S
(II)


338
COOCH2CH2-
S
(II)



(3-tetrahydrofuranyl)




341
CO—CH2CH2-(3-furanyl)
S
(II)


343
COCH2CH2-(4-methoxyphenyl)
S
(II)


345
COCH2CH2-(3,5-
S
(II)



dimethoxyphenyl)




349
COOCH2CH2CH2-(3-furanyl)
S
(II)


351
COO—CH2CH2CH2-(3-
S
(II)



tetrahydrofuranyl)




352
COOCH2CH2-(2-thienyl)
S
(II)


354
COOCH2CH2-(3-thienyl)
S
(II)


355
COCH2CH2-
S
(II)



(benzo[d][1,3]dioxol-5-yl)




358
COCH2CH2-(3-methoxyphenyl)
S
(II)


359
COOCH2CH2-(2-furanyl)
S
(II)


366
COOCH2-(2-thienyl)
S
(II)


374
COCH2OCH2C≡CH
S
(II)


430
COCH2OCH2-(2-furanyl)
S
(II)


431
COCH2OCH2-(3-furanyl)
S
(II)









In another preferred mode, provided is the pest control agent, wherein the pest is an animal-parasitic pest.


In a particularly preferable mode, provided is the pest control agent, wherein the pest is an animal-parasitic tick or mite.


As a second aspect of the present invention, provided is a compound represented by the chemical formula (Ia):




embedded image


(where Ar′ represents a heterocyclic group which may have a substituent on a ring thereof, X′ represents a sulfur atom, and Y′ represents COR1′ or CO2R9′,


when Y is COR1′, R1′ represents a substituted phenyl(C2-C4)alkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkyl group, a substituted or unsubstituted heterocyclyl(C2-C3)alkyl group, a substituted or unsubstituted (C1-C4)alkoxymethyl group, a 3-membered to 7-membered heterocycloalkyl group or a substituted or unsubstituted heterocycle, and


when Y′ is CO2R9′, R9′ represents a substituted or unsubstituted phenyl(C2-C4)alkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkyl group, or a substituted or unsubstituted heterocyclyl(C2-C3)alkyl group).


In a preferred mode, provided is the compound represented by the chemical formula (Ia) (where Ar′ is represented by the following chemical formula (II) or (III), and X′ and Y′ have the same meaning as described above:




embedded image


In a third aspect of the present invention, provided is a method for controlling a pest by use of the above-described pest control agent.


Advantageous Effects of Invention

The present invention makes it possible to effectively control pests such as animal-parasitic pests.


DESCRIPTION OF EMBODIMENTS

A pest control agent provided by the present invention means a pest control agent used in fields other than the agricultural field. For example, the pest control agent provided by the present invention is a control agent against an animal-parasitic pest, a public health pest, a nuisance pest, a stored-grain pest, a stored-product pest, a house and household pest, or the like, preferably a control agent against an animal-parasitic pest, and more preferably an acaricide against an animal-parasitic tick or mite.


Ar in the chemical formula (I) represents a heterocycle which may have a substituent on a ring thereof. Specific examples of 5-membered or 6-membered heterocycles include pyridine, thiazole, tetrahydrofuran, furan, and the like. A 3-pyridyl group, a 5-thiazolyl group, and a 3-tetrahydrofuranyl group are particularly desirable.


Moreover, the substituent on the heterocycle is not particularly limited, and examples thereof include halogen atoms (any of fluorine, chlorine, bromine, and iodine), C1-C4 alkyl groups, C1-C4 halogenated alkyl groups, C1-C4 alkoxy groups, di(C1-C4 alkyl)amino groups, a nitro group, and the like.


X in the chemical formula (I) represents a sulfur atom, CH2, or NR, where R represents a hydrogen atom or an alkyl group. The alkyl group is a C1-C4 alkyl group, and may be any one of primary, secondary, and tertiary groups. Examples thereof include a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, and the like. X is preferably a sulfur atom.


The alkyl group of each of the C1-C18 alkyl group represented by R1 or R9 and the C1-C18 halogenated alkyl group represented by R1 or R9 may be any one of primary, secondary and tertiary groups, and examples thereof include a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a n-pentyl group, a n-hexyl group, a n-decanyl group, a n-heptadecanyl group, and the like. R1 is a preferably C1-C4, more preferably C1-C3 halogenated alkyl group. R9 is a preferably C1-C6, more preferably C3-C4 halogenated alkyl group.


The alkyl group of each of the C1-C5 alkyl group represented by R3, R4, or R5 and the C1-C5 halogenated alkyl group represented by R3, R4, or R5 may be any one of primary, secondary and tertiary groups, and examples thereof include a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, and the like. C1-C3 alkyl groups are preferable.


The alkenyl group of each of the C2-C18 alkenyl group represented by the R1 or R9 and the C2-C18 halogenated alkenyl group represented by the R1 or R9 may be any one of primary, secondary and tertiary groups, and examples thereof include a vinyl group, a 2-propenyl group, a 3-butenyl group, a 4-pentenyl group, a 5-hexenyl group, 9-decenyl group, 16-heptadecenyl group, and the like. R1 is preferably a C2-C6 alkenyl group, and more preferably a C4-C6 alkenyl group. R9 is preferably a C3-C6 alkenyl group, and more preferably a C5-C6 alkenyl group.


The alkenyl group of each of the C2-C5 alkenyl group represented by R3, R4, or R5 and the C2-C5 halogenated alkenyl group represented by R3, R4, or R5 may be any one of primary, secondary and tertiary groups, and examples thereof include a vinyl group, a 2-propenyl group, and a 3-butenyl group.


The alkynyl group of each of the C2-C18 alkynyl group represented by the R1 or R9 and the C2-C18 halogenated alkynyl group represented by the R1 or R9 may be any one of primary, secondary and tertiary groups, and examples thereof include a 1-propynyl group, a 2-propynyl group, a 3-butynyl group, a 4-pentynyl group, a 5-hexynyl group, a 9-decynyl group, a 16-hepta decynyl group, and the like. R1 is preferably a C3-C6 alkynyl group, and more preferably a C4-C6 alkynyl group. R9 is preferably a C3-C6 alkynyl group, and more preferably a C3 or C4 alkynyl group.


The alkynyl group of each of the C2-C5 alkynyl group represented by R3 or R4 and the C2-C5 halogenated alkynyl group represented by R3 or R4 may be any one of primary, secondary and tertiary groups, and examples thereof include a 1-propynyl group, a 2-propynyl group, a 3-butynyl group, a 4-pentynyl group, and the like.


The C1-C3 alkoxy group represented by R3 or R4 may be any one of primary and secondary groups, and examples thereof include a methoxy group, an ethoxy group, and the like. C1-C2 alkoxy groups are preferable.


The substituted or unsubstituted C6-C10 aryl group represented by R1, R3, R4, R5, or R9 specifically represents a phenyl group, or a naphthyl group. Examples of substituents which may be introduced include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group, and the like. The substituents which are introduced in adjacent carbons together may form —O—(CH2)n-O—, wherein n is 1 or 2.


The (C6-C10)aryl of the substituted or unsubstituted (C6-C10)aryl(C1-C8)alkyl group represented by R1, R3, R4, R5, or R9 specifically represents a phenyl group or a naphthyl group, and the (C1-C8)alkyl group of the substituted or unsubstituted (C6-C10)aryl(C1-C8)alkyl group may be linear, branched, or cyclic. Examples of substituents which may be introduced include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group, and the like. The substituents which are introduced in adjacent carbons together may form —O—(CH2)n-O—, wherein n is 1 or 2. Examples of the substituted or unsubstituted (C6-C10)aryl(C1-C8)alkyl group include a benzyl group, a 1-phenylethyl group, a 2-phenylethyl group, a 1-phenyl-2-methylpropyl group, a phenylcyclopropyl group, a 3-phenylcyclobutyl group, a 1-phenyl-1-methylethyl group, a 2-(3-methoxyphenyl)ethyl group, and the like. R1 is preferably a substituted or unsubstituted phenyl(C1-C4)alkyl group, and more preferably a substituted phenyl(C2-C4)alkyl group. Specific examples of R1 include a benzyl group, a 1-phenylethyl group, a 2-phenylethyl group, a 1-phenyl-1-methylethyl group, a 1-phenylcyclopropyl group, a 2-(2-methoxyphenyl)ethyl group, a 2-(3-methoxyphenyl)ethyl group, a 2-(4-methoxyphenyl)ethyl group, a 2-(3,5-dimethoxyphenyl)ethyl group, a 2-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)ethyl group, a 2-(benzo[d][1,3]dioxole-5-yl)ethyl group, a 2-(2-methoxyphenyl)propyl group, and the like. R1 is more preferably a 2-(2-methoxyphenyl)ethyl group, a 2-(3-methoxyphenyl)ethyl group, a 2-(4-methoxyphenyl)ethyl group, a 2-(3,5-dimethoxyphenyl)ethyl group, a 2-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)ethyl group, a 2-(benzo[d][1,3] dioxole-5-yl)ethyl group or the like. R9 is preferably a substituted or unsubstituted phenyl(C1-C4)alkyl group, and examples thereof include a 3-methoxybenzyl group and a 2-(3-methoxyphenyl)ethyl group or the like.


The (C6-C10)aryl of the substituted or unsubstituted (C6-C10)aryl(C2-C8)alkenyl group represented by R1, R3, R4, or R9 specifically represents a phenyl group or a naphthyl group, and the (C2-C8)alkenyl group of the substituted or unsubstituted (C6-C10)aryl(C2-C8)alkenyl group may be linear, branched, or cyclic. Examples of substituents which may be introduced include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methyl sulfonyl group, a methoxy group, a nitro group, a cyano group, and the like. The substituents which are introduced in adjacent carbons together may form —O—(CH2)n-O—, wherein n is 1 or 2. Examples of the substituted or unsubstituted (C6-C10)aryl(C1-C5)alkenyl group include a 2-phenylethenyl group, a 3-phenyl-2-propenyl group, a phenyl cyclopropenyl group, a 4-phenyl-3-butenyl group, and the like. R1 is preferably a 2-phenylethenyl group. R9 is preferably a 3-phenyl-2-propenyl group.


The (C6-C10)aryl of the substituted or unsubstituted (C6-C10)aryl(C2-C8)alkynyl group represented by R1, R3, R4, or R9 specifically represents a phenyl group or a naphthyl group, and the (C2-C8)alkynyl group of the substituted or unsubstituted (C6-C10)aryl(C2-C8)alkynyl group may be linear, branched, or cyclic. Examples of substituents which may be introduced include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methyl sulfonyl group, a methoxy group, a nitro group, a cyano group, and the like. The substituents which are introduced in adjacent carbons together may form —O—(CH2)n-O—, wherein n is 1 or 2. Examples of the substituted or unsubstituted (C6-C10)aryl(C1-C5)alkynyl group include a 2-phenylethynyl group and the like.


The (C1-C4)alkoxy of the substituted or unsubstituted (C1-C4)alkoxy(C1-C5)alkyl group represented by R1, R3, R4, or R9 represents a (C1-C4)alkyloxy, alkenyloxy, or alkynyloxy which may be linear, branched, or cyclic. Examples of substituents which may be introduced include halogen atoms, C3-C6 cycloalkyl groups, a phenyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl group, a substituted or unsubstituted heterocycle, and the like. The phenyl group may be substituted with halogens, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, or a cyano group. The substituents which are introduced in adjacent carbons together may form —O—(CH2)n-O—, wherein n is 1 or 2. The heterocycloalkyl group may be substituted with halogens.


The heterocycle may be substituted with halogens. The (C1-C5)alkyl group of the substituted or unsubstituted (C1-C4)alkoxy(C1-C5)alkyl group may be linear, branched, or cyclic. Examples of the (C1-C4)alkoxy(C1-C5)alkyl group include a methyloxymethyl group, an ethyloxymethyl group, a methyloxyethyl group, an ethyloxyethyl group, an isopropyloxymethyl group, a t-butyloxymethyl group, and the like. The substituted or unsubstituted (C1-C4)alkoxy(C1-C5)alkyl group represented by R1 is preferably a substituted or unsubstituted (C1-C4)alkoxy(C1-C3)alkyl group, more preferably a substituted or unsubstituted (C1-C4)alkoxymethyl. Examples of the substituted or unsubstituted (C1-C4)alkoxy(C1-C5)alkyl group include a methoxymethyl group, a ethoxymethyl group, a ethynyloxymethyl group, a 2-propynyloxymethyl group, a (3,3,3,-trifluoropropyloxy)methyl group, a (4,4,4-trifluorobutyloxy)methyl group, a (2-furanylmethyloxy)methyl group, a (3-furanylmethyloxy)methyl group, a (2-tetrahydrofuranylmethyloxy)methyl group, a (3-tetrahydrofuranylmethyloxy)methyl group, a 2-(2-methoxyphenyl)ethyloxymethyl group, and a 2-(2-fluorophenyl)ethyloxymethyl group, and more preferably include a methoxymethyl group, a ethoxymethyl group, a propynyloxymethyl group, a (3,3,3,-trifluoropropyloxy)methyl group, a (4,4,4-trifluorobutyloxy)methyl group, a (2-furanylmethyloxy)methyl group, and a (3-furanylmethyloxy)methyl group. R9 is preferably a methoxy(C3-C4)alkyl group.


The (C1-C4)alkoxy of the substituted or unsubstituted (C1-C4)alkoxy(C2-C5)alkenyl group represented by R1, R3, R4, or R9 represents a (C1-C4)alkyloxy, alkenyloxy, or alkynyloxy group which may be linear, branched, or cyclic. Examples of substituents which may be introduced include halogen atoms, C3-C6 cycloalkyl groups, a phenyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl group, a substituted or unsubstituted heterocycle, and the like. The phenyl group may be substituted with halogens, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, or a cyano group. The substituents which are introduced in adjacent carbons together may form —O—(CH2)n-O—, wherein n is 1 or 2. The heterocycloalkyl group may be substituted with halogens. The heterocycle may be substituted with halogens. The (C2-C5)alkenyl group of the substituted or unsubstituted (C1-C4)alkoxy(C2-C5)alkenyl group may be linear, branched, or cyclic. Examples of the substituted or unsubstituted (C1-C4)alkoxy(C2-C5)alkenyl group include a 2-methoxyethenyl group, a 2-ethoxyethenyl group, a 3-methoxy-2-propenyl group, a 3-ethoxy-2-propenyl group, a (2-furanylmethyloxy)ethenyl group, a (3-furanylmethyloxy)ethenyl group, a (2-tetrahydrofuranylmethyloxy)ethenyl group, a (3-tetrahydrofuranylmethyloxy)ethenyl group and the like.


The (C1-C4)alkoxy of the substituted or unsubstituted (C1-C4)alkoxy(C2-C5)alkynyl group represented by R1, R3, R4, or R9 represents a (C1-C4)alkyloxy, alkenyloxy, or alkynyloxy group which may be linear, branched, or cyclic. Examples of substituents which may be introduced include halogen atoms, C3-C6 cycloalkyl groups, a phenyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl group, a substituted or unsubstituted heterocycle, and the like. The phenyl group may be substituted with halogens, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, or a cyano group. The substituents which are introduced in adjacent carbons together may form —O—(CH2)n-O—, wherein n is 1 or 2. The heterocycloalkyl group may be substituted with halogens. The heterocycle may be substituted with halogens. The (C2-C5)alkynyl group of the substituted or unsubstituted (C1-C4)alkoxy(C2-C5)alkynyl group may be linear, branched, or cyclic. Examples of the substituted or unsubstituted (C1-C4)alkoxy(C2-C5)alkynyl group include a 2-methoxyethynyl group, a 2-ethoxyethynyl group, a 3-methoxy-2-propynyl group, a 3-ethoxy-2-propynyl group, a (2-furanylmethyloxy)ethynyl group, a (3-furanylmethyloxy)ethynyl group, a (2-tetrahydrofuranylmethyloxy)ethynyl group, a (3-tetrahydrofuranylmethyloxy)ethynyl group and the like.


In the C1-C3 alkoxycarbonyl group represented by R1, the alkyl group of the alkoxy represents a C1-C3 alkyl group which may be linear, branched, or cyclic. Examples thereof include an ethyloxycarbonyl group and the like.


In the C1-C3 alkoxycarbonylmethyl group represented by R3 or R4, the alkyl group of the alkoxy represents a C1-C3 alkyl group which may be linear, branched, or cyclic. Examples thereof include a methoxycarbonylmethyl group, an ethoxycarbonylmethyl group, a n-propyloxycarbonylmethyl group, an isopropyloxycarbonylmethyl group, a cyclopropyloxycarbonylmethyl group, and the like.


The (C1-C3)alkylsulfonyl of the (C1-C3)alkylsulfonyl(C1-C3)alkyl group represented by R1 represents a (C1-C3)alkylsulfonyl, alkenylsulfonyl or alkynylsulfonyl which may be linear, branched, or cyclic, and the (C1-C3)alkyl group of the (C1-C3)alkylsulfonyl(C1-C3)alkyl group represents a (C1-C3)alkyl group which may be linear, branched, or cyclic. Examples thereof include a methylsulfonylethyl group, and the like.


The (C1-C4)alkylthio of the (C1-C4)alkylthio(C1-C5)alkyl group represented by R1, R3, R4, or R9 represents (C1-C4)alkylthio, alkenylthio, or alkynylthio which may be linear, branched, or cyclic, and the (C1-C5)alkyl group of the (C1-C4)alkylthio(C1-C5)alkyl group represents a (C1-C5)alkyl group which may be linear, branched, or cyclic. Examples thereof include a methylthiomethyl group, a methylthioethyl group, an ethylthiomethyl group, an isopropylthiomethyl group, a trifluoromethylthiomethyl group, and the like. A methylthiomethyl group and a methylthioethyl group are preferable.


The C3-C12 substituted or unsubstituted cycloalkyl group represented by R1, R3, R4, or R9 represents a C3-C12 alkyl group having one or more cycloalkyl groups, which may have alkenyl or alkynyl on the ring or in an alkyl moiety on the chain. Examples thereof include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cyclopropylmethyl group, a cyclohexylmethyl group, a cyclopentenyl group, and the like. The substituent is not particularly limited, and examples thereof include halogen atoms (any of chlorine, bromine, fluorine, and iodine) and C1-C3 alkyl groups. R1 is preferably a cyclopropyl group, a cyclopentyl group, or a cyclohexyl group, and more preferably a cyclohexyl group. R9 is preferably a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, or the like, and more preferably a cyclo butyl group.


The 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl group represented by R1, R3, R4, or R9 represents a heterocycloalkyl group containing one or two hetero atoms such as oxygen atoms, sulfur atoms, and nitrogen atoms. Examples thereof include an oxiranyl group, an azetidinyl group, a pyrrolidinyl group, a piperidinyl group, a piperazinyl group, a morpholinyl group, an oxetanyl group, a thietanyl group, a tetrahydrofuranyl group, a tetrahydropyranyl group, and the like. R1 is preferably a 2-oxiranyl group, a 3-azetidinyl group, a 1-morpholinyl group, or a tetrahydrofuranyl group, and more preferably a tetrahydrofuranyl group. R9 is preferably a 3-oxetanyl group, a 3-thietanyl group, or the like, and more preferably a 3-oxetanyl group or the like. Examples of substituents which may be introduced include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group, and the like.


The 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl of each of the 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C1-C8)alkyl group, the 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C8)alkenyl group, and the 3-membered to 7-membered substituted and unsubstituted heterocycloalkyl(C2-C8)alkynyl group represented by the R1 or R9 represents a heterocycloalkyl group containing one or two hetero atoms such as oxygen atoms, sulfur atoms, and nitrogen atoms. Examples thereof include an oxiranyl group, an azetidinyl group, a pyrrolidinyl group, a piperidinyl group, a piperazinyl group, a morpholinyl group, an oxetanyl group, a thietanyl group, a tetrahydrofuranyl group, a tetrahydropyranyl group, and the like. R1 is preferably a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C1-C3)alkyl group, or a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkenyl group, and more preferably a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkyl group or a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkenyl group. Specific examples thereof include a morpholinylmethyl group, a 2-(2-tetrahydrofuranyl)ethyl group, and a 3-tetrahydrofuranylmethyl group. R9 is preferably a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C1-C3)alkyl group, and more preferably a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkyl group. Specific examples thereof include a 2-oxiranylmethyl group, a 2-tetrahydrofuranylmethyl group, a 2-tetrahydropyranylmethyl group, a 3-(2-tetrahydrofuranyl)propyl group, a 2-(3-tetrahydrofuranyl)ethyl group, and the like. Examples of substituents which may be introduced include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group, and the like.


The (C1-C3)alkyl group of the cyano(C1-C3)alkyl group represented by R1 represents a (C1-C3)alkyl group which may be linear, branched, or cyclic. Examples of the cyano(C1-C3)alkyl group include a cyanomethyl group, and the like.


Examples of substituents which may be introduced in the phenoxy group of each of the substituted or unsubstituted phenoxy(C1-C8)alkyl group, the substituted or unsubstituted phenoxy(C2-C8)alkenyl group, and the substituted or unsubstituted phenoxy(C2-C8)alkynyl group represented by the R1 or R9 include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methyl sulfonyl group, a methoxy group, a nitro group, a cyano group, and the like. The (C1-C8)alkyl group of the substituted or unsubstituted phenoxy(C1-C8)alkyl group, the (C2-C8)alkenyl group of the substituted or unsubstituted phenoxy(C2-C8)alkenyl group, and the (C2-C8)alkynyl group of the substituted or unsubstituted phenoxy(C2-C8)alkynyl group may be linear, branched, or cyclic. Examples thereof include a phenoxymethyl group, a 1-phenoxyethyl group, a 2-phenoxyethyl group, a 2-phenoxyethenyl group, a 2-phenoxyethynyl group, a 1-phenoxy-1-methylethyl group, a 1-phenoxycyclopropyl group, a 2-(3-methoxyphenoxy)ethyl group, a 3-phenoxy-2-propenyl group, and the like. R1 is preferably a phenoxymethyl group.


The heterocyclyl of each of the substituted or unsubstituted heterocyclyl(C1-C8)alkyl group, the substituted or unsubstituted heterocyclyl(C2-C8)alkenyl group, and the substituted or unsubstituted heterocyclyl(C2-C8)alkynyl group represented by the R1 or R9 represents a 3- to 10-membered aromatic heterocyclyl group containing one or more hetero atoms such as oxygen atoms, sulfur atoms, and nitrogen atoms. Examples of the heterocyclyl include furanyl, thienyl, pyrazolyl, thiazolyl, imidazolyl, triazolyl, pyridyl, pyrimidinyl, quinolinyl, and the like. Examples of substituents which may be introduced in the heterocyclyl include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group, and the like. The (C1-C8)alkyl group of the substituted or unsubstituted heterocyclyl(C1-C8)alkyl group, the (C2-C8)alkenyl group of the substituted or unsubstituted heterocyclyl(C2-C8)alkenyl group, and the (C2-C8)alkynyl group of the substituted or unsubstituted heterocyclyl(C2-C8)alkynyl group may be linear, branched, or cyclic. Examples of the substituted or unsubstituted heterocyclyl(C1-C8)alkyl group, the substituted or unsubstituted heterocyclyl(C2-C8)alkenyl group, and the substituted or unsubstituted heterocyclyl(C2-C8)alkynyl group include a 2-furanylmethyl group, a 2-(2-furanyl)ethyl group, a 2-(3-furanyl)ethyl group, a 1-pyrazolylmethyl group, a 2-(1-pyrazolyl)ethyl group, a 1-imidazolylmethyl group, a 2-imidazolylethyl group, a 2-thienylmethyl group, a 1-triazolylmethyl group, and a 2-(4-thiazolyl)ethyl group. R1 is preferably a substituted or unsubstituted heterocyclyl(C1-C3)alkyl group or a substituted or unsubstituted heterocyclyl(C2-C3)alkenyl group, and more preferably a substituted or unsubstituted heterocyclyl(C2-C3)alkyl group. Specific examples thereof include a 2-furanylmethyl group, a 1-pyrazolylmethyl group, a 1-imidazolylmethyl group, a 2-thienylmethyl group, and a 1-triazolylmethyl group. R1 is more preferably a 1-pyrazolylmethyl group, a 2-furanylmethyl group, a 2-thienylmethyl group, a 2-(3-furanyl)ethyl group, or a 2-(2-furanyl)ethenyl group. R9 is preferably a substituted or unsubstituted heterocyclyl(C2-C3)alkyl group, and specifically a 2-furanyl group, a 3-pyridylmethyl group, a 4-pyridylmethyl group, a 3-(2-furanyl)propyl group, or a 3-(2-thienyl)propyl group.


The heterocyclyl of each of the substituted or unsubstituted heterocyclyloxy(C1-C8)alkyl group, the substituted or unsubstituted heterocyclyloxy(C2-C8)alkenyl group, and the substituted or unsubstituted heterocyclyloxy(C2-C8)alkynyl group represented by R1 or R9 represents a 3-10-membered aromatic heterocyclyl containing one or more hetero atoms such as oxygen atoms, sulfur atoms, and nitrogen atoms. Examples of the heterocyclyl include furanyl, thienyl, pyrazolyl, thiazolyl, imidazolyl, triazolyl, pyridyl, pyrimidinyl, quinolinyl, and the like. Examples of substituents which may be introduced in the heterocyclyl include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group, and the like. The (C1-C8)alkyl group of the substituted or unsubstituted heterocyclyloxy(C1-C8)alkyl group, the (C2-C8)alkenyl group of the substituted or unsubstituted heterocyclyloxy(C2-C8)alkenyl group, and the (C2-C8)alkynyl group of the substituted or unsubstituted heterocyclyloxy(C2-C8)alkynyl group may be linear, branched, or cyclic. Examples of the substituted or unsubstituted heterocyclyloxy(C1-C8)alkyl group, the substituted or unsubstituted heterocyclyloxy(C2-C8)alkenyl group, and the substituted or unsubstituted heterocyclyloxy(C2-C8)alkynyl group include a 2-furanyloxymethyl group, a 2-(2-furanyl)oxyethyl group, a 2-(3-furanyl)oxyethyl group, a 1-pyrazolyloxymethyl group, a 2-(1-pyrazolyl)oxyethyl group, a 1-imidazolyloxymethyl group, a 2-imidazolyloxyethyl group, a 2-thienyloxymethyl group, a 1-triazolyloxymethyl group, and a 2-(4-thiazolyl)oxyethyl group.


Examples of substituents which may be introduced in the pyridine ring of the substituted pyridylmethyl group represented by R3 or R4 include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group, and the like.


The substituted or unsubstituted heterocyclic ring represented by R1 represents a 5- to 10-membered heteroaromatic ring, and specific examples thereof include a quinoline ring, a benzofuran ring, an indole ring, an imidazoline ring, a pyridine ring, a pyrazine ring, a pyridazine ring, a pyrimidine ring, a thiophene ring, a thiazole ring, a tetrahydrofuran ring, a furan ring, and the like. The substituted or unsubstituted heterocyclic ring is preferably a 2,6-dichloro-3-pyridyl group, a 2,6-dichloro-4-pyridyl group, a 2-benzofuranyl group, a 2-imidazolyl group, a 2-pyridyl group, a 3-pyridyl group, a 4-pyridyl group, a 3-quinolinyl group, a 3-thienyl group, a 4-pyridazinyl group, a 5-pyrimidinyl group, or a 3-tetrahydrofuranyl group, and particularly preferably a 2-thienyl group or a 3-thienyl group.


The substituted or unsubstituted aromatic ring represented by R1 has the same meaning as C6-C10 aryl.


The (C1-C5)alkylcarbonylamino(C1-C3)alkyl group represented by R1 is a carbonylamino(C1-C3)alkyl group having a linear or branched (C1-C5)alkyl, and specific examples thereof include a methylcarbonylaminoethyl group and the like.


The (C1-C5)alkyloxycarbonylaminooxymethyl group represented by R1 is a carbonylaminooxymethyl group having a linear or branched (C1-C5)alkyloxy group, and specific examples thereof include an ethoxycarbonylaminooxymethyl group, and the like.


The (C1-C5)alkyloxycarbonylaminomethyl group represented by R1 is a carbonylaminomethyl group having a linear or branched (C1-C5)alkyloxy group, and specific examples thereof include a t-butyloxycarbonylaminomethyl group and the like.


The (C1-C5)alkylcarbonyloxymethyl group represented by R1 is a carbonyloxymethyl group having a linear or branched (C1-C5)alkyl group, and specific examples thereof include a methylcarbonyloxymethyl group and the like.


Examples of substituents which may be introduced on the benzene ring of the substituted or unsubstituted benzenesulfonyl group represented by R3 or R4 include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group, and the like.


The (C1-C5)alkylamino group represented by R3 or R4 is an amino group having a linear or branched (C1-C5)alkyl, and specific examples thereof include a methylamino group and the like.


Examples of substituents which may be introduced in the phenyl group of the substituted or unsubstituted phenylamino group represented by R3 or R4 include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group, and the like.


The (C1-C5)alkylcarbonylamino group represented by R3 or R4 is an amino group having a linear or branched (C1-C5)alkyl, and specific examples thereof include a methylcarbonylamino group and the like.


Examples of substituents which may be introduced on the benzene ring of the substituted or unsubstituted benzoylamino group represented by R3 or R4 include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group, and the like.


Examples of the ring formed by NR3R4 include an azetidine ring, a pyrrolidine ring, a piperidine ring, a morpholine ring, and the like.


Unless otherwise noted, the above-described alkyl groups, alkenyl groups, and alkynyl groups may be substituted with halogen atoms.


A preferred mode of the compound represented by the formula (I) is as follows.


Ar represents a heterocyclic group which may have a substituent on a ring thereof, X represents a sulfur atom, and Y represents COR1 or CO2R9.


When Y is COR1, R1 represents a C1-C4 halogenated alkyl group, a C2-C6 alkenyl group, a C3-C6 alkynyl group, a substituted or unsubstituted phenyl(C1-C4)alkyl group, a substituted or unsubstituted phenyl(C2-C3)alkenyl group, a substituted or unsubstituted (C1-C4)alkoxy(C1-C3)alkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C1-C3)alkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C1-C3)alkenyl group, a substituted or unsubstituted heterocyclyl(C1-C3)alkyl group, or a substituted or unsubstituted heterocyclyl(C2-C3)alkenyl group.


When Y is CO2R9, R9 represents a C1-C6 halogenated alkyl group, more preferably a C3-C4 halogenated alkyl group; a C3-C6 alkenyl group, more preferably a C5-C6 alkenyl group; a C3-C6 alkynyl group, more preferably a C3-C4 alkynyl group; a substituted or unsubstituted phenyl(C1-C4)alkyl group or a substituted or unsubstituted phenyl(C1-C4)alkenyl group, preferably a substituted or unsubstituted phenyl(C2-C4)alkyl group or a substituted or unsubstituted phenyl(C2-C4)alkenyl group; a methoxy(C3-C4)alkyl group; a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C1-C3)alkyl group, more preferably a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkyl group; or a substituted or unsubstituted heterocyclyl(C2-C3)alkyl group.


A more preferred mode of the compound represented by formula (I) is as follows.


Ar represents a heterocyclic group represented by the chemical formula (II) or (III), X represents a sulfur atom, and Y represents COR1 or CO2R9.


When Y is COR1, R1 represents a C1-C3 halogenated alkyl group, a C4-C6 alkenyl group, a C4-C6 alkynyl group, a substituted phenyl(C2-C4)alkyl group, a substituted or unsubstituted phenyl(C2-C3)alkenyl group, a substituted or unsubstituted (C1-C4)alkoxymethyl group, a 3-membered 5 to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkenyl group, a substituted or unsubstituted heterocyclyl(C2-C3)alkyl group, or a substituted or unsubstituted heterocyclyl(C2-C3)alkenyl group.


When Y of the compound represented by formula (I) is CO2R9, R9 represents a C3-C4 halogenated alkyl group, a C5-C6 alkenyl group, a C3-C4 alkynyl group, a substituted or unsubstituted phenyl(C2-C4)alkyl group, a substituted or unsubstituted phenyl(C2-C4)alkenyl group, a methoxy(C3-C4)alkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkyl group, or a substituted or unsubstituted heterocyclyl(C2-C3)alkyl group.


Tables 2 to 8 show specific examples of the compound of the present invention.












TABLE 2





Compound





No.
Y
X
Ar


















2
COCH2CF3
S
(II)


3
COCMe3
S
(II)


4
COCMe(CF3)2
S
(II)


5
COCCl3
S
(II)


6
CO-phenyl
S
(II)


7
CO-4-chlorophenyl
S
(II)


8
CO-4-methylphenyl
S
(II)


9
CO-cyclohexyl
S
(II)


10
CO-benzyl
S
(II)


11
CO-3-quinolinyl
S
(II)


12
CO-3-indolyl
S
(II)


13
CO-3-pyridyl
S
(II)


14
CO-2-pyrazinyl
S
(II)


15
CO-(6-chloro-3-pyridyl)
S
(II)


15
CO-6-Cl-3-Py
S
(II)


16
CO-(5-chloro-2-pyrazinyl)
S
(II)


17
CO-(2,6-dichloro-4-pyridyl)
S
(II)


18
CO-2-pyridazinyl
S
(II)


20
CO-(5-bromo-3-pyridyl)
S
(II)


21
CO-(4-trifluoromethyl-3-pyridyl)
S
(II)


22
CO-(5,6-dichloro-3-pyridyl)
S
(II)


23
CO-(2,6-dichloro-3-pyridyl)
S
(II)


24
CO-(2,3,4,5,6-pentafluorophenyl)
S
(II)


28
CONH2
S
(II)


29
CONHMe
S
(II)


32
CONHCOPh
S
(II)


34
CONHCHMe2
S
(II)


35
CO-4-morpholinyl
S
(II)


36
CONH-phenyl
S
(II)


37
CONH-cyclohexyl
S
(II)


42
COOMe
S
(II)


43
COOC3H7-n
S
(II)


44
COOC3H7-i
S
(II)


45
COOCH2CH2Cl
S
(II)


46
COOCH2CH2OMe
S
(II)


47
COOCH2-phenyl
S
(II)


48
COO-4-chlorophenyl
S
(II)


49
COO-2-chlorophenyl
S
(II)


51
COO-phenyl
S
(II)


51
COO-phenyl
S
(II)


52
COO-cyclohexyl
S
(II)


53
COO-3-naphtalene
S
(II)


57
COPh
S
(III)


58
CHO
S
(II)


59
CHO
CH2
(II)


61
CHO
S
(III)


62
CHO
CH2
(III)


63
CO-2-pyrazinyl
CH2
(II)


64
CO-(4-trifluoromethyl-3-pyridyl)
CH2
(II)


65
CO-2-pyrazinyl
NH
(II)


66
CO-4-trifluoromethyl-3-pyridyl
NH
(II)


67
COCH(CF3)2
S
(II)


70
CO-6-norborna-2-enyl
S
(II)


71
CO-(1-adamantyl)
S
(II)


72
COMe
S
(II)


73
COCH2Cl
S
(II)


74
COCHCl2
S
(II)


75
COCH2Br
S
(II)


76
COCHF2
S
(II)


77
COCClF2
S
(II)


78
COCH2OMe
S
(II)


79
COCH2CN
S
(II)


80
COCH2O-phenyl
S
(II)


81
COCH2CH2OMe
S
(II)


82
COCH2NCS
S
(II)


83
COCH═CH2
S
(II)



















TABLE 3





Compound





No.
Y
X
Ar


















84
COCCl═CCl2
S
(II)


85
COCH2CH═CHMe
S
(II)


88
COCO2CH2CH3
S
(II)


89
COCH2SMe
S
(II)


90
COCH2CH2SMe
S
(II)


93
CO-2-methylcyclopropyl
S
(II)


94
CO-1-methylcyclopropyl
S
(II)


96
CO-2-furanyl
S
(II)


100
COCH2-3-pyridyl
S
(II)


104
COCH2-1-imidazolyl
S
(II)


106
CONHOMe
S
(II)


107
CONHOEt
S
(II)


110
CONHCH2-2-pyridyl
S
(II)


111
COO-4-methoxyphenyl
S
(II)


111
CONHCH2CH2OMe
S
(II)


113
COOC2H5
S
(II)


113
COOEt
S
(II)


114
COOCH2CH2F
S
(II)


115
COOCH2CHF2
S
(II)


116
COOCH2CF3
S
(II)


117
COOCH2CCl3
S
(II)


119
COOCH2CH2SMe
S
(II)


120
COOCH2CH2SiMe3
S
(II)


121
COOCH2CH2OCH2CF3
S
(II)


122
COOCH2CH2CH2F
S
(II)


123
COOCH(CH2F)2
S
(II)


124
COOCH(Me)CF3
S
(II)


125
COOCH(CF3)2
S
(II)


126
COOCH2CH═CH
S
(II)


127
COOCH2CCl═CCl2
S
(II)


128
COO-n-butyl
S
(II)


129
COOCH2CHMe2
S
(II)


130
COOCH(Me)CH2CH3
S
(II)


131
COO-t-butyl
S
(II)


132
COOCH2CH2CH2CH2F
S
(II)


133
COOCH2CH2CH2CF3
S
(II)


134
COOCH2CF2CF2CF3
S
(II)


135
COOCH2CH═CMe2
S
(II)


139
COO—CH2-cyclopropyl
S
(II)


140
COOCH2-2-oxiranyl
S
(II)


141
COO-cyclobutyl
S
(II)


142
COO-3-oxetanyl
S
(II)


143
COO-cycopentyl
S
(II)


144
COOCH2-3-tetrahydrofuranyl
S
(II)


145
COOCH2-(2,2-dimethyl-1,3-
S
(II)



dioxolan-4-yl)


147
COOCH2-2-tetrahydropyranyl
S
(II)


148
COO-4-nitrophenyl
S
(II)


149
COO-2-methoxyphenyl
S
(II)


150
COOCH2-3-pyridyl
S
(II)


151
COOCH2-4-pyridyl
S
(II)


152
COOCH2-2-furanyl
S
(II)


153
COCH2-3-furanyl
S
(II)


154
COCH2-2-thienyl
S
(II)


155
COCH2-3-thienyl
S
(II)


156
COO-3-pyridyl
S
(II)


163
COO-phenyl
S
(III)


160
COO-iso-propyl
S
(III)


167
COOCHMe2
CH2
(II)


169
COOMe
NH
(II)


170
COOMe
N—Me
(II)


171
COOCH2C≡CH
S
(II)


173
COOCH2CH2CH═CH2
S
(II)


174
CO-(2,4,6-trimethylphenyl)
S
(II)


175
CO-4-biphenyl
S
(II)


176
COCH2tBu
S
(II)


177
CO-(4-t-butylphenyl)
S
(II)



















TABLE 4





Compound





No.
Y
X
Ar







178
CO-2-biphenyl
S
(II)


179
CO-2-naphthyl
S
(II)


180
CO-3-naphthyl
S
(II)


181
CO-(2-nitro-3-chlorophenyl)
S
(II)


182
CO-(2-iodophenyl)
S
(II)


183
CO-3-quinolinyl
S
(II)


184
COCH2OEt
S
(II)


185
CO-4-fluorophenyl
S
(II)


186
CO-cyclopentyl
S
(II)


187
CO-1-cyclopentenyl
S
(II)


188
CO-3-cyclopentenyl
S
(II)


189
CO(CH2)16CH3
S
(II)


190
CO—CH2-1-pyrazolyl
S
(II)


191
CO—CH2-(4-oxo-2-thioxothiazolidin-3-yl)
S
(II)


192
CO—CH2-rodanine
S
(II)


193
CO—CH2-(3-methyl-5-oxo-1,2,4-
S
(II)



oxadiazol-5(4H)-yl)


194
COO—CH2-1-cyclopentyl
S
(II)


195
COO—CH2-3-cyclopentyl
S
(II)


196
COCH(Br)—t-Bu
S
(II)


197
COCH2tBu
S
(III)


198
CO-4-t-butylphenyl
S
(III)


199
CO-3-iodophenyl
S
(II)


200
COO-4-trifluoromethylpheny
S
(II)


201
COCH2-cyclohexyl
S
(II)


202
CO-3,5-dimethylphenyl
S
(II)


203
CO-2,3-dimethylphenyl
S
(II)


204
COCH(Me)-phenyl
S
(II)


205
COCH(Me)-phenyl
S
(III)


206
COOCH2-2-tetrahydrofuranyl
S
(II)


207
COCH2CH2OEt
S
(II)


208
COOCH2-3-tetrahydrofuranyl
S
(III)


209
COO-3-thietanyl
S
(II)


210
COO-3-thietanyl
S
(III)


211
COO-n-pentyl
S
(II)


212
COOCH2CH2SOOMe
S
(II)


213
CO-2,2-difluorocyclopropyl
S
(II)


214
CONMeOMe
S
(II)


215
CONHOCH2CH═CH2
S
(II)


216
COCH2CH2CF3
S
(II)


217
COCH2CH2NHCOMe
S
(II)


218
COOCH2CH2OMe
S
(III)


219
COO-3-oxetanyl
S
(III)


220
COOCH2C≡CMe
S
(II)


221
COC≡CMe
S
(II)


222
COCH═CHCH3
S
(II)


223
COCH2CH═CH2
S
(II)


224
COO-(2,5-dioxopyrrolidin-1-yl)
S
(II)


225
CONHCH2COOEt
S
(II)


226
COO-n-hexyl
S
(II)


227
COOCH2t-Bu
S
(II)


228
COO-CH2-Crownether(18-C-6)
S
(II)


229
COCH2-2-furanyl
S
(II)


230
COCH2OCOMe
S
(II)


231
COCH2-4-morpholinyl
S
(II)


232
COCH2-1-(1,2,4-triazolyl)
S
(II)


233
COCH2ONHCOOEt
S
(II)


234
CO-(2-oxo-2H-pyran-5-yl)
S
(II)


235
COCH2-4-imidazolyl
S
(II)


236
COCH2-(2,4-dioxothiazolidin-3-yl)
S
(II)


237
COCH2-(2,5-dioxoimidazolidin-1-yl)
S
(II)


238
COOMe
CH2
(II)


239
COCF3
NH
(III)


240
COCF3
S
(II)


241
COCF3
S
(III)


242
CONHCH2-3-pyridyl
S
(II)


243
CONHCH2CH2SMe
S
(II)



















TABLE 5





Compound





No.
Y
X
Ar







244
COO-3-methoxyphenyl
S
(II)


245
COCH═CH-phenyl
S
(II)


246
COOCH2CH═CH-phenyl
S
(II)


247
CO-(2-acetoaminophenyl)
S
(II)


248
CO-(2-acetoamino-3-
S
(II)



methylphenyl)


249
CO-3-tetrahydrofuranyl
S
(II)


250
COCF3
NH
(II)


251
COOH2CH2CH2NO2
S
(II)


252
CO-4-idophenyl
S
(II)


253
CO—C(Me)2-O-(4-
S
(II)



chlorophenyl)


254
COOCH2CH2SiMe3
S
(II)


255
COOCH2CH2morpholinyl
S
(II)


256
CO-2-methoxyphenyl
S
(II)


257
CO-4-methoxyphenyl
S
(II)


258
CO-3-thienyl
S
(II)


259
CO-2-chlorophenyl
S
(II)


260
CO-2-thienyl
S
(II)


261
CO-4cyclohexylphenyl
S
(II)


262
CO-2-benzofuranyl
S
(II)


263
COC≡C-phenyl
S
(II)


264
CO-3-methoxyphenyl
S
(II)


265
CO-4-ethylphenyl
S
(II)


266
CO-4-cyanophenyl
S
(II)


267
CO-3-methylphenyl
S
(II)


268
CO-2-fluorophenyl
S
(II)


269
CO-3-cyanophenyl
S
(II)


270
CO-2-methylphenyl
S
(II)


271
CO-(2,3-dihydro-1H-indenyl)
S
(II)


272
CO-4-methylsulfonylphenyl
S
(II)


273
CO-3-chlorophenyl
S
(II)


274
COCH2CH(Me)2
S
(II)


275
CO-3-nitrophenyl
S
(II)


276
CO-4-nitrophenyl
S
(II)


277
COCH2OCH(Me)2
S
(II)


278
CO-[3-(1,2,3,4-tetra-
S
(II)



hydronaphthalenyl)]


279
CO—CH2O—t-Bu
S
(II)


280
CO-3-fluorophenyl
S
(II)


281
CO-1-phenylcyclopropyl
S
(II)


282
CO—C(Me)2-phenyl
S
(II)


283
CO(CH2CH2)-phenyl
S
(II)


284
CO-3-pyrimidinyl
S
(II)


285
COCH2NHCOO—t-Bu
S
(II)


286
CO-2-oxirane
S
(II)


287
CO-3-bromophenyl
S
(II)


288
CO-3-azetydine
S
(II)


289
CO-2-pyridyl
S
(II)


290
CO-4-pyridyl
S
(II)


291
CO-5-chloro-2-thienyl
S
(II)


292
CO-2-fluorophenyl
S
(III)


293
CO-phenyl
NH
(II)


294
CO-2-fluorophenyl
NH
(II)


295
CO-phenyl
S
4CF3-3pyr


296
CO-2-fluorophenyl
S
4CF3-3pyr


297
COO-phenyl
S
4CF3-3pyr


298
CO-2-trifluoromethylphenyl
S
(II)


299
CO-phenyl
S
4,5-dichloro-3pyr


300
CO-phenyl
S
4F-3pyr


301
CO-phenyl
S
4Cl5F3pyr


302
CO-phenyl
S
4Br-3pyr


303
COOCH2CH2C≡CH
S
(II)


304
COCH2CH2-2-methoxyphenyl
S
(II)


305
COCH2CH2-2-methoxyphenyl
S
(III)


306
COOCH2CH2CH2C≡CH
S
(II)


307
COOCH2CH2CH2CH2C≡CH
S
(II)


308
COCH2CH2C≡CH
S
(II)


309
COCH2CH2CH2C≡CH
S
(II)



















TABLE 6





Compound





No.
Y
X
Ar







310
COOCH2CH2CH2CH2CH═CH2
S
(II)


311
COOCH2CH2CH2CH2CH═CH2
S
(III)


312
COCH2CH2CH2CH2C≡CH
S
(II)


313
COCH2CH2CH2CH2C≡CH
S
(III)


314
COOCH2CH2CH2CH═CH2
S
(II)


315
COOCH2CH2CH2CH═CH2
S
(III)


316
COCH2CH2CH2CH2CH═CH2
S
(II)


317
COCH2CH2CH2CH2CH═CH2
S
(III)


318
COCH2CH2CH2CH═CH2
S
(II)


319
CCCH2CH2CH2CH═CH2
S
(III)


320
COCH2CH2CH═CH2
S
(II)


321
COCH2CH2CH═CH2
S
(III)


322
COOCHCH3CF3
S
(III)


323
COCH═CH-(3-thienyl)
S
(II)


324
COCH═CH-(4-(2-thienyl)-2-thienyl)
S
(II)


325
COOCH2CH═CH-(3-thienyl)
S
(II)


326
COCH2-(2-tetrahydrofuranyl)
S
(II)


327
COCH═CH-(2-furanyl)
S
(II)


328
COCH2CH2-(2-thienyl)
S
(II)


329
COOCH2CH2-(2-tetrahydrofuranyl)
S
(II)


330
COOCH2CH2CH2-(2-thienyl)
S
(II)


331
COCH═CH-(2-thienyl)
S
(II)


332
COCH2CH2-(2-furanyl)
S
(II)


333
COCH2CH2CF3
S
(II)


334
COCH2CH2CH2OCH3
S
(II)


335
COCH2-(3-tetrahydrofuranyl)
S
(II)


336
COCH2CH2-(2-tetrahydrofuranyl)
S
(II)


337
COOCH2CH2CH2-(2-furanyl)
S
(II)


338
COOCH2CH2-(3-tetrahydrofuranyl)
S
(II)


339
COCH═CH-(3-furanyl)
S
(II)


340
COO—CH2CH2CH2-(2-tetrahydrofuranyl)
S
(II)


341
CO—CH2CH2-(3-furanyl)
S
(II)


342
COOCH2CH2CH2CF3
S
(II)


343
COCH2CH2-(4-methoxyphenyl)
S
(II)


344
COOCH2CH2CH2OCH3
S
(II)


345
COCH2CH2-(3,5-dimethoxyphenyl)
S
(II)


346
COOCH2CH2CH2CH2OCH3
S
(II)


347
COOCH2-(3-methoxyphenyl)
S
(II)


348
COOCH2CH2-(3-methoxyphenyl)
S
(II)


349
COOCH2CH2CH2-(3-furanyl)
S
(II)


350
COCH2CH2-(3-tetrahydrofuranyl)
S
(II)


351
COO—CH2CH2CH2-(3-tetrahydrofuranyl)
S
(II)


352
COOCH2CH2-(2-thienyl)
S
(II)


353
COCH2CH2CH2-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)
S
(II)


354
COOCH2CH2-(3-thienyl)
S
(II)


355
COCH2CH2-(benzo[d][1,3]dioxol-5-yl)
S
(II)


356
COOCH2CH2CF3
S
(II)


357
COCH2CH2-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)
S
(II)


358
COCH2CH2-(3-methoxyphenyl)
S
(II)


359
COOCH2CH2-(2-furanyl)
S
(II)


360
COOCH2CH2-(3-furanyl)
S
(II)


361
COCH2Br
S
(II)


362
COCH2I
S
(II)


363
COCHF2
S
(II)


364
COCF2Cl
S
(II)


365
COCCl3
S
(II)


366
COOCH2-(2-thienyl)
S
(II)


367
COOCH2-(3-thienyl)
S
(II)


368
COCF3
NMe
(II)


369
COCF3
S
3-tetrahydrofuranyl


370
COCF3
NMe
(II)


371
CO-(6-Cl-3-pyridyl)
S
(II)


372
COCH═CHCF3
S
(II)


373
COOCH2CH2CN
S
(II)


374
COCH2OCH2C≡CH
S
(II)


375
COCH2CH═CH-(2-furanyl)
S
(II)



















TABLE 7





Compound





No.
Y
X
Ar







376
COCH2CH═CH-(2-thienyl)
S
(II)


377
COCH2CH═CH-(3-furanyl)
S
(II)


378
COCH2CH═CH-(3-thienyl)
S
(II)


379
COCH2CH2-(3-thienyl)
S
(II)


380
COCH2CH2CH═CH-(2-furanyl)
S
(II)


381
COCH2CH2CH═CH-(2-thienyl)
S
(II)


382
COCH2CH2CH═CH-(3-furanyl)
S
(II)


383
COCH2CH2CH═CH-(3-thienyl)
S
(II)


384
COCH2CH2CH2-(2-furanyl)
S
(II)


385
COCH2CH2CH2-(2-methoxyphenyl)
S
(II)


386
COCH2CH2CH2-(2-
S
(II)



tetrahyrofuranyl)


387
COCH2CH2CH2-(2-thienyl)
S
(II)


388
COCH2CH2CH2-(3-furanyl)
S
(II)


389
COCH2CH2CH2-(3-methoxyphenyl)
S
(II)


390
COCH2CH2CH2-(3-
S
(II)



tetrahydrofuranyl)


391
COCH2CH2CH2-(3-thienyl)
S
(II)


392
COCH2CH2CH2CF3
S
(II)


393
COCH2CH2CH2CH2-(2-furanyl)
S
(II)


394
COCH2CH2CH2CH2-(2-
S
(II)



tetrahydrofuranyl)


395
COCH2CH2CH2CH2-(2-thienyl)
S
(II)


396
COCH2CH2CH2CH2-(3-furanyl)
S
(II)


397
COCH2CH2CH2CH2-(3-
S
(II)



tetrahydrofuranyl)


398
COCH2CH2CH2CH2-(3-thienyl)
S
(II)


399
COCH2CH2CH2CH2CF3
S
(II)


400
COCH2CH2CH2CH2CH2OMe
S
(II)


401
COCH2CH2CH2CH2OMe
S
(II)


402
COOCH2CH2CH═CH-(2-furanyl)
S
(II)


403
COOCH2CH2CH═CH-(2-thienyl)
S
(II)


404
COOCH2CH2CH═CH-(3-furanyl)
S
(II)


405
COOCH2CH2CH═CH-(3-thienyl)
S
(II)


406
COOCH2CH2CH2-(3-thienyl)
S
(II)


407
COOCH2CH2CH2CH═CH-(2-furanyl)
S
(II)


408
COOCH2CH2CH2CH═CH-(2-thienyl)
S
(II)


409
COCCH2CH2CH2CH═CH-(3-furanyl)
S
(II)


410
COOCH2CH2CH2CH═CH-(3-thienyl)
S
(II)


411
COOCH2CH2CH2CH2-(2-furanyl)
S
(II)


412
COOCH2CH2CH2CH2-(2-
S
(II)



tetrahydrofuranyl)


413
COOCH2CH2CH2CH2-(2-thienyl)
S
(II)


414
COOCH2CH2CH2CH2-(3-furanyl)
S
(II)


415
COOCH2CH2CH2CH2-(3-
S
(II)



tetrahydrofuranyl)


416
COOCH2CH2CH2CH2-(3-thienyl)
S
(II)


417
COOCH2CH2CH2CH2CF3
S
(II)


418
COOCH2CH2CH2CH2CH2-(2-furanyl)
S
(II)


419
COOCH2CH2CH2CH2CH2-
S
(II)



(2-tetrahydrofuranyl)


420
COOCH2CH2CH2CH2CH2-(2-thienyl)
S
(II)


421
COOCH2CH2CH2CH2CH2-(3-furanyl)
S
(II)


422
COOCH2CH2CH2CH2CH2-
S
(II)



(3-tetrahydrofuranyl)


423
COOCH2CH2CH2CH2CH2-(3-thienyl)
S
(II)


424
COOCH2CH2CH2CH2CH2CF3
S
(II)


425
COOCH2CH2CH2CH2CH2CH2OMe
S
(II)


426
COOCH2CH2CH2CH2CH2OMe
S
(II)


427
COCH2OCH2CH2CF3
S
(II)


428
COCH2OCH2CH2C≡CH
S
(II)


429
COCH2OCH2CH2CH2CF3
S
(II)


430
COCH2OCH2-(2-furanyl)
S
(II)


431
COCH2OCH2-(3-furanyl)
S
(II)


432
CO-(4-ethynylphenyl)
S
(II)


433
CO—CH2OCH2CH2CH═CH2
S
(II)


434
CO—CH2OCH2CH═CH2
S
(II)


435
COOCH2CH2CH2-(2-methoxyphenyl)
S
(II)


436
CO—CH2OCH2-
S
(II)



(2-tetrahydrofuranyl)


437
CO—CH2OCH2-
S
(II)



(3-tetrahydrofuranyl)


438
CO—CH2OCH2-(2-thienyl)
S
(II)


439
CO—CH2OCH2-(3-thienyl)
S
(II)


440
CO—CH2OCH2-phenyl
S
(II)


441
CO—CH2OCH2-(2-fluorophenyl)
S
(II)



















TABLE 8





Compound





No.
Y
X
Ar







442
CO—CH2OCH2-(3-fluorophenyl)
S
(II)


443
CO—CH2OCH2-(2-methoxyphenyl)
S
(II)


444
CO—CH2OCH2-(3-methoxyphenyl)
S
(II)


445
CO—CH2OCH2-(2-trifluoromethoxyphenyl)
S
(II)


445
CO—CH2CH2-(2-fluorophenyl)
S
(II)


447
CO—CH2CH2-(3-fluorophenyl)
S
(II)









Examples of substituents which may be introduced on the substituted phenyl(C2-C4)alkyl group represented by R1′ in the chemical formula (Ia) include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group and the like. The substituents which are introduced in adjacent carbons together may form —O—(CH2)n-O—, wherein n is 1 or 2. The substituents are preferably halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, or C1-C4 alkyloxy groups which may be substituted with halogens. The substituents which are introduced in adjacent carbons together may form —O—(CH2)n-O—, wherein n is 1 or 2. The substituents are more preferably a methoxy group. The substituents which are introduced in adjacent carbons together may form —O—(CH2)n-O—, wherein n is 1 or 2.


Examples of substituents which may be introduced on the 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkyl group represented by R1′ include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group and the like.


Examples of substituents which may be introduced on the substituted or unsubstituted heterocyclyl(C2-C3)alkyl group represented by R1′ include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group and the like.


Examples of substituents which may be introduced on the substituted or unsubstituted (C1-C4)alkoxymethyl group represented by R1′ include halogen atoms, C3-C6 cycloalkyl groups, a phenyl group, a 3-membered to 7-membered heterocycloalkyl group, a substituted or unsubstituted heterocycle, and the like, and preferably include halogen atoms, a 3-membered to 7-membered heterocycloalkyl group, a heterocycle, and the like. The phenyl group may be substituted with halogens, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, or a cyano group. The substituents which are introduced in adjacent carbons together may form —O—(CH2)n-O—, wherein n is 1 or 2. The heterocycloalkyl group and the heterocycle may be substituted with halogens.


Examples of substituents which may be introduced on the substituted or unsubstituted phenyl(C2-C4)alkyl group represented by R9′ include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group and the like, and preferably include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens and the like. The substituents which are introduced in adjacent carbons together may form —O—(CH2)n-O—, wherein n is 1 or 2.


Examples of substituents which may be introduced on the 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkyl group represented by R9′ include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group and the like.


Examples of substituents which may be introduced on the substituted or unsubstituted heterocyclyl(C2-C3)alkyl group represented by R9′ include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens, C3-C6 cycloalkyl groups, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group and the like.


A preferred mode of the compound represented by formula (Ia) is as follows.


Ar′ represents a heterocyclic group represented by the chemical formula (II) or (III), X′ represents a sulfur atom, and Y′ represents COR1′ or CO2R9′.


When Y′ is COR1′, R1′ represents a substituted phenyl(C2-C4)alkyl group, a 3-membered to 7-membered unsubstituted heterocycloalkyl(C2-C3)alkyl group, a unsubstituted heterocycloalkyl(C2-C3)alkyl group, or a substituted or unsubstituted (C1-C4)alkoxymethyl group.


When Y′ is CO2R9′, R9′ represents a substituted or unsubstituted phenyl(C2-C4)alkyl group, a 3-membered to 7-membered unsubstituted heterocycloalkyl(C2-C3)alkyl group, or a unsubstituted heterocyclyl(C2-C3)alkyl group.


A more preferred mode of the compound represented by formula (Ia) is as follows.


Ar′ represents a heterocyclic group represented by the chemical formula (II) or (III), X′ represents a sulfur atom, and Y′ represents COR1′ or CO2R9′.


When Y′ is COR1′, R1′ represents a phenylethyl group, a tetrahydrofuranyl(C2-C3)alkyl group, a furanyl(C2-C3)alkyl group, a thienyl(C2-C3)alkyl group, a furanylmethyloxymethyl group, or a halogenated (C1-C4)alkyloxymethyl group. The phenylethyl group is substituted with one or two methoxy group. The substituents which are introduced in adjacent carbons together may form —O—(CH2)n-O—, wherein n is 1 or 2.


When Y′ is CO2R9′, R9′ represents a substituted or unsubstituted phenyl(C2-C4)alkyl group, a 3-membered to 7-membered unsubstituted heterocycloalkyl(C2-C3)alkyl group, or a unsubstituted heterocyclyl(C2-C3)alkyl group. Examples of substituents which may be introduced include halogen atoms, C1-C4 alkyl groups which may be substituted with halogens, C1-C4 alkyloxy groups which may be substituted with halogens and the like. The substituents which are introduced in adjacent carbons together may form —O—(CH2)n-O—, wherein n is 1 or 2.


The compound represented by the chemical formula (I) and contained in the pest control agent of the present invention can be obtained by the method described in WO2010/001922 (Patent Document 3).


Examples of animal-parasitic pests against which the pest control agent of the present invention is used include ticks (for example, Amblyomma americanum, Amblyomma maculatum, Boophilus microplus, Dermacentor andersoni, Dermacentor occidentalis, Dermacentor variabilis, Haemaphysalis campanulata, Haemaphysalis flava, Haemaphysalis longicornis, Haemaphysalis megaspinosa, Ixodes nipponensis, Ixodes ovatus, Ixodes pacificus, Ixodes persulcatus, Ixodes ricinus, Ixodes scapularis, Ornithodoros moubata, and Rhipicephalus sanguineus); mites of the family Cheyletidae (for example, Cheyletiella blakei and Cheyletiella yasguri); mites of the family Demodicidae (for example, Demodex canis and Demodex cati); mites of the family Psoroptidae (for example, Psoroptes cummunis); mites of the family Sarcoptidae (for example, Chorioptes bovis and Otodectes cynotis); mites of the family Macronyssidae (for example, Ornithonyssus sylviarum); Dermanyssus gallinae, mites of the Family Analgidae (for example, Megninia cubitalis and Pterolichus obtusus); mites of the family Trombiculidae (for example, Helenicula miyagawai and Leptotrombidium akamushi), fleas (for example, Ctenocephalides fells and Pulex irritans); lice of the order Mallophaga (for example, Trichodectes canis and Menopon gallinae); lice of the order Anoplura (for example, Haematopinus suis, Linognathus setosus, Pediculus humanus corporis, Pediculus humanus humanus, and Phthirus pubis), flies (for example, Hypoderma bovis and Stomoxys calcitrans), horse-flies, trematodes, acanthocephalans, cestodes, nematodes, protozoa, sporozoa, and the like. Preferred examples include animal-parasitic fleas, mites, and ticks, and more preferred examples include animal-parasitic mites and ticks. Examples of public health pests, nuisance pests, stored-grain pests, stored-product pests, and house and household pests against which the pest control agent of the present invention is used include mosquitoes (for example, Aedes albopictus and Culex pipiens pallens), cockroaches (Periplaneta fuliginosa, Periplaneta japonica, and Blattella germanica), mites of the family Acaridae (for example, Tyrophagus putrescentiae), flies (for example, Musca domestica, flesh flies (flies of the family Sarcophagidae), moth flies, flies of the family Drosophilidae, flies of the family Chironomidae), insects of the family Simuliidae, insects of the family Ceratopogonidae, insects of the order Hymenoptera (for example, ants such as Camponotus japonicus, and Solenopsis spp. and wasps such as Vespa mandarina), arthropods of the order Isopoda (for example, Porcellio scaber, Ligia exotica, and Armadillidium vulgare), insects of the order Hemiptera (for example, Cimex lectularius), arthropods of the subphylum Myriapoda (for example, centipedes, house centipedes, and millipedes), arthropods of the order Araneae (for example, Heteropoda venatoria), insects of the order Coleoptera (for example, ground beetles), arthropods of the order Collembola (for example, Onychiurus folsomi), insects of the order Dermaptera (for example, Labidura riparia), insects of the order Orthoptera (for example, insects of the family Rhaphidophoridae), insects of the order Coleoptera (for example, Callosobruchus chinensis, Sitophilus zeamais, Tenebroides mauritanicus, Tribolium castaneum, insects of the family Ptinidae, insects of the family Anobiidae, insects of the family Scolytidae, insects of the family Dermestidae, and Chlorophorus diadema), insects of the order Lepidoptera (for example, insects of the family Pyralidae, and clothes moths), insects of the family Cucujidae, insects of the order Isoptera (for example, Coptotermes formosanus, Incisitermes minor, and Odontotermes formosanus), insects of the order Thysanura (for example, Ctenolepisma villosa), and the like.


For preparation of the pest control agent of the present invention, existing agents can also be blended in addition to the compound represented by the chemical formula (I).


For preparation of the pest control agent of the present invention, a carrier selected depending on how the pest control agent is used can be used in addition to the compound represented by the chemical formula (I).


Examples of usable carriers include liquid carriers, solid carriers, gas carriers, surfactants, dispersing agents, other auxiliary agents for formulation use, and the like.


Examples of the solid carriers include fine powders or particles of clays (kaolin clay, diatomite, bentonite, acid clay, and the like), synthetic hydrated silicon oxide, talc, ceramics, other inorganic minerals (selenite, quartz, sulfur, activated carbon, calcium carbonate, hydrated silica, and the like), and the like; starches; lactose; cellulose; synthetic polymers such as vinyl chloride-based polymers and polyurethane; foods; animal feeds (animal feed cakes, oil cakes; grain powders; coarse grain powders; and the like).


Examples of the liquid carriers include alcohols (methanol, ethanol, isopropanol, polyethylene glycol, propylene glycol, dipropylene glycol, tripropylene glycol, glycerin, and the like), ketones (acetone, methyl ethyl ketone, and the like), aromatic hydrocarbons (benzyl alcohol, benzene, toluene, xylene, ethylbenzene, methylnaphthalene, and the like), aliphatic hydrocarbons (paraffin, n-hexane, cyclohexane, kerosene, lamp oil, and the like), ethers (diethylene glycol monoethyl ether, diethylene glycol monomethyl ether, diisopropyl ether, diethyl ether, dioxane, tetrahydrofuran, and the like), esters (propylene carbonate, ethyl acetate, butyl acetate, benzyl benzoate, isopropyl myristate, fatty acid esters of propylene glycol, and the like), nitriles (acetonitrile, isobutyronitrile, and the like), amides (dimethylformamide, dimethylacetamide, N-methylpyrrolidone, and the like), halogenated hydrocarbons (dichloromethane, trichloroethane, carbon tetrachloride, and the like), animal or vegetable oils such as soybean oil and cottonseed oil, dimethyl sulfoxide, silicone oils, higher fatty acids, glycerol formal, water, and the like.


Examples of the gas carriers include LPG, air, nitrogen, carbon dioxide, dimethyl ether, and the like.


Examples of the surfactants and dispersing agents used for emulsifying, dispersing, spreading, or the like include alkyl sulfuric acid esters, alkyl(aryl)sulfonic acid salts, polyoxyalkylene alkyl(aryl)ethers, polyvalent alcohol esters, lignin sulfonic acid salts, and the like.


In addition, examples of the auxiliary agents used to improve the properties of the preparation include carboxymethyl cellulose, gum arabic, polyethylene glycol, calcium stearate, and the like.


The above-described carriers, surfactants, dispersing agents, and auxiliary agents are used alone or in combination on an as-needed basis.


The pest control agent of the present invention is provided in various forms such as a liquid, a wettable powder, an emulsion, pellets, water dispersible granules, liquefied drops (a spot-on agent, a pour-on agent), a spray, a foam formulation, an aerosol, tablets, granules, fine granules, a powder, capsules, chewables, an injection, suppositories, a cream, a shampoo, a rinse, a resinous formulation, a fumigant, a toxic bait, and the like.


When the pest control agent of the present invention is a control agent against an animal-parasitic pest, preferred forms are a liquid, an emulsion, liquefied drops (a spot-on agent, a pour-on agent), a spray, a foam formulation, an aerosol, tablets, granules, fine granules, a powder, capsules, chewables, an injection, a suppository, a cream, a shampoo, a rinse, a resinous formulation, a fumigant, a toxic bait, and the like, and particularly preferred forms are a liquid, and liquefied drops (a spot-on agent, a pour-on agent).


The liquid can be blended further with ordinary auxiliary agents for formulation use such as emulsifiers, dispersing agents, spreading agents, wetting agents, suspending agents, stabilizers, preservatives, and propellants. Moreover, ordinary film-forming agents can also be blended. Examples of the surfactants used for emulsifying, dispersing, spreading, or the like include soaps, polyoxyalkylene alkyl(aryl)ethers, polyoxyethylene alkylallyl ethers, polyoxyethylene fatty acid esters, higher alcohols, alkylarylsulfonic acid salts, and the like. Examples of the dispersing agents include casein, gelatin, polysaccharides, lignin derivatives, saccharides, synthetic water-soluble polymers, and the like. Examples of the spreading and wetting agents include glycerin, polyethylene glycol, and the like. Examples of the suspending agents include casein, gelatin, hydroxypropylcellulose, gum arabic, and the like. Examples of the stabilizers include phenol-based antioxidants (BHT, BHA, and the like), amine-based antioxidants (diphenylamine and the like), organic-sulfur-based antioxidants, and the like. Examples of the preservatives include methylparaben, ethylparaben, propylparaben, butylparaben, and the like. The above-described carriers, surfactants, dispersing agents, and the auxiliary agents are used alone or in combination on an as-needed basis. The liquid may further contain a flavor, a fragrance, a synergist, and the like. An appropriate amount of the active ingredient contained in the pest control agent of the present invention is generally 1 to 75% by weight, when the pest control agent is a liquid.


The liquefied drops (the spot-on agent, the pour-on agent) can be prepared as follows. Specifically, the active ingredient of the present invention is dissolved, suspended or emulsified in a liquid carrier applicable onto the skin. Then an absorption enhancer, a coloring agent, a preservative, and the like are added thereto, if needed. Here, examples of the liquid carrier applicable onto the skin include aliphatic hydrocarbons such as alcohols and paraffin, esters such as propylene glycol fatty acid esters, animal or vegetable oils, water, and the like.


The tablets, the granules, the fine granules, the powder, the capsules, and the chewables can be prepared as follows. Specifically, the active ingredient of the present invention is divided into small portions. Then each of the portions is mixed with an excipient such as starch or lactose, and, if needed, a disintegrator such as cellulose, a binder such as gum arabic or hydroxypropylcellulose, and a lubricant such as magnesium stearate or talc are added thereto. Then, the mixture is tableted, molded, pelletized, granulated, or capsulated depending on the formulation form. An appropriate amount of the active ingredient contained in the pest control agent of the present invention is generally 0.1 to 50% by weight.


The carrier used for preparation of the injection needs to be prepared as an aseptic solution. The solution may contain other substances, for example, salt enough to make the solution isotonic to the blood, glucose, or the like. Examples of usable carriers include esters such as glycerides, benzyl benzoate, isopropyl myristate, and derivatives of propylene glycol and fatty acids; and organic solvent such as N-methylpyrrolidone and glycerol formal. An appropriate amount of the active ingredient contained in the pest control agent of the present invention is generally 0.01 to 10% by weight, when the pest control agent is an injection.


Examples of the carrier used for preparation of the cream include non-volatile hydrocarbons (liquid paraffin and the like), fats obtained by hydrogenating lanolin, higher fatty acids, fatty acid esters, animal or vegetable oils, silicone oils, water, and the like. Moreover, emulsifiers, humectants, antioxidants, fragrances, borax, and ultraviolet absorbers are used alone or in combination, if needed. Examples of the emulsifiers include fatty acid sorbitan esters, polyoxyethylene alkyl ethers, fatty acid polyoxyethylene esters, and the like. An appropriate amount of the active ingredient contained in the pest control agent of the present invention is generally 0.5 to 70% by weight, when the pest control agent is a cream.


Examples of the carrier used for preparation of the resinous formulation include vinyl chloride-based polymers and polyurethane. If needed, a plasticizer such as a phthalic acid ester, an adipic acid ester, or stearic acid can be added to such a base material. The active ingredient is kneaded with the base material, and then the mixture is molded by injection molding, extrusion molding, press molding, or the like. Further, an animal ear tag or an insect repellent collar for an animal can be formed through additional appropriate processes such as molding and cutting.


Examples of the carrier used for the toxic bait include foods, animal feeds, attracting substances (grain powders such as wheat flour and maize powder; starches such as corn starch and potato starch; saccharides such as granulated sugar, maltose, and honey; food flavors such as glycerin, onion flavor, and milk flavor; animal powders such as pupa powders and fish powders; and various pheromones), and the like. An appropriate amount of the active ingredient contained in the pest control agent of the present invention is generally 0.0001 to 90% by weight, when the pest control agent is a toxic bait.


The pest control agent of the present invention enables the control of a pest, for example, by orally administering or injecting the pest control agent into the body of an animal to be treated; by administering the pest control agent to the entirety or part of the body surface of an animal to be treated; or by coating with the pest control agent a region where the pest is expected to enter, parasitize, or move about.


The pest control agent of the present invention may be used as it is, or in some cases can be used after diluted with water, a liquid carrier, a commercially available shampoo, rinse, feed, or bedding material for a stable, or the like.







EXAMPLES

Hereinafter, the present invention will be described specifically on the basis of Examples. However, the present invention is not limited to these Examples.


SYNTHESIS EXAMPLES
Synthesis Example 1
Compound No. 345



embedded image


Into 3 ml of anhydrous dichloromethane, 114 mg (0.50 mmol) of 3-(2-chloro-5-pyridinylmethyl)-2-iminothiazolidine synthesized in accordance with the method described in Journal of Medicinal Chemistry 42(12), 2227, (1999), 96 mg (0.50 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC-HCl), and 65 mg (0.53 mmol) of 4-dimethylaminopyridine (DMAP) were dissolved. To this solution, 105 mg (0.50 mmol) of 3-(3,5-dimethoxyphenyl)propionic acid was added, followed by stirring at room temperature over night. After completion of the reaction, the reaction liquid was diluted with dichloromethane, washed with 1% NaOH aq. and with 1% HCl aq. in this order, and dried over anhydrous magnesium sulfate, followed by evaporation of the solvent. The residue was purified on preparative TLC plates (developed twice on two 0.5-mm plates with hexane:ethyl acetate=1:1). Thus, the target product was obtained. Yield: 134 mg (Percentage Yield: 63%).


Synthesis Example 2
Compound No. 309



embedded image


Into 3 ml of anhydrous dichloromethane, 15 mg (0.13 mmol) of 5-hexynoic acid was dissolved. To this solution, mg (0.13 mmol) of 3-(2-chloro-5-pyridinylmethyl)-2-iminothiazolidine, 29 mg (0.15 mmol) of EDC-HCl, and 20 mg (0.16 mmol) of DMAP were added in this order, followed by stirring at room temperature for one hour. After completion of the reaction, the reaction liquid was diluted with dichloromethane, washed with 1% NaOH aq. and 1% HCl aq. in this order, and dried over anhydrous magnesium sulfate, followed by evaporation of the solvent. The residue was purified on a preparative TLC plate (developed on one 0.5-mm plate with 100% Ethyl acetate). Thus, the target product was obtained. Yield: 16 mg (Percentage Yield: 40%).


Synthesis Example 3
Compound No. 340



embedded image


Into 10 ml of anhydrous dichloromethane, 104 mg (0.80 mmol) of 3-(tetrahydrofuran-2-yl)propan-1-ol was dissolved. To this solution, 132 μl (96 mg, 0.96 mmol) of triethylamine and 190 mg (0.80 mmol) of 4-nitrophenyl chloroformate were added in this order, followed by stirring at room temperature for one hour. After completion of the reaction, the reaction liquid was diluted with dichloromethane, washed with 1% HCl aq., and dried over anhydrous magnesium sulfate, followed by concentration under vacuum. The residue was purified by silica gel column chromatography (hexane:ethyl acetate=1:4). Thus, 54 mg of 4-nitrophenyl 3-(tetrahydrofuran-2-yl)propyl carbonate was obtained (Percentage Yield: 34%).


Separately, 28 mg (0.12 mmol) of 3-(2-chloro-5-pyridinylmethyl)-2-iminothiazolidine was dissolved into 7 ml of anhydrous acetonitrile. To this solution, 36 mg (0.12 mmol) of 4-nitrophenyl 3-(tetrahydrofuran-2-yl)propyl carbonate obtained by the above-described method and 20 mg (0.14 mmol) of potassium carbonate were added in this order, followed by stirring at 60° C. for six hours. After completion of the reaction, the insoluble materials were removed by vacuum filtration using Celite, and the filtrate was concentrated under vacuum. The residue was dissolved in ethyl acetate, washed with 1% NaOH aq. and with 1% HCl aq. in this order, and dried over anhydrous magnesium sulfate, followed by concentration under vacuum. The residue was purified on a preparative TLC plate (developed on one 0.5-mm plate with hexane:ethyl acetate=1:3). Thus, the target product was obtained. Yield: 16 mg (Percentage Yield: 35%).


Synthesis Example 4
Compound No. 346



embedded image


Into 1.0 ml of anhydrous dichloromethane, 92 mg (0.88 mmol) of 4-methoxybutan-1-ol was dissolved. To this solution, 122 μl (89 mg, 0.88 mmol) of triethylamine was added, followed by stirring at 0° C. for 30 minutes. To this mixture, 161 mg (0.80 mmol) of 4-nitrophenyl chloroformate dissolved in 2 ml of anhydrous dichloromethane was added, followed by stirring at room temperature for one day. After completion of the reaction, the reaction liquid was poured into 25 ml of water, and extracted with chloroform three times. The organic layers combined were washed twice with saturated aqueous sodium hydrogen carbonate, and once with saturated aqueous sodium chloride, and then dried over anhydrous sodium sulfate, followed by evaporation of the solvent. Thus, 188 mg of 4-methoxybutyl 4-nitrophenyl carbonate was obtained (Percentage Yield: 79%).


Into 7 ml of anhydrous acetonitrile, 148 mg (0.50 mmol) of the obtained 4-methoxybutyl 4-nitrophenyl carbonate was dissolved. To this solution, 114 mg (0.50 mmol) of 3-(2-chloro-5-pyridinylmethyl)-2-iminothiazolidine and 80 mg (0.58 mmol) of potassium carbonate were added in this order, followed by stirring at 50° C. for 14 hours and at room temperature for 90 hours. After completion of the reaction, the reaction liquid was poured into 30 ml of water, and extracted twice with ethyl acetate. The ethyl acetate layers combined were washed once with water, and once with saturated aqueous sodium chloride, and dried over anhydrous magnesium sulfate, followed by concentration under vacuum. Thus, 222 mg of a crude product was obtained. Of the crude product, 163 mg was purified on preparative TLC plates (developed on two 0.25-mm plates with hexane:ethyl acetate=1:1). Thus, 102 mg of the target product was obtained (Percentage Yield: 78%).


Synthesis Example 5
Compound No. 257



embedded image


Into 10 ml of anhydrous acetonitrile, 100 mg (0.44 mmol) of 3-(2-chloro-5-pyridinylmethyl)-2-iminothiazolidine was dissolved. To this solution, 87 μl (61 mg, 0.57 mmol) of triethylamine and 82 mg (0.48 mmol) of 4-methoxybenzyl chloride were added in this order, followed by stirring at room temperature overnight. After completion of the reaction, acetonitrile was evaporated under vacuum. Upon addition of methanol, crystals were precipitated. The crystals were collected by filtration, washed well with methanol, and dried. Thus, the target product was obtained. Yield: 112 mg, (Percentage Yield: 71%)


Synthesis Example 6
Compound No. 215



embedded image


Into 15 ml of acetonitrile, 486 mg (2.0 mmol) of 3-(2-chloro-5-pyridinylmethyl)-2-iminothiazolidine was dissolved, and 260 mg (2.5 mmol) of triethylamine was added thereto. To the mixture being cooled on ice, a solution obtained by dissolving 406 mg (2.0 mmol) of 4-nitrophenyl chloroformate in 5 ml of dichloromethane was added dropwise, followed by reflux by heating for 10 hours. After completion of the reaction, acetonitrile was removed under vacuum. To the residue, 1% HCl aq. and ethyl acetate were added, and the resultant crystals were collected by filtration. The filtrate was washed with 1% HCl aq., water, saturated aqueous sodium hydrogen carbonate, and water in this order, and then dried over anhydrous magnesium sulfate. Thereafter, ethyl acetate was evaporated. Crystals precipitated upon addition of ether were collected by filtration and combined with the aforementioned crystals. Thus, (Z)-4-nitrophenyl 3-((6-chloropyridin-3-ly)methyl)thiazolidin-2-ylidenec arbamate was obtained. Yield: 624 mg (Percentage Yield: 82%).


Into 20 ml of acetonitrile, 395 mg (1 mmol) of (Z)-4-nitrophenyl 3-((6-chloropyridin-3-yl)methyl)thiazolidin-2-ylidenec arbamate obtained by the above-described method and 164 mg (2.0 mmol) of sodium acetate were dissolved. To the solution being cooled on ice, a solution obtained by dissolving o-allylhydroxylamine hydrochloride dissolved into acetonitrile was added dropwise with stirring, followed by reflux by heating for 3 hours. After completion of the reaction, the solvent was evaporated under vacuum, and the residue was dissolved in ethyl acetate. The solution was washed with 1% HCl aq., water, saturated aqueous sodium hydrogen carbonate, and water, then dried over anhydrous magnesium sulfate, and concentrated under vacuum. As a result, crystals were precipitated. The crystals were collected by filtration. Yield: 203 mg (Percentage Yield: 65%).


Synthesis Example 7
Compound No. 230



embedded image


Into 20 ml of anhydrous acetonitrile, 400 mg (1.76 mmol) of 3-(2-chloro-5-pyridinylmethyl)-2-iminothiazolidine was dissolved, and 290 μl (211 mmol, 2.11 mg) of triethylamine was added thereto. To the mixture being cooled on ice, 152 μl (1.76 mmol, 354 mg) of bromoacetyl chloride was added, followed by stirring at room temperature overnight. After completion of the reaction, the reaction liquid was concentrated under vacuum, and the residue was dissolved in dichloromethane. The solution was washed with 1% NaOH aq. and with 1% HCl aq., then dried over anhydrous magnesium sulfate, and concentrated. Then, the residue was purified by silica gel column chromatography (hexane:ethyl acetate=2:3). Thus, (Z)-2-bromo-N-(3-((6-chloropyridin-3-yl)methyl)thiazol idin-2-ylidene)acetamide was obtained. Yield: 321 mg (Percentage Yield: 53%).


Into 2 ml of anhydrous acetonitrile, 66 mg (0.19 mmol) of the (Z)-2-bromo-N-(3-((6-chloropyridin-3-yl)methyl)thiazol idin-2-ylidene)acetamide obtained by the above-described method was dissolved. To this solution, 20 mg (0.22 mmol) of potassium acetate and 32 mg (0.10 mmol) of tetrabutylammonium bromide were added, followed by reflux by heating for 13 hours. After completion of the reaction, the solvent was evaporated under vacuum. As a result, crystals were precipitated. Chloroform was added to the crystals, and the insoluble substance was collected by filtration. Thus, the target product was obtained. Moreover, the filtrate was washed with water, then dried over anhydrous magnesium sulfate, and concentrated under vacuum. Crystals formed upon addition of hexane were collected by filtration and combined with the above-described crystals. Yield: 43 mg (Percentage Yield: 66%).


The compounds listed in Tables 2 to 8 were similarly synthesized. The results of synthesis and materials properties are shown in Tables 9 to 19.














TABLE 9










IR (KBr,


Compound
Chemical
Chemical
Synthesis

v, cm−1)


No.
Precursor 1
Precursor 2
Example
NMR (CDCl3, δ, ppm)
or MS




















4
HOOC—C(Me)(CF3)2
3-(2-chloro-5-
1, 2
1.70 (3H, m), 3.22 (2H, t), 3.67 (2H, t), 4.84 (2H,
1640, 1542




pyridinylmethyl)-2-

s), 7.35 (1H, d), 7.65 (1H, dd), 8.33 (1H, d




iminothiazolidine


7
(4-chlorophenyl)-COCl
3-(2-chloro-5-
5
3.20 (2H, t), 3.63 (2H, t), 4.97 (2H, s), 7.32 (1H,
m/z = 366




pyridinylmethyl)-2-

d), 7.38 (2H, d), 7.69 (1H, dd), 8.19 (2H, d), 8.39
(M + H)




iminothiazolidine

(1H, d)


8
HOOC-(4-methylphenyl)
3-(2-chloro-5-
1, 2
2.41 (3H, s), 3.18 (2H, t), 3.60 (2H, t), 4.97 (2H,
m/z = 346




pyridinylmethyl)-2-

s), 7.22 (2H, d), 7.31 (1H, d), 7.72 (1H, d), 8.15
(M + H)




iminothiazolidine

(2H, dd), 8.39 (1H, d)


15
HOOC-(6-chloro-3-pyridyl)
3-(2-chloro-5-
1, 2
3.23 (2H, t), 3.67 (2H, t), 4.96 (2H, s), 7.31 (1H,
1628 (C═O)




pyridinylmethyl)-2-

d), 7.39 (1H, d), 7.67 (1H, dd), 8.40 (2H, m), 9.22




iminothiazolidine

(1H, d)


18
(2-pyridazinyl)-COOH
3-(2-chloro-5-
1, 2
3.27 (2H, t), 3.71 (2H, t), 5.00 (2H, s), 7.35 (1H,
m/z = 334




pyridinylmethyl)-2-

d), 7.67 (1H, dd), 8.13 (1H, dd), 8.39 (1H, d),
(M + H)




iminothiazolidine

9.38 (1H, dd), 9.87 (1H, d)


20
(3-bromo-5-
3-(2-chloro-5-
5
3.24 (2H, t), 3.67 (2H, t), 4.98 (2H, s), 7.34 (1H,
1624 (C═O)



pyridyl)-COCl
pyridinylmethyl)-2-

d), 7.67 (1H, dd), 8.38 (1H, s), 8.59 (1H, s), 8.78




iminothiazolidine

(1H, s), 9.35 (1H, s)


46
ClCOOCH2CH2OMe
3-(2-chloro-5-
5
3.17 (2H, t), 3.43 (3H, s), 3.55 (2H, t), 3.68 (2H,
1657 (C═O)




pyridinylmethyl)-2-

t), 4.32 (2H, t), 4.84 (2H, s), 7.32 (1H, d), 7.66




iminothiazolidine

(1H, dd), 8.30 (1H, d)


53
HO-3-naphthalene
3-(2-chloro-5-
3, 4
3.23 (2H, t), 3.74 (2H, t), 4.80 (2H, s), 7.30 (1H,
1664, 1546




pyridinylmethyl)-2-

d), 7.35 (1H, m), 7.48 (2H, m), 7.61 (1H, m),




iminothiazolidine

7.69 (1H, m), 7.86 (3H, m), 8.37 (1H, s)


65
(2-pyrazinyl)-COCl
3-(2-chloro-5-
5
3.48 (2H, t), 3.78 (2H, t), 4.73 (2H, s), 7.32 (1H,
1628, 1606




pyridinylmethyl)-2-

d), 7.72 (1H, d), 8.38 (1H, s), 8.64 (1H, d), 8.70




iminothiazolidine

(1H, d), 8.91 (1H, s), 9.52 (1H, s)


73
ClCH2COCl
3-(2-chloro-5-
5
3.18 (2H, t), 7.62 (2H, t), 4.22 (2H, s), 4.82 (2H,
m/z = 304




pyridinylmethyl)-2-

s), 7.33 (1H, d), 7.69 (1H, dd), 8.35 (1H, d)
(M + H)




iminothiazolidine


75
BrCOCH2Br
3-(2-chloro-5-
5
3.18 (2H, t), 3.62 (2H, t), 4.02 (2H, s), 4.83 (2H,
1540, 1532




pyridinylmethyl)-2-

s), 7.35 (1H, d), 7.72 (1H, dd), 8.36 (1H, d)




iminothiazolidine


76
CHF2COOH
3-(2-chloro-5-
1, 2
3.23 (2H, t), 3.68 (2H, t), 4.87 (2H, s), 5.94 (1H,
1564, 1548




pyridinylmethyl)-2-

t), 7.34 (1H, d), 7.70 (1H, d), 8.36 (1H, s)




iminothiazolidine


78
MeOCH2COOH
3-(2-chloro-5-
1, 2
3.15 (2H, t), 3.48 (3H, s), 3.57 (2H, t), 4.17 (2H,
m/z = 300




pyridinylmethyl)-2-

s), 4.80 (2H, s), 7.32 (1H, d), 7.64 (1H, dd), 8.34
(M + H)




iminothiazolidine

(1H, d)


104
BrCOCH2Br,
3-(2-chloro-5-
7
3.17 (2H, t), 3.60 (2H, t), 4.68 (2H, s), 4.78 (2H,
1729, 1636,



imidazole
pyridinylmethyl)-2-

s), 6.98 (1H, s), 7.08 (1H, s), 7.32 (1H, d), 7.42
1536




iminothiazolidine

(1H, dd), 7.53 (1H, s), 8.26 (1H, d)


111
MeOCH2CH2NH2
3-(2-chloro-5-
6
3.09 (2H, t), 3.37 (2H, s), 3.47 (4H, m), 3.50
1607, 1578,




pyridinylmethyl)-2-

(2H, t), 4.71 (2H, s), 7.31 (1H, d), 7.62 (1H, dd),
1531




iminothiazolidine

8.31 (1H, d)


113
EtOCOCl
3-(2-chloro-5-
5
1.36 (3H, t), 3.18 (2H, t), 3.63 (2H, t), 4.24 (2H,
1664, 1552,




pyridinylmethyl)-2-

q), 4.86 (2H, s), 7.46 (1H, s)
1529




iminothiazolidine


117
CCl3CH2OCOCl
3-(2-chloro-5-
5
3.21 (2H, t), 3.63 (2H, t), 4.84 (2H, s), 4.85 (2H,
1668, 1536




pyridinylmethyl)-2-

s), 7.33 (1H, d), 7.67 (1H, dd), 8.33 (1H, d)




iminothiazolidine


124
HO—CH(Me)CF3
3-(2-chloro-5-
3, 4
1.45, 1.46 (3H, s), 3.19 (2H, t), 3.61 (2H, t),
1668, 1543




pyridinylmethyl)-2-

4.81 (1H, d), 4.85 (1H, d) 5.31 (1H, m), 7.33 (1H,




iminothiazolidine

d), 7.66 (1H, d), 8.32 (1H, d)


128
CH3(CH2)3COCl
3-(2-chloro-5-
5
0.96 (3H, t), 1.44 (2H, m), 1.72 (2H, m), 3.17
1661, 1550,




pyridinylmethyl)-2-

(2H, t), 3.37 (2H, t), 4.19 (2H, t), 4.86 (2H, s),
1528




iminothiazolidine

7.46 (1H, s)


129
HO—CH2CHMe2
3-(2-chloro-5-
3, 4
0.96 (6H, d), 2.04 (1H, m), 3.15 (2H, t), 3.56
1658, 1550




pyridinylmethyl)-2-

(2H, t), 3.95 (2H, d), 4.82 (2H, s), 7.32 (1H, d),




iminothiazolidine

7.66 (1H, dd), 8.32 (1H, d)


131
t-BuOH
3-(2-chloro-5-
3, 4
1.52 (9H, s), 3.12 (2H, t), 3.51 (2H, t), 4.81 (2H,
1653, 1560




pyridinylmethyl)-2-

s), 7.32 (1H, d), 7.63 (1H, dd), 8.31 (1H, d)




iminothiazolidine


134
HO—CH2CF2CF2CF3
3-(2-chloro-5-
3, 4
3.21 (2H, t), 3.64 (2H, t), 4.68 (2H, m), 4.82 (2H,
1681, 1552




pyridinylmethyl)-2-

s), 7.33 (1H, d), 7.67 (1H, d), 8.33 (1H, s)




iminothiazolidine


139
HO—CH2-cyclopropyl
3-(2-chloro-5-
3, 4
0.32 (2H, m), 0.58 (2H, m), 1.24 (1H, m), 3.16
1662, 1550




pyridinylmethyl)-2-

(2H, t), 3.56 (2H, t), 4.00 (2H, d), 4.81 (2H, s),




iminothiazolidine

7.32 (1H, d), 7.65 (1H, d), 8.32 (1H, s)





















TABLE 10










IR (KBr,


Compound
Chemical
Chemical
Synthesis

v, cm−1)


No.
Precursor 1
Precursor 2
Example
NMR (CDCl3, δ, ppm)
or MS







140
HO—CH2-2-oxiranyl
3-(2-chloro-5-
3, 4
2.68 (1H, dd), 2.84 (1H, dd), 3.18 (2H, t), 3.30
1666, 1550




pyridinylmethyl)-2-

(1H, m), 3.61 (2H, t), 4.11 (1H, dd), 4.37 (1H,




iminothiazolidine

dd), 4.81 (2H, s), 7.33 (1H, d), 7.77 (1H, dd),






8.32 (1H, d)


141
HO-cyclobutyl
3-(2-chloro-5-
3, 4
1.61 (1H, m), 1.80 (1H, m), 2.19 (2H, m), 2.39
1664, 1548




pyridinylmethyl)-2-

(2H, m), 3.15 (2H, t), 3.56 (2H, t), 4.82 (2H, s)




iminothiazolidine

5.02 (1H, m), 7.32 (1H, d), 7.64 (1H, dd), 8.32






(1H, d)


143
ClCOO-cycopentyl
3-(2-chloro-5-
5
1.51-1.97 (8H, m), 3.14 (2H, t), 3.54 (2H, t),
1650, 1546




pyridinylmethyl)-2-

4.81 (2H, s) 5.15 (1H, m), 7.32 (1H, d), 7.63




iminothiazolidine

(1H, dd), (8.32 (1H, d)


144
HO—CH2-3-
3-(2-chloro-5-
3, 4
1.65 (1H, m), 2.06 (1H, m), 2.69 (1H, m), 3.17
1665, 1550



tetrahydrofuranyl
pyridinylmethyl)-2-

(2H, t), 3.58 (2H, t), 3.61 (1H, m), 3.76 (1H, m),




iminothiazolidine

4.08 (1H, m), 4.17 (1H, m), 7.33 (1H, d), 7.64






(1H, dd), 8.32 (1H, d)


147
HO—CH2-2-
3-(2-chloro-5-
3, 4
1.30-1.92 (6H, m), 3.15 (2H, t), 3.44 (1H, td),
1661, 1543



tetrahydropyranyl
pyridinylmethyl)-2-

3.55 (2H, t), 3.60 (1H, m), 3.95 (1H, m), 4.23




iminothiazolidine

(2H, d), 4.82 (2H, s), 7.35 (1H, d), 7.66 (1H, dd),






8.30 (1H, d)


153
HOOC—CH2-3-fruanyl
3-(2-chloro-5-
3, 4
3.16 (2H, t), 3.57 (2H, t), 4.79 (2H, s), 5.07 (2H,
1657, 1557




pyridinylmethyl)-2-

s), 6.50 (1H, s), 7.30 (1H, d), 7.38 (1H, d), 7.52




iminothiazolidine

(1H, s), 7.63 (1H, dd), 8.30 (1H, d)


154
HOOC—CH2-2-thienyl
3-(2-chloro-5-
1, 2
3.11 (2H, t), 3.55 (2H, t), 3.98 (2H, s), 4.78 (2H,
m/z = 352




pyridinylmethyl)-2-

s) 6.93 (2H, m), 7.17 (1H, dd), 7.26 (1H, m),
(M + H)




iminothiazolidine

7.53 (1H, dd), 8.29 (1H, d)


155
HOOC—CH2-3-thienyl
3-(2-chloro-5-
1, 2
3.11 (2H, t), 3.54 (2H, t), 3.81 (2H, s), 4.75 (2H,
m/z = 352




pyridinylmethyl)-2-

s) 7.07 (1H, dd), 7.23 (1H, d), 7.25 (2H, m), 7.47
(M + H)




iminothiazolidine

(1H, dd), 8.27 (1H, d)


156
(3-pyridyl)-OH
3-(2-chloro-5-
3, 4
3.23 (2H, t), 3.67 (2H, t), 4.84 (2H, s), 7.30-
1682, 1548




pyridinylmethyl)-2-

7.37 (2H, m), 7.58 (1H, dd), 7.67 (1H, dd), 8.34




iminothiazolidine

(1H, d), 8.45 (1H, dd), 8.53 (1H, d)


160
CH(Me)2OCOCl
3-(2-chloro-5-
5
1.33 (6H, d), 3.16 (2H, t), 3.62 (2H, t), 4.87 (2H,
1667, 1550,




thiazolylmethyl)-2-

s) 5.03 (1H, sept), 7.45 (1H, s9
1530




iminothiazolidine


163
PhOCOCl
3-(2-chloro-5-
5
3.21 (2H, t), 3.69 (2H, t), 4.89 (2H, s), 7.19-




thiazolylmethyl)-2-

7.47 (6H, m)




iminothiazolidine


167
HO—CHMe2
3-(2-chloro-5-
3, 4
1.31 (6H, d), 2.04 (2H, m), 3.10 (2H, t), 3.32
1671, 1587




pyridinylmethyl)-2-

(2H, t), 4.69 (2H, s) 4.94 (1H, sept), 7.30 (1H,




iminopyrrolidine

d), 7.62 (1H, d), 8.30 (1H, d)


171
HO—CH2C≡CH
3-(2-chloro-5-
3, 4
2.47 (1H, t), 3.19 (2H, t), 3.61 (2H, t), 4.76 (2H,
1658, 1550




pyridinylmethyl)-2-

d), 4.81 (2H, s) 7.33 (1H, d), 7.67 (1H, dd), 8.31




iminothiazolidine

(1H, d)


174
(2,4,6-
3-(2-chloro-5-
5
2.27 (9H, s), 3.18 (2H, t), 3.59 (2H, t), 4.81 (2H,



trimethylphenyl)-COCl
pyridinylmethyl)-2-

s) 6.83 (2H, s), 7.28 (1H, d), 7.59 (1H, dd), 8.29




iminothiazolidine

(1H, d)


175
4-diphenyl-COCl
3-(2-chloro-5-
5
3.19 (2H, t), 3.63 (2H, t), 4.99 (2H, s), 7.30-
1620, 1526,




pyridinylmethyl)-2-

7.50 (4H, m), 7.65 (4H, m), 7.73 (1H, dd), 8.32
1407, 1279




iminothiazolidine

(2H, d), 8.40 (1H, d)


176
tBuCH2COCl
3-(2-chloro-5-
5
1.05 (9H, s), 2.40 (2H, s), 3.11 (2H, t), 3.52 (2H,
1625, 1518,




pyridinylmethyl)-2-

t), 4.80 (2H, s), 7.30 (1H, d), 7.64 (1H, dd), 8.34
1458, 1400




iminothiazolidine

(1H, d)


177
HOOC-(4-t-butylphenyl)
3-(2-chloro-5-
1, 2
1.34 (9H, s), 3.17 (2H, t), 3.61 (2H, t), 4.90 (2H,
1621, 1529,




pyridinylmethyl)-2-

s), 7.30 (1H, d), 7.45 (2H, d), 7.72 (1H, dd), 8.19
1404, 1286




iminothiazolidine

(2H, d), 8.40 (1H, d)


178
HOOC-2-diphenyl
3-(2-chloro-5-
1, 2
3.04 (2H, t), 3.38 (2H, t), 4.13 (2H, s), 7.17-
1621, 1528,




pyridinylmethyl)-2-

7.50 (10H, m), 7.95 (1H, d), 8.08 (1H, s)
1404




iminothiazolidine


179
HOOC-1-naphthyl
3-(2-chloro-5-
1, 2
3.25 (2H, t), 3.75 (2H, t), 4.93 (2H, s), 7.52 (4H,
1525, 1402,




pyridinylmethyl)-2-

m), 7.81 (1H, dd), 7.95 (1H, dd), 8.05 (1H, d),
1238




iminothiazolidine

8.27 (1H, d), 8.43 (1H, d), 8.89 (1H, m)


180
HOOC-2-naphthyl
3-(2-chloro-5-
1, 2
3.21 (2H, t), 3.64 (2H, t), 5.04 (2H, s), 7.33 (1H,
1615, 1526,




pyridinylmethyl)-2-

d), 7.51 (1H, dd), 7.5 (1H, dd), 7.76 (1H, dd), 7.87
1402




iminothiazolidine

(2H, d), 7.96 (1H, d), 8.30 (1H, dd), 8.44 (1H, d),






8.82 (1H, s)


181
(2-nitro-3-
3-(2-chloro-5-
1, 2
3.28 (2H, t), 3.74 (2H, t), 4.90 (2H, s), 7.45 (1H,
1623, 1545,



chlorophenyl)-COOH
pyridinylmethyl)-2-

d), 7.66 (1H, td), 7.77 (1H, d), 7.81 (1H, d), 8.17
1524, 1398




iminothiazolidine

(1H, d), 8.41 (1H, s)


182
(2-iodophenyl)-COOH
3-(2-chloro-5-
1, 2
3.15 (2H, t), 3.62 (2H, t), 4.90 (2H, s), 7.07 (1H,
1620, 1523,




pyridinylmethyl)-2-

dd), 7.32 (1H, d), 7.38 (1H, dd), 7.67 (1H, dd),
1404




iminothiazolidine

7.89 (1H, d), 7.95 (1H, d), 8.36 (1H, d)


183
(3-quinolinyl)-COOH
3-(2-chloro-5-
1, 2
3.26 (2H, t), 3.81 (2H, t), 5.08 (2H, s), 7.49 (1H,
1626, 1614,




pyridinylmethyl)-2-

d), 7.60 (1H, dd), 7.85 (1H, dd), 7.90 (1H, dd),
1588, 1523,




iminothiazolidine

8.23 (1H, s) 8.51 (1H, d), 9.04 (1H, d), 9.53 (1H, d)
1456, 1399





















TABLE 11










IR (KBr,


Compound
Chemical
Chemical
Synthesis

v, cm−1)


No.
Precursor 1
Precursor 2
Example
NMR (CDCl3, δ, ppm)
or MS







184
HOOC—CH2OEt
3-(2-chloro-5-
1, 2
1.27 (3H, t), 3.15 (2H, t), 3.56 (2H, t), 3.63 (2H,
1648, 1587




pyridinylmethyl)-2-

q), 4.21 (2H, s) 4.80 (2H, s), 7.32 (1H, d), 7.65




iminothiazolidine

(1H, dd), 8.34 (1H, d)


185
HOOC-4-fluorophenyl
3-(2-chloro-5-
1, 2
3.19 (2H, t), 3.62 (2H, t), 4.96 (2H, s), 7.07-
1622, 1523




pyridinylmethyl)-2-

7.27 (2H, m), 7.33 (1H, d), 7.70 (1H, dd), 8.28




iminothiazolidine

(2H, m), 8.40 (1H, d)


186
HOOC-cyclopentyl
3-(2-chloro-5-
1, 2
1.58 (2H, m), 1.71 (2H, m), 1.82-1.94 (4H, m),
1626, 1568




pyridinylmethyl)-2-

2.90 (1H, m), 3.12 (2H, t), 3.55 (2H, t), 4.84 (2H,




iminothiazolidine

s), 7.32 (1H, d), 7.66 (1H, dd), 8.36 (1H, d)


187
HOOC-1-cyclopentenyl
3-(2-chloro-5-
1, 2
1.97 (2H, t), 2.52 (2H, m), 2.64 (2H, m), 3.12
1633, 1600,




pyridinylmethyl)-2-

(2H, t), 3.53 (2H,), 4.84 (2H, s), 6.90 (1H, m),
1532




iminothiazolidine

7.31 (1H, d), 7.67 (1H, dd), 8.37 (1H, d)


188
HOOC-3-cyclopentenyl
3-(2-chloro-5-
1, 2
2.61-2.77 (4H, m), 3.12 (2H, t), 3.28 (1H, m),
1632, 1527




pyridinylmethyl)-2-

3.56 (2H, t), 4.81 (2H, s), 5.67 (2H, m), 7.31




iminothiazolidine

(1H, d), 7.66 (1H, dd), 8.35 (1H, d)


189
CH3(CH2)16COCl
3-(2-chloro-5-
5
0.87 (3H, t), 1.24 (28H, m), 1.66 (2H, m), 2.47
2918, 2849,




pyridinylmethyl)-2-

(2H, t), 3.10 (2H, t), 3.50 (2H, t), 4.30 (2H, s),
1529, 1399




iminothiazolidine

7.31 (1H, d), 7.65 (1H, dd), 8.33 (1H, d)


180
BrCOCH2Br, pyrazole
3-(2-chloro-5-
7
3.14 (2H, t), 3.57 (2H, t), 4.68 (2H, s), 5.03 (2H,
1647, 1534




pyridinylmethyl)-2-

s), 6.30 (1H, t), 7.30 (1H, d), 7.52 (3H, m), 8.25




iminothiazolidine

(1H, d)


191
BrCOCH2Br, rodanine
3-(2-chloro-5-
7
3.18 (2H, t), 3.62 (2H, t), 3.98 (2H, s), 4.35 (2H,




pyridinylmethyl)-2-

s), 4.82 (2H, s), 7.36 (1H, d), 7.68 (1H, dd), 8.33




iminothiazolidine

(1H, d)


192
BrCOCH2Br, rodanine
3-(2-chloro-5-
7
3.19 (2H, t), 3.63 (2H, t), 3.98 (2H, s), 4.35 (2H,
1728, 1706,




pyridinylmethyl)-2-

s) 4.82 (2H, s), 7.36 (1H, d), 7.69 (1H, dd), 8.33
1626, 1542




iminothiazolidine

(1H, d)


193
BrCOCH2Br, 3-methyl-1,2,4-
3-(2-chloro-5-
7
2.20 (3H, s) 3.21 (2H, t), 3.65 (2H, t), 4.39 (2H,
1772, 1641,



oxaziazolin-5-on
pyridinylmethyl)-2-

s), 4.76 (2H, s), 7.35 (1H, d), 7.59 (1H, dd), 8.29
1545



potassium salt
iminothiazolidine

(1H, d)


194
HO—CH2-1-cyclopentyl
3-(2-chloro-5-
3, 4
1.91 (2H, t), 2.34 (2H, m), 3.17 (2H, t), 3.58 (2H,
1546




pyridinylmethyl)-2-

t), 4.73 (2H, s), 4.82 (2H, s), 5.71 (1H, m), 7.32




iminothiazolidine

(1H, d), 7.6 (1H, dd), 8.32 (1H, d)


195
HO—CH2-3-cyclopentyl
3-(2-chloro-5-
3, 4
2.15 (2H, m), 2.53 (2H, m), 2.73 (1H, m), 3.16
1654, 1550




pyridinylmethyl)-2-

(2H, t), 3.57 (2H, t), 4.08 (2H, d), 4.85 (2H, s),




iminothiazolidine

5.65 (2H, m), 7.33 (1H, d), 7.65 (1H, dd), 8.32






(1H, d)


196
tBuCH(Br)COCl
3-(2-chloro-5-
5
1.20 (9H, s) 3.16 (2H, td), 3.61 (2H, t), 4.34
1627, 1526,




pyridinylmethyl)-2-

(1H, s), 4.70 (1H, d), 4.90 (1H, d), 7.32 (1H, d),
1408




iminothiazolidine

7.73 (1H, dd), 8.35 (1H, d)


197
tBuCH2COCl
3-(2-chloro-5-
5
1.08 (9H, s), 2.44 (2H, s), 3.12 (2H, t), 3.58 (2H,
1627, 1513,




thiazolylmethyl)-2-

t), 4.83 (2H, s), 7.47 (1H, s)
1399, 1231




iminothiazolidine


198
(4-t-butylphenyl)-COOH
3-(2-chloro-5-
1, 2
1.34 (9H, s), 3.18 (2H, t), 3.66 (2H, t), 4.99 (2H,
1618, 1520,




thiazolylmethyl)-2-

s), 7.47 (1H, s), 7.49 (2H, d), 8.24 (2H, d)
1408




iminothiazolidine


199
(3-iodophenyl)-COOH
3-(2-chloro-5-
1, 2
3.19 (2H, t), 3.63 (2H, t), 4.99 (2H, s), 7.17 (1H,
2360, 1618,




pyridinylmethyl)-2-

dd), 7.33 (1H, d), 7.68 (1H, dd), 7.82 (1H, d),
1527, 1417




iminothiazolidine

8.20 (1H, d), 8.39 (1H, s), 8.58 (1H, d)


201
cyclohexyl-CH2COCl
3-(2-chloro-5-
5
0.90-1.31 (4H, m), 1.60-1.76 (4H, m), 1.90 (1H,
2923, 1632,




pyridinylmethyl)-2-

m), 2.35 (2H, d), 3.12 (2H, t), 3.51 (2H, t), 4.80
1526, 1460,




iminothiazolidine

(2H, s), 7.30 (1H, d), 7.64 (1H, dd), 8.34 (1H, d)
1403


202
(3,5-dimethylphenyl)-COOH
3-(2-chloro-5-
1, 2
2.36 (6H, s) 3.15 (2H, t), 3.59 (2H, t), 4.96 (2H,
1526, 1430




pyridinylmethyl)-2-

s), 7.14 (1H, s), 7.30 (1H, d), 7.70 (1H, dd), 7.86




iminothiazolidine

(2H, s), 8.38 (1H, d)


203
(2,3-dimethylphenyl)-COOH
3-(2-chloro-5-
1, 2
2.32 (3H, s) 2.56 (3H, s), 3.17 (2H, t), 3.59 (2H,
1623, 1524,




pyridinylmethyl)-2-

t), 4.89 (2H, s), 7.11 (1H, dd), 7.23 (1H, d), 7.30
1457, 1457,




iminothiazolidine

(1H, d), 7.65 (1H, dd), 7.70 (1H, d), 8.35 (1H, d)
1401


204
phenyl-CH(Me)-COCl
3-(2-chloro-5-
5
1.56 (3H, d), 3.08 (2H, m), 3.49 (2H, m), 3.85
1634, 1530,




pyridinylmethyl)-2-

(1H, q), 4.51 (1H, d), 4.82 (1H, d), 7.09 (1H, d),
1457, 1401




iminothiazolidine

7.20-7.38 (6H, m), 8.20 (1H, d)


205
phenyl-CH(Me)-COCl
3-(2-chloro-5-
5
164 (3H, d), 3.08 (2H, m), 3.49 (2H, m), 3.85
1634, 1530,




thiazolylmethyl)-2-

(1H, q), 4.51 (1H, d), 4.82 (1H, d), 7.45 (1H, s)
1458, 1401




iminothiazolidine


206
HO—CH2-2-
3-(2-chloro-5-
3, 4
1.65 (1H, m), 1.85-2.05 (3H, m), 3..16 (2H, t),
1657, 1549



tetrahydrofranyl
pyridinylmethyl)-2-

3.57 (2H, t), 3.78 (1H, dd), 3.89 (1H, dd), 4.10-




iminothiazolidine

4.23 (3H, m), 4.80 (2H, s), 7.32 (1H, d), 7.66






(1H, dd), 8.30 (1H, d)





















TABLE 12










IR (kBr,


Compound
Chemical
Chemical
Synthesis

v, cm−1)


No.
Precursor 1
Precursor 2
Example
NMR (CDCl3, δ, ppm)
or MS







207
HOOC—CH2CH2OEt
3-(2-chloro-5-
1, 2
1.19 (3H, t), 2.78 (2H, t), 3.12 (2H, t), 3.53 (4H,





pyridinylmethyl)-2-

m), 3.78 (2H, t), 4.81 (2H, t), 7.31 (1H, d), 7.66





iminothiazolidine

(1H, dd), 8.33 (1H, d)



208
HO—CH2-3-
3-(2-chloro-5-
3, 4
1.71 (2H, m), 2.07 (1H, m), 2.71 (1H, m), 3.18
1661, 1549,



tetrahydrofranyl
thiazolylmethyl)-2-

(2H, t), 3.64 (2H, t), 3.78 (1H, m), 3.89 (2H, m),
1527




iminothiazolidine

4.10 (1H, dd), 4.20 (1H, dd), 4.86 (2H, s), 7.46







(1H, s)



209
HO-3-thietanyl
3-(2-chloro-5-
3, 4
3.17 (2H, t), 3.34 (2H, m), 3.59 (4H, m), 3.64





pyridinylmethyl)-2-

(1H, m), 7.33 (1H, d), 7.63 (1H, dd), 8.32 (1H, d)





iminothiazolidine





210
HO-3-thietanyl
3-(2-chloro-5-
3, 4
3.19 (2H, t), 3.36 (2H, t), 3.65 (4H, m), 4.86 (2H,





thiazolylmethyl)-2-

s), 5.64 (1H, m), 7.46 (1H, s)





iminothiazolidine





211
ClCOO-n-pentyl
3-(2-chloro-5-
5
0.90 (3H, t), 1.36 (4H, m), 1.73 (2H, m), 3.15
1660, 1561




pyridinylmethyl)-2-

(2H, t), 3.56 (2H, t), 4.16 (2H, t), 4.81 (2H, s),





iminothiazolidine

7.31 (1H, d), 7.65 (1H, dd), 8.31 (1H, d)



212
HO—CH2CH2SOOMe
3-(2-chloro-5-
3, 4
3.01 (3H, s), 3.20 (2H, t), 3.39 (2H, t), 3.61 (2H,





pyridinylmethyl)-2-

t), 4.56 (2H, t), 4.78 (2H, s), 7.32 (1H, d), 7.62





iminothiazolidine

(1H, dd), 8.31 (1H, d)



213
HOOC-2,2-
3-(2-chloro-5-
1, 2
1.68 (1H, m), 2.13 (1H, m), 2.64 (1H, m), 3.15




difluorocyclopropyl
pyridinylmethyl)-2-

(2H, t), 3.61 (2H, t), 4.74 (1H, d), 4.91 (1H, d),





iminothiazolidine

7.35 (1H, d), 7.76 (1H, dd), 8.34 (1H, d)



214
(CH3ONHCH3)•HCl
3-(2-chloro-5-
6
3.14 (2H, t), 3.29 (3H, s), 3.57 (2H, t), 3.73 (3H,





pyridinylmethyl)-2-

s), 4.77 (2H, s), 7.33 (1H, d), 7.66 (1H, dd), 8.33





iminothiazolidine

(1H, d)



215
(H2NOCH2CH═CH2)•HCl
3-(2-chloro-5-
6
3.14 (2H, t), 3.54 (2H, t), 4.43 (2H, d), 4.71 (2H,





pyridinylmethyl)-2-

s), 5.28 (1H, d), 5.34 (1H, d), 5.99 (1H, m), 7.31





iminothiazolidine

(1H, d), 7.61 (1H, dd), 8.30 (1H, d)



216
HOOC—CH2CH2CF3
3-(2-chloro-5-
1, 2
2.49 (2H, m), 2.72 (2H, m), 3.15 (2H, m), 3.62





pyridinylmethyl)-2-

(2H, m), 4.84 (2H, s), 7.32 (1H, d), 7.67 (1H, dd),





iminothiazolidine

8.33 (1H, d)



217
HOOC—CH2CH2NHCOCH3
3-(2-chloro-5-
1, 2
1.94 (3H, s), 2.71 (2H, t), 3.16 (2H, t), 3.54 (2H,





pyridinylmethyl)-2-

t), 3.56 (2H, t), 4.81 (2H, s), 6.30 (1H, br s),





iminothiazolidine

7.33 (1H, d), 7.63 (1H, dd), 8.33 (1H, d)



218
HO—CH2CH2OMe
3-(2-chloro-5-
3, 4
2.80 (2H, t), 3.13 (2H, t), 3.38 (3H, s), 3.62 (2H,





thiazolylmethyl)-2-

t), 3.77 (2H, t), 4.85 (2H, s), 7.46 (1H, s)





iminothiazolidine





219
HO-3-oxetanyl
3-(2-chloro-5-
3, 4
3.28 (2H, t), 3.76 (2H, t), 4.85 (2H, m), 4.90 (2H,





thiazolylmethyl)-2-

s), 5.04 (2H, m), 5.22 (1H, m), 7.54 (1H, s)





iminothiazolidine





220
HO—CH2C≡CMe
3-(2-chloro-5-
3, 4
1.85 (3H, t), 3.17 (2H, t), 3.58 (2H, t), 4.73 (2H,





pyridinylmethyl)-2-

t), 4.81 (2H, s), 7.31 (1H, d), 7.66 (1H, dd), 8.31





iminothiazolidine

(1H, d)



221
HOOC—C≡C—CH3
3-(2-chloro-5-
1, 2
2.00 (3H, s), 3.18 (2H, t), 3.61 (2H, t), 4.85 (2H,





pyridinylmethyl)-2-

s), 7.33 (1H, d), 7.68 (1H, dd), 3.34 (1H, d)





iminothiazolidine





222
HOOC—CH═OH—CH3
3-(2-chloro-5-
1, 2
1.89 (3H, d), 3.12 (2H, t), 3.56 (2H, t), 4.84 (2H,





pyridinylmethyl)-2-

s), 6.13 (1H, m), 7.06 (1H, m), 7.31 (1H, d), 7.66





iminothiazolidine

(1H, dd), 8.35 (1H, d)



223
HOOC—CH2CH═CH2
3-(2-chloro-5-
1, 2
1.89 (2H, dd), 3.12 (2H, t), 3.26 (1H, m), 3.56





pyridinylmethyl)-2-

(2H, t), 4.86 (2H, s), 6.08 (1H, m), 7.07 (1H, m),





iminothiazolidine

7.35 (1H, d), 7.71 (1H, dd), 8.36 (1H, d)



224
HO-1-pyrrolidinyl-2,5-dione
3-(2-chloro-5-
3, 4
2.76 (4H, s), 3.35 (2H, t), 3.82 (2H, t), 4.81 (2H,
1731, 1552




pyridinylmethyl)-2-

s), 7.52 (1H, d), 7.79 (1H, d), 8.39 (1H, d)





iminothiazolidine

DMSO-d6



225
EtOCOCH2NCO
3-(2-chloro-5-
another
1.23 (3H, t), 3.08 (2H, m), 3.57 (2H, m), 3.82
1742, 1610,




pyridinylmethyl)-2-
methods
(2H, s), 4.10 (2H, m), 4.74 (2H, s), 7.37 (1H, m),
1578, 1531




iminothiazolidine

7.77 (1H, m), 8.41 (1H, m)



226
HO—(CH2)5CH3
3-(2-chloro-5-
3, 4
0.89 (3H, t), 1.31 (6H, m), 1.40 (2H, m), 1.71
1724, 1657,




pyridinylmethyl)-2-

(2H, m), 3.15 (2H, t), 3.56 (2H, t), 4.16 (2H, t),
1552




iminothiazolidine

4.81 (2H, s), 7.31 (1H, d), 7.65 (1H, dd), 8.31







(1H, d)



227
HO—CH2tBu
3-(2-chloro-5-
3, 4
0.98 (9H, S), 3.15 (2H, t), 3.56 (2H, t), 3.90 (2H,
1661, 1548




pyridinylmethyl)-2-

s), 4.82 (2H, s), 7.32 (1H, d), 7.66 (1H, dd), 8.32





iminothiazolidine

(1H, d)



228
HO—CH2-
3-(2-chloro-5-
3, 4
3.16 (2H, t), 3.57 (2H, t), 3.70 (22H, m), 3.85
1663, 1550



Crownether(18-C-6)
pyridinylmethyl)-2-

(2H, m), 4.23 (2H, dd), 4.80 (2H, dd), 7.32 (1H,





iminothiazolidine

d), 7.65 (1H, dd), 8.31 (1H, d)



229
HOOC—CH2-2-furanyl
3-(2-chloro-5-
3, 4
3.12 (2H, t), 3.56 (2H, t), 3.83 (2H, s), 4.73 (2H,





pyridinylmethyl)-2-

s), 6.20 (1H, d), 6.33 (1H < d), 7.27 (1H, d), 7.34





iminothiazolidine

(1H, d), 7.55 (1H, dd), 8.28 (1H, d)





















TABLE 13










IR (kBr,


Compound
Chemical
Chemical
Synthesis

v, cm−1)


No.
Precursor 1
Precursor 2
Example
NMR (CDCl3, δ, ppm)
or MS







230
BrCOCH2Br,
3-(2-chloro-5-
7
2.17 (3H, s), 3.16 (2H, t), 3.57 (2H, t), 4.76 (2H,
1744, 1660,



CH3COOK
pyridinylmethyl)-2-

s), 4.79 (2H, s), 7.33 (1H, d), 7.63 (1H, dd), 8.33
1537, 1417




iminothiazolidine

(1H, d)



231
BrCOCH2Br,
3-(2-chloro-5-
7
2.62 (4H, m), 3.14 (2H, t), 3.37 (2H, s), 3.56
1730, 1646,



morpholine
pyridinylmethyl)-2-

(2H, t), 3.77 (4H, t), 4.80 (2H, s), 7.32 (1H, d),
1531, 1460,




iminothiazolidine

7.64 (1H, dd), 8.34 (1H, d)
1409


232
BrCOCH2Br,
3-(2-chloro-5-
7
3.18 (2H, t), 3.60 (2H, t), 4.68 (2H, s), 5.07 (2H,
1632, 1534



1,2,4-triazole
pyridinylmethyl)-2-

s), 7.32 (1H, d), 7.50 (1H, dd), 7.95 (1H, s), 8.21





iminothiazolidine

(1H, d), 8.27 (1H, d)



233
BrCOCH2Br,
3-(2-chloro-5-
7
1.28 (3H, t), 3.19 (2H, t), 3.60 (2H, t), 4.20 (2H,
1733, 1707,



HONHCOOEt
pyridinylmethyl)-2-

q), 4.56 (2H, s), 4.80 (2H, s), 7.33 (1H, d), 7.61
1647, 1596,




iminothiazolidine

(1H, dd), 8.32 (1H, d)
1534


234
HOOC-5-(2H-
3-(2-chloro-5-
1, 2
3.22 (2H, t), 3.64 (2H, t), 4.89 (2H, s), 6.32 (1H,
1730, 1638,



pyranyl-2-one)
pyridinylmethyl)-2-

d), 7.34 (1H, d), 7.61 (1H, d), 8.02 (1H, d), 8.36
1528




iminothiazolidine

(1H, s), 8.51 (1H, s)



235
BrCOCH2Br,
3-(2-chloro-5-
7
3.12 (2H, t), 3.56 (2H, t), 3.83 (2H, d), 4.77 (2H,
1621, 1530



imidazole•HCl
pyridinylmethyl)-2-

s), 6.92 (aH, d), 7.30 (1H, m), 7.57 (2H m), 8.29





iminothiazolidine

(1H, d)



236
BrCOCH2Br,
3-(2-chloro-5-
7
3.16 (2H, t), 3.59 (2H, t), 4.00 (2H, s), 4.47 (2H,
1748, 1683,



thiazolidinedione
pyridinylmethyl)-2-

s), 4.79 (2H, s), 7.36 (1H, d), 7.63 (1H, dd), 8.32
1644, 1537




iminothiazolidine

(1H, d)



237
BrCOCH2Br,
3-(2-chloro-5-
7
3.19 (2H, t), 3.68 (2H, t), 3.96 (2H, s), 4.11 (2H,
1713, 1529



imidazolidine-
pyridinylmethyl)-2-

s), 4.78 (2H, s), 7.52 (1H, d), 7.80 (1H, dd), 8.09




2,4-dione
iminothiazolidine

(1H, s), 8.40 (1H, d) DMSO-d6



242
H2N—CH2-(3-pyridyl)
3-(2-chloro-5-
6
3.11 (2H, t), 3.51 (2H, t), 4.52 (2H, d), 4.70 (2H,
1626, 1524




pyridinylmethyl)-2-

s), 7.19-7.31 (3H, m), 7.60 (1H, dd), 7.70 (1H,





iminothiazolidine

d), 8.31 (1H, d), 8.50 (1H, d), 8.56 (1H, s)



243
H2N—CH2CH2SMe
3-(2-chloro-5-
6
2.13 (3H, s), 2.69 (2H, t), 3.10 (2H, t), 3.49 (4H,
1605, 1577,




pyridinylmethyl)-2-

m), 4.76 (2H, s), 5.61 (br s), 7.30 (1H, d), 7.61
1521, 1507




iminothiazolidine

(1H, dd), 8.31 (1H, d)



245
HOOC—CH═CH-phenyl
3-(2-chloro-5-
1, 2
3.14 (2H, t), 3.58 (2H, t), 4.90 (2H, s), 6.73 (1H,
1637, 1593,




pyridinylmethyl)-2-

d), 7.35 (4H, m), 7.56 (2H, m), 7.70 (1H, dd),
1529




iminothiazolidine

7.79 (1H, d), 8.38 (1H, d)



246
HO—CH2CH═CH-phanyl
3-(2-chloro-5-
3, 4
3.17 (2H, t), 3.57 (2H, t), 4.81 (2H, s), 4.84 (2H,
1669, 1654,




pyridinylmethyl)-2-

d), 6.39 (1H, m), 6.78 (!H, d), 7.20-7.41 (6H, m),
1546




iminothiazolidine

7.66 (1H, dd), 8.31 (1H, d)



247
1H-benzo[d][1,3]oxazin-
3-(2-chloro-5-
another
2.26 (3H, s), 3.22 (2H, t), 3.65 (2H, t), 4.96 (2H,
1682, 1592,



4(2H)-one
pyridinylmethyl)-2-
methods
s), 7.05 (1H, m), 7.32 (1H, d), 7.49 (1H, td), 7.69
1517, 1460,




iminothiazolidine

(1H, dd), 8.38 (1H, d), 8.43 (1H, dd), 8.70 (1H, d)
1395


248
8-methyl-1H-
3-(2-chloro-5-
another
2.22 (3H, s), 2.34 (3H, s), 3.19 (2H, t), 3.62 (2H,
1532, 1460,



benzo[d][1,3]oxazin-
pyridinylmethyl)-2-
methods
t), 4.91 (2H, s), 7.13 (1H, m), 7.34 (2H, m), 7.68
1407



4(2H)-one
iminothiazolidine

(1H, dd), 8.08 (1H, d), 8.34 (1H, d)



249
HOOC-3-
3-(2-chloro-5-
1, 2
2.14 (1H, m), 2.28 (1H, m), 3.15 (2H, t), 3.25
1629, 1529,



tetrahydrofuranyl
pyridinylmethyl)-2-

(1H, m), 3.58 (2H, t), 3.80-4.05 (4H, m), 4.82
1411




iminothiazolidine

(2H, d × 2), 7.33 (1H, d), 7.64 (1H, dd), 8.34







(1H, d)



251
HO—CH2CH2CH2NO2
3-(2-chloro-5-
3, 4
2.42 (2H, m), 3.18 (2H, t), 3.59 (2H, t), 4.28 (2H,





pyridinylmethyl)-2-

t), 4.54 (2H, t), 4.80 (2H, s), 7.35 (1H, d), 7.65





iminothiazolidine

(1H, dd), 8.31 (1H, d)



252
(4-idophenyl)-COCl
3-(2-chloro-5-
5
3.18 (2H, t), 3.61 (2H, t), 4.94 (2H, s), 7.31 (1H,
1530, 1405,




pyridinylmethyl)-2-

d), 7.66 (1H, dd), 7.75 (2H, d), 7.96 (2H, d), 8.37
1278




iminothiazolidine

(1H, d)



253
(4-chlorophenyl)-
3-(2-chloro-5-
1, 2
1.57 (6H, s), 3.14 (2H, t), 3.55 (2H, t), 4.68 (2H,
1635, 1530,



O—C(Me)2—
pyridinylmethyl)-2-

s), 6.70 (2H, d), 7.08 (1H, d), 7.17 (3H, m), 8.21
1489, 1463,



COOH
iminothiazolidine

(1H, s)
1402


254
HO—CH2CH2SiMe3
3-(2-chloro-5-
3, 4
0.05 (9H, s), 1.09 (2H, t), 3.13 (2H, t), 3.54 (2H,
2951, 1665,




pyridinylmethyl)-2-

t), 4.24 (2H, t), 4.79 (2H, s), 7.30 (1H, d), 7.64
1541




iminothiazolidine

(1H, dd), 8.30 (1H, d)



255
HO—CH2CH2morpholinyl
3-(2-chloro-5-
3, 4
2.65 (4H, m), 2.78 (2H, t), 3.15 (2H, t), 3.56 (2H,
1705, 1550,




pyridinylmethyl)-2-

t), 3.74 (4H, m), 4.29 (2H, t), 4.78 (2H, s), 7.29
1459




iminothiazolidine

(1H, d), 7.62 (1H, dd), 8.31 (1H, d)



256
(2-methoxyphenyl)-COOH
3-(2-chloro-5-
1, 2
3.16 (2H, t), 3.58 (2H, t), 3.91 (3H, s), 4.91 (2H,
m/z = 362




pyridinylmethyl)-2-

s), 6.97 (2H, m), 7.31 (1H, d), 7.42 (1H, td), 7.72
(M + H)




iminothiazolidine

(1H, dd), 8.00 (1H, dd), 8.38 (1H, d)



257
(4-methoxyphenyl)-COCl
3-(2-chloro-5-
5
3.17 (2H, t), 3.60 (2H, t), 3.86 (3H, s), 4.96 (2H,
m/z = 362




pyridinylmethyl)-2-

s), 6.91 (2H, d), 7.31 (1H, d), 7.71 (1H, dd), 8.22
(M + H)




iminothiazolidine

(2H, d), 8.40 (1H, d)



258
HOOC-3-thienyl
3-(2-chloro-5-
1, 2
3.17 (2H, d), 3.60 (2H, t), 4.92 (2H, s), 7.27 (1H,
m/z = 338




pyridinylmethyl)-2-

m), 7.33 (1H, d), 7.64 (1H, d), 7.70 (1H, dd), 8.21
(M + H)




iminothiazolidine

(1H, d), 8.38 (1H, d)





















TABLE 14










IR (kBr,


Compound
Chemical
Chemical
Synthesis

v, cm−1)


No.
Precursor 1
Precursor 2
Example
NMR (CDCl3, δ, ppm)
or MS







259
(2-chlorophenyl)-COCl
3-(2-chloro-5-
5
3.21 (2H, t), 3.62 (2H, t), 4.91 (2H, s). 7.26-
m/z = 366




pyridinylmethyl)-2-

7.36 (3H, m), 7.42 (1H, d), 7.68 (1H, dd), 7.93
(M + H)




iminothiazolidine

(1H, dd), 8.36 (1H, d)



260
2-thienyl-COCl
3-(2-chloro-5-
5
3.18 (2H, t), 3.63 (2H, t), 4.90 (2H, s), 7.10 (1H,
m/z = 366




pyridinylmethyl)-2-

m), 7.31 (1H, d), 7.49 (1H, m), 7.76 (1H, dd),
(M + H)




iminothiazolidine

7.88 (1H, dd), 8.41 (1H, d)



261
HOOC-(4-cyclohexyl)Ph
3-(2-chloro-5-
1, 2
1.20-1.32 (1H, m), 1.36-1.48 (4H, m), 1.75 (1H,
m/z = 338




pyridinylmethyl)-2-

m), 1.83-1.89 (4H, m), 2.56 (1H, m), 3.17 (2H,
(M + H)




iminothiazolidine

t), 3.60 (2H, t), 4.97 (2H, s), 7.25 (2H, d), 7.31







(1H, d), 7.72 (1H, dd), 8.18 (2H, d), 8.39 (1H, d)



262
HOOC-2-benzofuranyl
3-(2-chloro-5-
1, 2
3.22 (2H, t), 3.65 (2H, t), 4.97 (2H, s), 7.27 (2H,
m/z = 414




pyridinylmethyl)-2-

d), 7.34 (1H, d), 7.41 (1H, td), 7.60 (1H, m), 7.66
(M + H)




iminothiazolidine

(1H, d), 7.77 (1H, dd), 8.34 (1H, d)



263
HOOC—C≡C—Ph
3-(2-chloro-5-
1, 2
3.18 (2H, t), 3.61 (2H, t), 4.90 (2H, s), 7.33-
m/z = 356




pyridinylmethyl)-2-

7.42 (4H, m), 7.60 (2H, m), 7.72 (1H, dd), 8.36
(M + H)




iminothiazolidine

(1H, d)



264
HOOC-(3-methoxyphenyl)
3-(2-chloro-5-
1, 2
3.19 (2H, t), 3.62 (2H, t), 3.85 (3H, s), 4.97 (2H,
m/z = 362




pyridinylmethyl)-2-

s), 7.08 (1H, dd), 7.26-7.35 (2H, m), 7.72 (1H,
(M + H)




iminothiazolidine

dd), 7.83 (1H, m), 7.89 (1H, d), 8.39 (1H, d)



265
HOOC-(4-ethylphenyl)
3-(2-chloro-5-
1, 2
1.26 (2H, t), 2.70 (2H, t), 3.18 (2H, t), 3.60 (2H,
m/z = 360




pyridinylmethyl)-2-

t), 4.97 (2H, s), 7.25 (2H, d), 7.32 (1H, d), 7.18
(M + H)




iminothiazolidine

(1H, dd), 8.18 (2H, d), 8.40 (1H, d)



266
HOOC-(4-cyanophenyl)
3-(2-chloro-5-
1, 2
3.23 (2H, t), 3.66 (2H, t), 4.98 (2H, s), 7.34 (1H,
m/z = 357




pyridinylmethyl)-2-

d), 7.66 (1H, dd), 7.72 (2H, d), 8.33 (2H, d), 8.40
(M + H)




iminothiazolidine

(1H, d)



267
HOOC-(3-methylphenyl)
3-(2-chloro-5-
1, 2
2.40 (3H, s), 3.18 (2H, t), 3.61 (2H, t), 4.93 (2H,
m/z = 346




pyridinylmethyl)-2-

s), 7.32 (3H, m), 7.72 (1H, dd), 8.07 (2H, m),
(M + H)




iminothiazolidine

8.40 (1H, d)



268
HOOC-(2-fluorophenyl)
3-(2-chloro-5-
1, 2
3.19 (2H, t), 3.62 (2H, t), 4.92 (2H, s), 7.11 (1H,
m/z = 350




pyridinylmethyl)-2-

dd), 7.17 (1H, m), 7.31 (1H, d), 7.45 (1H, m),
(M + H)




iminothiazolidine

7.73 (1H, dd), 8.10 (1H, td), 8.39 (1H, d)



269
HOOC-(3-cyanophenyl)
3-(2-chloro-5-
1, 2
7.23 (2H, t), 7.66 (2H, t), 5.00 (2H, s), 7.35 (1H,
m/z = 357




pyridinylmethyl)-2-

d), 7.56 (1H, t), 7.67 (1H, dd), 7.77 (1H, d), 8.39
(M + H)




iminothiazolidine

(1H, d), 8.45 (1H, d), 8.56 (1H, s)



270
(2-methylphenyl)-COCl
3-(2-chloro-5-
5
2.67 (3H, s), 3.18 (2H, t), 3.59 (2H, t), 4.92 (2H,
m/z = 346




pyridinylmethyl)-2-

s), 7.22 (2H, m), 7.33 (2H, m), 7.68 (1H, dd),
(M + H)




iminothiazolidine

8.12 (1H, d), 8.37 (1H, d)



271
HOOC-(2,3-dihydro-1H-indenyl)
3-(2-chloro-5-
1, 2
3.12 (2H, t), 3.23 (2H, dd), 3.32 (2H, dd), 3.48
m/z = 372




pyridinylmethyl)-2-

(1H, m), 3.57 (2H, t), 4.77 (2H, s), 7.12 (2H, m),
(M + H)




iminothiazolidine

7.19 (2H, m), 7.27 (1H, d), 7.53 (1H, dd), 8.31







(1H, d)



272
HOOC-(4-SO2Me-phenyl)
3-(2-chloro-5-
1, 2
3.23 (2H, t), 3.67 (2H, t), 4.99 (2H, s), 7.34 (1H,
m/z = 410




pyridinylmethyl)-2-

dd), 7.67 (1H, dd), 8.00 (2H, dd), 8.41 (2H, dd),
(M + H)




iminothiazolidire

8.43 (1H, d)



273
HOOC-(3-chlorophenyl)
3-(2-chloro-5-
1, 2
3.20 (2H, t), 3.63 (2H, t), 4.98 (2H, s), 7.35 (2H,
m/z = 366




pyridinylmethyl)-2-

dd), 7.48 (1H, dd), 7.70 (1H, dd), 8.11 (1H, dd),
(M + H)




iminothiazolidine

8.23 (1H, t), 8.40 (1H, d)



274
HOOCCH2CH(Me)2
3-(2-chloro-5-
1, 2
0.95 (6H, d) 2.20 (1H, m), 2.36 (2H, d), 3.11 (2H,
m/z = 312




pyridinylmethyl)-2-

t), 3.53 (2H, t), 4.80 (2H, s), 7.31 (1H, d), 7.63
(M + H)




iminothiazolidine

(1H, dd), 8.34 (1H, d)



275
HOOC-(3-nitrophenyl)
3-(2-chloro-5-
1, 2
3.24 (2H, t), 3.69 (2H, t), 5.01 (2H, s), 7.35 (1H,
m/z = 377




pyridinylmethyl)-2-

d), 7.62 (1H, m), 7.71 (1H, dd), 8.36 (1H, dd),
(M + H)




iminothiazolidine

8.41 (1H, d), 8.55 (1H, d), 9.08 (1H, d)



276
(4-nitrophenyl)-OCCCl
3-(2-chloro-5-
5
3.24 (2H, t), 3.67 (2H, t), 5.00 (2H, s), 7.34 (1H,
m/z = 377




pyridinylmethyl)-2-

d), 7.68 (1H, dd), 8.26 (2H, dd), 8.39 (3H, m)
(M + H)




iminothiazolidine





277
HOOC—CH2OCH(Me)2
3-(2-chloro-5-
1, 2
3.15 (2H, t), 3.57 (2H, t), 3.74 (1H, sept), 4.22
m/z = 328




pyridinylmethyl)-2-

(2H, s), 4.81 (2H, s), 7.33 (1H, d), 7.65 (1H, dd),
(M + H)




iminothiazolidine

8.34 (1H, d)



278
HOOC-[3-(1,2,3,4-
3-(2-chloro-5-
1, 2
1.91 (1H, m), 2.24 (1H, m), 2.88 (3H, m), 3.06
m/z = 386



tetrahydronaphthalenyl)]
pyridinylmethyl)-2-

(2H, m), 3.13 (2H, t), 3.55 (2H, t), 4.81 (2H, d),
(M + H)




iminothiazolidine

7.09 (4H, m), 7.30 (1H, d), 7.59 (1H, dd), 8.33







(1H, d)



279
HOOC—CH2OtBu
3-(2-chloro-5-
1, 2
1.25 (9H, s), 3.13 (2H, t), 3.55 (2H, t), 4.17 (2H,
m/z = 342




pyridinylmethyl)-2-

s), 4.79 (2H, s), 7.32 (1H, d), 7.67 (1H, dd), 8.34
(M + H)




iminothiazolidine

(1H, d)



280
HOOC-(3-fluorophenyl)
3-(2-chloro-5-
1, 2
3.20 (2H, t), 3.63 (2H, t), 4.97 (2H, s), 7.20 (1H,
m/z = 350




pyridinylmethyl)-2-

td), 7.34 (1H, d), 7.40 (1H, m), 7.70 (1H, dd),
(M + H)




iminothiazolidine

7.93 (1H, dd), 8.04 (1H, dd), 8.40 (1H, d)





















TABLE 15










IR (kBr,


Compound
Chemical
Chemical
Synthesis

v, cm−1)


No.
Precursor 1
Precursor 2
Example
NMR (CDCl3, δ, ppm)
or MS







281
HOOC—C(cyclo-
3-(2-chloro-5-
1, 2
1.21 (2H, t), 1.68 (2H, t), 3.08 (2H, t), 3.52 (2H,
m/z = 372



propyl)-Ph
pyridinylmethyl)-2-

t), 4.47 (2H, s), 7.17 (3H, m), 7.12-7.28 (4H, m),
(M + H)




iminothiazolidine

7.44 (2H, m), 8.11 (1H, d)



282
HOOC—C(Me)2—Ph
3-(2-chloro-5-
1, 2
1.62 (6H, s), 3.06 (2H, t), 3.50 (2H, t), 4.57 (2H,
m/z = 374




pyridinylmethyl)-2-

s), 7.00 (2H, m), 7.19-7.37 (4H, m), 8.12 (1H, d)
(M + H)




iminothiazolidine





283
HOOC—(CH2CH2)—Ph
3-(2-chloro-5-
1, 2
2.82 (2H, t), 3.02 (2H, t), 3.11 (2H, t), 3.52 (2H,
m/z = 360




pyridinylmethyl)-2-

t), 4.78 (2H, s), 7.16-7.32 (5H, m), 7.57 (1H,
(M + H)




iminothiazolidine

dd), 8.32 (1H, d)



284
HOOC-3-
3-(2-chloro-5-
1, 2
3.25 (2H, t), 3.69 (2H, t), 4.98 (2H, s), 7.34 (1H,
m/z = 334



pyrimidinyl
pyridinylmethyl)-2-

d), 7.67 (1H, dd), 8.38 (1H, d), 9.31 (1H, d), 9.46
(M + H)




iminothiazolidine

(1H, d)



285
HOOC-CH2NHCOOtBu
3-(2-chloro-5-
1, 2
1.45 (9H, s), 3.16 (2H, t), 3.58 (2H, t), 4.06 (1H,
m/z = 385




pyridinylmethyl)-2-

d), 4.81 (2H, s), 7.32 (1H, d), 7.65 (1H, dd), 8.31
(M + H)




iminothiazolidine

(1H, d)



286
HOOC-2-oxirane
3-(2-chloro-5-
1, 2
2.93 (1H, dd), 3.00 (1H, dd), 3.17 (2H, t) 3.56
m/z = 298




pyridinylmethyl)-2-

(1H, dd), 3.60 (2H, t), 4.81 (1H, d), 4.86 (1H, d),
(M + H)




iminothiazolidine

7.34 (!H, d), 7.67 (1H, dd), 8.34 (1H, d)



287
(3-bromophenyl)-COCl
3-(2-chloro-5-
5
3.20 (2H, t), 3.63 (2H, t), 4.97 (2H, s), 7.28-
m/z = 410




pyridinylmethyl)-2-

7.35 (2H, m), 7.63 (1H, dd), 7.69 (1H, dd), 8.18
(M + H)




iminothiazolidine

(1H, d), 8.38 (2H, m)



288
HOOC-3-azetydine
3-(2-chloro-5-
1, 2
3.14 (2H, t), 3.49 (1H, m), 3.58 (2H, t), 3.74 (2H,
m/z = 311




pyndinylmethyl)-2-

m), 2.97 (2H, m), 4.81 (2H, s), 7.31 (1H, d), 7.63
(M + H)




iminothiazolidine

(1H, dd), 8.33 (1H, d)



289
(2-pyridyl)-COCl
3-(2-chloro-5-
5
8.21 (2H, t), 33.64 (2H, t), 5.00 (2H, s), 7.32
m/z = 333




pyridinylmethyl)-2-

(1H, d), 7.40 (1H, m), 7.79 (2H, m), 8.29 (1H, d),
(M + H)




iminothiazolidine

8.42 (1H, s), 8.77 (1H, d)



290
HOOC-4-pyridyl
3-(2-chloro-5-
1, 2
3.23 (2H, t), 3.66 (2H, t), 4.98 (2H, s), 7.32 (1H,
m/z = 333




pyridinylmethyl)-2-

m), 7.67 (1H, dd), 8.30 (2H, m), 8.40 (1H, d),
(M + H)




iminothiazolidine

8.74 (2H, m)



291
HOOC-(5-chloro-
3-(2-chloro-5-
1, 2
3.21 (2H, t), 3.63 (2H, t), 4.87 (2H, s), 6.83 (1H,




2-thienyl)
pyridinylmethyl)-2-

t), 7.35 (1H, dd), 7.64 (1H, m), 7.73 (1H, dd),





iminothiazolidine

8.40 (1H, d)



292
(2-fluorophenyl)-COOH
3-(2-chloro-5-
1, 2
3.21 (2H, t), 3.68 (2H, t), 4.99 (2H, 3), 7.13 (1H,





thiazolylmethyl)-2-

dd), 7.21 (1H, m), 7.48 (1H, m), 7.50 (1H, s),





iminothiazolidine

8.17 (1H, td)



293
PhCOCl
3-(2-chloro-5-
5
3.41 (2H, t), 3.71 (2H, t), 4.71 (2H, s), 7.31 (1H,
m/z = 315




pyridinylmethyl)-2-

d), 7.40 (2H, m), 7.46 (1H, m), 7.73 (1H, dd),
(M + H)




iminothiazolidine

8.24 (2H, m), 8.38 (1H, d), 8.89 (1H, br s)



294
(2-fluorophenyl)-COOH
3-(2-chloro-5-
1, 2
3.41 (2H, t), 3.71 (2H, t), 4.65 (2H, s), 7.05-





pyridinylmethyl)-2-

7.16 (2H, m), 7.32 (1H, d), 7.39 (1H, m), 7.73





iminothiazolidine

(1H, dd), 8.01 (1H, td), 8.37 (1H, d), 8.81







(1H, be s)



295
PhCOCl
3-(2-trifluoromethyl-5-
5
3.20 (2H, t), 3.63 (2H, t), 5.06 (2H, s), 7.42 (2H,
m/z = 366




pyridinylmethyl)-2-

m), 7.51 (1H, m), 7.67 (1H, d), 7.90 (1H, d), 8.25
(M + H)




iminothiazolidine

(2H, d), 8.74 (1H, s)



296
(2-fluorophenyl)-COOH
3-(2-trifluoromethyl-5-
1, 2
3.21 (2H, t), 3.66 (2H, t), 5.03 (2H, s), 7.10 (1H,
m/z = 384




pyridinylmethyl)-2-

dd), 7.19 (1H, m), 7.45 (1H, m), 7.69 (1H, d),
(M + H)




iminothiazolidine

7.94 (1H, d), 8.08 (1H, td), 8.74 (1H, s)



297
PhOCOCl
3-(2-trifluoromethyl-5-
5
3.21 (2H, t), 3.65 (2H, t), 4.93 (2H, s), 7.18 (3H,
m/z = 382




pyridinylmethyl)-2-

m), 7.37 (2H, m), 7.69 (1H, d), 7.85 (1H, dd),
(M + H)




iminothiazolidine

8.68 (1H, d)



298
(2-trifluoro-
3-(2-chloro-5-
5
2.65 (3H, s), 4.58 (2H, s), 7.33 (1H, d), 7.43 (2H,
m/z = 400



methylphenyl)-COCl
pyridinylmethyl)-2-

m), 7.50 (1H, m), 7.65 (1H, dd), 8.23 (2H, m),
(M; H)




iminothiazolidine

8.38 (1H, d)



299
PhCOCl
3-(5,6-dichloro-
5
3.29 (2H, t), 3.63 (2H, t), 4.96 (2H, s), 7.43 (2H
m/z = 366




3-pyridinylmethyl)-

m), 7.51 (1H, m), 7.82 (1H, d), 8.24 (2H m),
(M; H)




2-iminothiazolidine

8.31 (1H, d)



300
PhCOCl
3-(6fluoro-3-
5
3.17 (2H, t), 3.61 (2H, t), 4.98 (2H, s), 6.93 (1H,
m/z = 316




pyridinylmethyl)-2-

dd), 7.43 (2H, m), 7.51 (1H, m), 7.86 (1H, td),
(M; H)




iminothiazolidine

8.22 (1H, d), 8.28 (2H, d)



301
PhCOCl
3-(6-chloro-5-fluoro-3-
5
3.20 (2H, t), 3.63 (2H, t), 4.98 (2H, s), 7.41-
m/z = 350




pyridinylmethyl)-2-

7.53 (4H, m), 8.24 (2H, m)
(M; H)




iminothiazolidine





302
PhCOCl
3-(6-bromo-3-
5
3.15 (2H, t), 3.59 (2H, t), 4.93 (2H, s), 7.42-
m/z = 376




pyridinylmethyl)-2-

7.62 (5H, m), 8.24 (2H, m), 8.36 (1H, d)
(M; H)




iminothiazolidine





303
HO—CH2CH2C≡CH
3-(2-chloro-
3, 4
2.00 (1H, d), 2.63 (2H, td), 3.18 (2H, t), 3.58
m/z = 324




5-pyridinylmethyl)-2-

(2H, t), 4.28 (2H, t), 4.83 (2H, s), 7.32 (1H, d),
(M; H)




iminothiazolidine

7.65 (1H, dd), 8.31 (1H, d)





















TABLE 16










IR (kBr,


Compound
Chemical
Chemical
Synthesis

v, cm−1)


No.
Precursor 1
Precursor 2
Example
NMR (CDCl3, δ, ppm)
or MS







304
HOOC—CH2CH2-(2-
3-(2-chloro-5-
1, 2
2.80(1H, m), 3.00(1H, m),
m/z = 390



methoxyphenyl)
pyridinylmethyl)-2-

3.11(2H, m), 3.81(3H, s),
(M + H)




iminothiazolidine

4.12(2H, s), 6.85(2H, m),







7.17(2H, m), 7.30(1H, t),







7.62(1H, m), 8.33(1H, s)



305
HOOC—CH2CH2-(2-
3-(2-chloro-5-
1, 2
2.85(1H, t), 3.04(1H, m),
m/z = 398



methoxyphenyl)
pyridinylmethyl)-2-

3.14(1H, t), 3.60(1H, t),
(M + H)




iminothiazolidine

3.83(3H, s), 4.13(1H, q),







4.83(2H, s), 6.85(1H, d),







6.89(1H, d), 7.20(2H, m),







7.45(1H, s)



306
HO—CH2CH2CH2C≡CH
3-(2-chloro-5-
3, 4
1.96 (3H, m), 2.33 (2H, td),
m/z = 338




pyridinylmethyl)-2-

3.16 (2H, t), 3.57 (2H, t),
(M; H)




iminothiazolidine

4.27 (2H, t), 4.85 (2H, s),







7.32 (1H, d), 7.64 (1H, dd),







8.31 (1H, d)



307
HO—CH2CH2CH2CH2C≡CH
3-(2-chloro-5-
3, 4
1.64 (2H, m), 1.84 (2H, m),
m/z = 352




pyridinylmethyl)-2-

1.94 (1H, d), 2.23 (2H, td),
(M; H)




minothiazolidine

3.16 (2H, t), 3.56 (2H, t),







4.19 (2H, t), 4.81 (2H, s),







7.31 (1H, d), 7.64 (1H, dd),







8.32 (1H, d)



308
HOOC—CH2CH2C≡CH
3-(2-chloro-5-
1, 2
1.96 (3H, m), 2.56 (2H, td),
m/z = 308




pyridinylmethyl)-2-

2.73 (2H, t), 3.13 (2H, t),
(M; H)




iminothiazolidine

3.56 (2H, t), 4.82 (2H, t),







7.32 (1H, d), 7.67 (1H, dd),







8.34 (1H, d)



309
HOOC—CH2CH2CH2C≡CH
3-(2-chloro-5-
1, 2
1.92 (3H, m), 2.27 (2H, t),
m/z = 322




pyridinylmethyl)-2-

2.61 (2H, t), 3.12 (2H, t),
(M; H)




iminothiazolidine

3.53 (2H, t), 4.80 (2H, s),







7.31 (1H, d), 7.65 (1H, dd),







8.31 (1H, d)



310
HO—CH2CH2CH2CH2CH═CH2
3-(2-chloro-5-
3, 4
1.50 (2H, m), 1.75 (2H, m), 2.09
m/z = 354




pyridinylmethyl)-2-

(2H, q), 3.16 (2H, t), 3.56 (2H, t),
(M + H)




iminothiazolidine

4.17 (2H, t), 4.81 (2H, s), 4.96







(1H, m), 5.02(1H, m), 5.81 (1H, m),







7.29 (1H, d), 7.64 (1H, dd),







8.31 (1H, d)



311
HO—CH2CH2CH2CH2CH═CH2
3-(2-chloro-5-
3, 4
1.51 (2H, m), 1.76 (2H, m), 2.13
m/z = 360




thiazolylmethyl)-2-

(2H, m), 3.17 (2H, t), 3.63
(M + H)




iminothiazolidine

(2H, t), 4.21 (2H, t), 4.96







(1H, m), 5.04 (1H, m), 5.80







(1H, m), 7.45 (1H, s)



312
HOOC—CH2CH2CH2CH2C≡CH
3-(2-chloro-5-
1, 2
1.60 (2H, m), 1.77 (2H, m), 1.94
m/z = 336




pyridinylmethyl)-2-

(1H, t), 2.22 (2H, td), 2.50
(M + H)




iminothiazolidine

(2H, t), 3.13 (2H, t), 3.53







(2H, t), 4.80 (2H, s), 7.31







(1H, d), 7.65 (1H, dd), 8.33







(1H, d)



313
HOOC—CH2CH2CH2CH2C≡CH
3-(2-chloro-5-
1, 2
1.60 (2H, m), 1.84 (2H, m), 1.95
m/z = 342




thiazolylmethyl)-2-

(1H, t), 2.25 (2H, ts), 2.56
(M + H)




iminothiazolidine

(2H, t), 3.14 (2H, t), 3.60







(2H, t), 4.83 (2H, s), 7.45 (1H, s)



314
HO—CH2CH2CH2CH═CH2
3-(2-chloro-5-
3, 4
1.83 (2H, m), 2.17 (2H, m),
m/z = 340




pyridinylmethyl)-2-

3.16 (2H, t), 3.58 (2H, t), 4.18
(M + H)




iminothiazolidine

(2H, t), 4.98 (1H, m), 5.04







(1H, m), 5.83 (1H, m), 7.33







(1H, d), 7.65 (1H, dd), 8.32







(1H, d)



315
HO—CH2CH2CH2CH═CH2
3-(2-chloro-5-
3, 4
1.84 (2H, m), 2.17 (2H, m),
m/z = 346




thiazolylmethyl)-2-

3.17 (2H, t), 3.63 (2H, t),
(M + H)




iminothiazolidine

4.20 (2H, t), 4.86 (2H, s),







4.99 (1H, m), 5.06 (1H, m),







5.85 (1H, m), 7.45 (1H, s)



316
HOOC—CH2CH2CH2CH2CH═CH2
3-(2-chloro-5-
1, 2
1.44 (2H, m), 1.70 (2H, m),
m/z = 338




pyridinylmethyl)-2-

2.07 (2H, m), 2.49 (2H, t),
(M + H)




iminothiazolidine

3.11 (2H, t), 3.53 (2H, t),







4.80 (2H, s), 4.94 (1H, m),







5.00 (1H, m), 5.82 (1H, m),







7.40 (1H, d), 7.64 (1H, dd),







8.34 (1H, d)



317
HOOC—CH2CH2CH2CH2CH═CH2
3-(2-chloro-5-
1, 2
1.40 (2H, m), 1.74 (2H, m),
m/z = 344




thiazolylmethyl)-2-

2.10 (2H, m), 2.54 (2H, t),
(M + H)




iminothiazolidine

3.13 (2H, t), 3.59 (2H, t),







4.83 (2H, s), 4.95 (1H, m),







5.03 (1H, m), 5.83 (1H, m),







7.45 (1H, s)



318
HOOC—CH2CH2CH2CH═CH2
3-(2-chloro-5-
1, 2
1.78 (2H, m), 2.11 (2H, m),
m/z = 324




pyridinylmethyl)-2-

2.50 (2H, t), 3.11 (2H, t),
(M + H)




iminothiazolidine

3.53 (2H, t), 4.80 (2H, s),







4.96 (1H, m), 5.03 (1H, m),







5.82 (1H, m), 7.33 (1H, d),







7.64 (1H, dd), 8.34 (1H, d)



319
HOOC—CH2CH2CH2CH═CH2
3-(2-chloro-5-
1, 2
1.82 (2H, m), 2.14 (2H, m),
m/z = 330




thiazolylmethyl)-2-

2.54 (2H, t), 3.13 (2H, t),
(M + H)




iminothiazolidine

3.59 (2H, t), 4.84 (2H, s),







4.97 (1H, m), 5.05 (1H, m),







5.85 (1H, m), 7.45 (1H, s)



320
HOOC—CH2CH2CH═CH2
3-(2-chloro-5-
1, 2
2.43 (2H, m), 2.59 (2H, m),
m/z = 310




pyridinylmethyl)-2-

3.12 (2H, t), 3.54 (2H, t),
(M + H)




iminothiazolidine

4.81 (2H, s), 4.97 (1H, m),







5.06 (1H, m), 5.89 (1H, m),







7.40 (1H, d), 7.65 (1H, dd),







8.34 (1H, d)



321
HOOC—CH2CH2CH═CH2
3-(2-chloro-5-
1, 2
2.47 (2H, m), 2.63 (2H, m),
m/z = 316




thiazolylmethyl)-2-

3.14 (2H, t), 3.60 (2H, t),
(M + H)




iminothiazolidine

4.84 (2H, s), 4.99 (1H, m),







5.07 (1H, m), 5.92 (1H, m),







7.45 (1H, s)



322
HO—CHCH3CF3
3-(2-chloro-5-
3, 4
1.48 (3H, d), 3.21 (2H, t),
m/z = 374




thiazolylmethyl)-2-

3.68 (2H, t), 4.88 (2H,
(M + H)




iminothiazolidine

s), 5.32 (1H, m), 7.48 (1H, s)



323
HOOC—CH═CH-(3-thienyl)
3-(2-chloro-5-
1, 2
3.14 (2H, t), 3.57 (2H, t),
m/z = 364




pyridinylmethyl)-2-

4.89 (2H, s), 6.58 (1H, d),
(M + H)




iminothiazolidine

7.32 (3H, m), 7.46 (1H, d),







7.70 (1H, dd), 7.77 (1H, d),







8.37 (1H, d)



324
HOOC—CH═CH-(4-(2-
3-(2-chloro-5-
1, 2
3.15 (2H, t), 3.57 (2H, t),
m/z = 446



thienyl)-2-thienyl)
pyridinylmethyl)-2-

4.89 (2H, s), 6.53 (1H, m),
(M + H)




iminothiazolidine

7.10 (1H, dd), 7.13 (1H, dd),







7.22 (1H, d), 7.27 (1H, d),







7.35 (1H, d), 7.69 (1H, dd),







7.81 (1H, d), 8.37 (1H, d)



325
HO—CH2CH═CH-(3-thienyl)
3-(2-chloro-5-
3, 4
3.17 (2H, t), 3.57 (2H, t),





pyridinylmethyl)-2-

4.82 (2H, dd), 4.84 (2H, s),





iminothiazolidine

6.23 (1H, dt), 6.67 (1H, d),







7.22 (1H, dd), 7.26 (1H, m),







7.32 (1H, d), 7.64 (1H, dd),







8.31(1H, d)





















TABLE 17










IR (kBr,


Compound
Chemical
Chemical
Synthesis

v, cm−1)


No.
Precursor 1
Precursor 2
Example
NMR (CDCl3, δ, ppm)
or MS







326
HOOC—CH2-(2-
3-(2-chloro-5-
1, 2
1.57 (1H, m), 1.89 (2H, m), 2.08 (1H, m), 2.62
m/z = 340



tetrahydrofuranyl)
pyridinylmethyl)-2-

(1H, dd), 2.80 (1H, dd), 3.11 (2H, t), 3.53 (2H, t),
(M + H)




iminothiazolidine

3.73 (1H, m), 3.88 (1H, m), 4.36 (1H, m), 4.81







(2H, s), 7.31 (1H, d), 7.67 (1H, dd), 8.33 (1H, d)



327
HOOC—CH═CH-(2-furanyl)
3-(2-chloro-5-
1, 2
3.14 (2H, t), 3.57 (2H, t), 4.89 (2H, s), 6.46 (1H,
m/z = 347




pyridinylmethyl)-2-

dd), 6.58 (1h, d), 6.63 (1H, d), 7.32(1H, d), 7.47
(M + H)




iminothiazolidine

(1H, d), 7.69 (1H, dd), 837 (1H, d)



328
HOOC—CH2CH2-(2-thienyl)
3-(2-chloro-5-
1, 2
2.88 (2H, t), 3.12 (2H, t), 3.24 (2H, t), 3.54 (2H,
m/z = 366




pyridinylmethyl)-2-

t), 4.80 (2H, s), 6.82 (1H, d), 6.90 (1H, dd), 7.10
(M + H)




iminothiazolidine

(1H, dd), 7.30 (1H, d), 7.60 (1H, dd), 8.32 (1h, d)



329
HO—CH2CH2-(2-
3-(2-chloro-5-
3, 4
1.50 (1H, m), 1.82 (7H, m), 3.15 (2H, t), 3.56
m/z = 370



tetrahydrofuranyl)
pyridinylmethyl)-2-

(2H, t), 3.72 (1H, m), 3.86 (1H, dd), 3.95 (1H,
(M + H)




iminothiazolidine

dd), 4.26 (2H, m), 4.81 (2H, d × 2), 7.31 (1H, d),







7.64 (1H, d), 8.31 (1H, d)



330
HO—CH2CH2CH2-(2-thienyl)
3-(2-chloro-5-
3, 4
2.10 (2H, m), 2.96 (2H, t), 3.16 (2H, t), 3.57 (2H,
m/z = 396




pyridinylmethyl)-2-

t), 4.23 (2H, t), 4.82 (2H, s), 6.81 (1H, d), 6.91
(M + H)




iminothiazolidine

(1H, dd), 7.11 (1H, dd), 7.32 (1H, d), 7.65 (1H,







dd), 8.32 (1H, d)



331
HOOC—CH═CH-(2-thienyl)
3-(2-chloro-5-
1, 2
3.15 (2H, t), 3.57 (2H, t), 4.90 (2H, s), 6.54 (1H,
m/z = 364




pyridinylmethyl)-2-

d), 7.04 (1H, dd), 7.23 (1H, d), 7.34 (1H, dd),
(M + H)




iminothiazolidine

7.70 (1H, dd), 7.88 (1H, d), 8.37 (1H, d)



332
HOOC—CH2CH2-(2-furanyl)
3-(2-chloro-5-
1, 2
2.84 (2H, t), 3.01 (2H, t), 3.12 (2H, t), 3.54 (2H,
m/z = 350




pyridinylmethyl)-2-

t), 4.80 (2H, s), 6.00 (1H, d), 6.20 (1H, dd), 7.29
(M + H)




iminothiazolidine

(1H, d), 7.31 (1H, d), 7.60 (1H, dd), 8.31 (1H, d)



333
HOOC—CH2CH2CF3
3-(2-chloro-5-
1, 2
2.52 (2H, m), 2.75 (2H, m), 3.14 (2H, t), 3.57
m/z = 352




pyridinylmethyl)-2-

(2H, t), 4.81 (2H, s), 7.33 (1H, d), 7.62 (1H, dd),
(M + H)




iminothiazolidine

8.33 (1H, d)



334
HOOC—CH2CH2CH2COCH3
3-(2-chloro-5-
1, 2
1.95 (2H, m), 2.56 (2H, t), 3.12 (2H, t), 3.3 (3H,
m/z = 328




pyridinylmethyl)-2-

s), 3.43 (2H, t), 3.52 (2H, t), 4.80 (2H, s), 7.31
(M + H)




iminothiazolidine

(1H, d), 7.64 (1H, dd), 8.33 (1H, d)



335
HOOC—CH2-(3-
3-(2-chloro-5-
1, 2
1.58 (1H, m), 2.13 (1H, m), 2.60 (2H, m), 2.71
m/z = 340



tetrahydrofuranyl)
pyridinylmethyl)-2-

(1H, m), 3.13 (2H, t), 3.45 (1H, m), 3.52 (2H, t),
(M + H)




iminothiazolidine

3.77 (1H, q), 3.85 (1H, m), 3.99 (1H, m), 4.80







(2H, s), 7.32 (1H, d), 7.61 (1H, dd), 8.33 (1H, d)



336
HOOC—CH2CH2-(2-
3-(2-chloro-5-
1, 2
1.49 (1H, m), 1.80-2.05 (5H, m), 2.61 (2H, m),
m/z = 354



tetrahydrofuranyl)
pyridinylmethyl)-2-

3.11 (2H, t), 3.53 (2H, t), 3.71 (1H, m), 3.84 (2H,
(M + H)




iminothiazolidine

m), 4.84 (2H, s), 7.33 (1H, d), 7.65 (1H, dd), 8.33







(1H, d)



337
HO—CH2CH2CH2-(2-
3-(2-chloro-5-
3, 4
2.06 (2H, m), 2.76 (2H, t), 3.16 (2H, t), 3.56 (2H,
m/z = 380



furanyl)
pyridinylmethyl)-2-

t), 4.21 (2H, t), 4.81 (2H, s), 6.01 (1H, dd), 6.27
(M + H)




iminothiazolidine

(1H, dd), 7.30 (1H, d), 7.33 (1H, d), 7.64 (1H, dd),







8.31 (1H, d)



338
HO—CH2CH2-(3-
3-(2-chloro-5-
3, 4
1.56 (1H, m), 1.83 (2H, m), 2.08 (1H, m), 2.32
m/z = 370



tetrahydrofuranyl)
pyridinylmethyl)-2-

(1H, m), 3.17 (2H, t), 3.40 (1H, dd), 3.58 (2H, t),
(M + H)




iminothiazolidine

3.76 (1H, m), 3.86 (1H, m), 3.94 (1H, m), 4.20







(2H, m), 4.81 (2H, s), 7.31 (1H, d), 7.64 (1H, dd),







8.31 (1H, d)



339
HOOC—CH═CH-(3-furanyl)
3-(2-chloro-5-
1, 2
3.14 (2H, t), 3.56 (2H, t), 4.89 (2H, s), 6.46 (1H,
m/z = 348




pyridinylmethyl)-2-

d), 6.64 (1H, s), 7.32 (1H, d), 7.42 (1H, s), 7.63
(M + H)




iminothiazolidine

(1H, s), 7.69 (2H, m), 8.32 (1H, d)



340
HO—CH2CH2CH2-(2-
3-(2-chloro-5-
3, 4
1.40-2.01 (8H, m), 3.15 (2H, t), 3.56 (2H, t),
m/z = 384



tetrahydrofuranyl)
pyridinylmethyl)-2-

3.71 (1H, td), 3.84 (2H, t), 4.20 (2H, m), 4.81
(M + H)




iminothiazolidine

(2H, s), 7.33 (1H, d), 7.64 (1H, dd), 8.30 (1H, d)



341
HOOC—CH2CH2-(3-furanyl)
3-(2-chloro-5-
1, 2
2.75 (2H, m), 2.82 (2H, m), 3.11 (2H, t), 3.55
m/z = 350




pyridinylmethyl)-2-

(2H, t), 4.80 (2H, s), 6.29 (1H, d), 7.24 (1H, d),
(M + H)




iminothiazolidine

7.32 (1H, d), 7.34 (1H, d), 7.60 (1H, dd), 8.32







(1H, d)



342
HO—CH2CH2CH2CF3
3-(2-chloro-5-
3, 4
2.00 (2H, m), 2.24 (2H, m), 3.17 (2H, td), 3.58
m/z = 370




pyridinylmethyl)-2-

(2h, t), 4.23 (2H, t), 4.82 (2H, s), 7.34 (1H, d),
(M + H)




iminothiazolidine

7.65 (1H, dd), 8.32 (1H, d)



343
HOOC—CH2CH2-
3-(2-chloro-5-
1, 2
2.78 (2H, t), 2.96 (2H, t), 3.11 (2H, t), 3.52 (2H,




(4-methoxyphenyl)
pyridinylmethyl)-2-

t), 3.78 (3H, s), 4.78 (2H, s), 6.81 (2H, d), 7.14





iminothiazolidine

(2H, d), 7.29 (1H, d), 7.56 (1H, dd), 8.31 (1H, d)



344
HO—CH2CH2CH2OCH3
3-(2-chloro-5-
3, 4
1.99 (2H, m), 3.15 (2H, t), 3.34 (3H, s), 3.49
m/z = 344




pyridinylmethyl)-2-

(2H, t), 3.56 (2H, t), 4.26 (2H, t), 4.82 (2H, s),
(M + H)




iminothiazolidine

7.33 (1H, d), 7.64 (1H, dd), 8.32 (1H, d)



345
HOOC—CH2CH2-(3,5-
3-(2-chloro-5-
1, 2
2.81 (2H, t), 2.98 (2H, t), 3.14 (2H, t), 3.51 (2H,




dimethoxyphenyl)
pyridinylmethyl)-2-

t), 3.75 (6H, s), 4.79 (2H, s), 6.29 (1H, d), 6.39





iminothiazolidine

(2H, d), 7.30 (1H, d), 7.60 (1H, dd), 8.32 (1H, d)





















TABLE 18










IR (kBr,


Compound
Chemical
Chemical
Synthesis

v, cm−1)


No.
Precursor 1
Precursor 2
Example
NMR (CDCl3, δ, ppm)
or MS







346
HO—CH2CH2CH2CH2OCH3
3-(2-chloro-5-
3, 4
1.68 (2H, m), 1.78 (2H, m), 3.16 (2H, t), 3.33
m/z = 358




pyridinylmethyl)-2-

(3H, s), 3.41 (2H, t), 3.56 (2H, t), 4.20 (2H, t),
(M + H)




iminothiazolidine

4.80 (2H, s), 7.34 (1H, d), 7.65 (1H, dd), 8.34







(1H, d)



347
HO—CH2-(3-
3-(2-chloro-5-
3, 4
3.16 (2H, t), 3.56 (2H, t), 3.81 (3H, s), 4.80 (2H,
m/z = 392



methoxyphenyl)
pyridinylmethyl)-2-

s), 5.19 (2H, s), 6.84 (1H, m), 7.00 (2H, m), 7.24
(M + H)




iminothiazolidine

(1H, m), 7.32 (1H, d), 7.64 (1H, dd), 8.31 (1H, d)



348
HO—CH2CH2-(3-
3-(2-chloro-5-
3, 4
3.02 (2H, t), 3.17 (2H, t), 3.57 (2H, t), 3.80 (3H,
m/z = 406



methoxyphenyl)
pyridinylmethyl)-2-

s), 4.37 (2H, t), 4.80 (2H, t), 6.80 (3H, m), 7.22
(M + H)




iminothiazolidine

(1H, m), 7.32 (1H, d), 7.65 (1H, dd), 8.32 (1H, d)



349
HO—CH2CH2CH2-(3-furanyl)
3-(2-chloro-5-
3, 4
1.98 (2H, m), 2.54(2H, t), 3.16 (2H, t), 3.56 (2H,
m/z = 380




pyridinylmethyl)-2-

t), 4.21 (2H, t), 4.81 (2H, s), 6.28 (1H, s), 7.23
(M + H)




iminothiazolidine

(1H, d), 7.33 (1H, d), 7.34 (1H, d), 7.64 (1H, dd),







8.31 (1H, d)



350
HOOC—CH2CH2-(3-
3-(2-chloro-5-
1, 2
1.35 (1H, m), 1.78 (3H, m), 2.04 (1H, m), 2.23
m/z = 354



tetrahydrofuranyl)
pyridinylmethyl)-2-

(1H, m), 2.50 (2H, m), 3.12 (2H, t), 3.36 (1H, t),
(M + H)




iminothiazolidine

3.54 (2H, t), 3.75 (1H, q), 3.85 (2H, m), 4.80







(2H, s), 7.31 (1H, d), 8.62 (1H, dd), 8.34 (1H, d)



351
HO—CH2CH2CH2-(3-
3-(2-chloro-5-
3, 4
1.48-1.74 (5H, m), 2.03 (1H, m), 2.20 (1H, m),
m/z = 384



tetrahydrofuranyl)
pyridinylmethyl)-2-

3.16 (2H, t), 3.34 (1H, m), 3.57 (2H, t), 3.75-
(M + H)




iminothiazolidine

3.92 (3H, m), 4.17 (2H, t), 4.81 (2H, s), 7.33







(1H, d), 7.64 (1H, dd), 8.32 (1H, d)



352
HO—CH2CH2-(2-thienyl)
3-(2-chloro-5-
3, 4
3.17 (2H, t), 3.25 (2H, t), 3.57 (2H, t), 4.39 (2H,
m/z = 382




pyridinylmethyl)-2-

t), 4.82 (2H, s), 6.89 (1H, dd), 6.94 (1H, dd), 7.16
(M + H)




iminothiazolidine

(1H, dd), 7.33 (1H, d), 7.67 (1H, dd), 8.32 (1H, d)



353
HOOC—CH2CH2CH2-(2,3-
3-(2-chloro-5-
1, 2
1.96 (2H, m), 2.49 (2H, t), 2.58 (2H, t), 3.12 (2H,




dihydrobenzo[b][1,4]dioxin-
pyridinylmethyl)-2-

t), 3.52 (2H, t), 4.21 (4H, s), 4.76 (2H, s), 6.66




6-yl)
iminothiazolidine

(1H, dd), 6.70 (1H, d), 6.77 (1H, d), 7.31 (1H, d),







7.64 (1H, dd), 8.33 (1h, d)



354
HO—CH2CH2-(3-thienyl)
3-(2-chloro-5-
3, 4
3.17 (2H, t), 3.17 (2H, t), 3.57 (2H, t), 4.37 (2H,
m/z = 382




pyridinylmethyl)-2-

t), 4.80 (2H, s), 7.00 (1H, dd), 7.06 (1H, dd), 7.26
(M + H)




iminothiazolidine

(1H, dd), 7.32 (1H, d), 7.65 (1H, dd), 8.32 (1H, d)



355
HOOC—CH2CH2-
3-(2-chloro-5-
1, 2
2.77 (2H, t), 2.94 (2H, t), 3.12 (2H, t), 3.53 (2H,




(benzo[d][1,3]dioxol-5-yl)
pyridinylmethyl)-2-

t), 4.79 (2H, s), 5.91 (2H, s), 6.68 (1H, dd), 6.71





iminothiazolidine

(1H, d), 6.73 (1H, d), 7.30 (1H, d), 7.58 (1H, dd),







8.32 (1H, d)



356
HO—CH2CH2CF3
3-(2-chloro-5-
3, 4
2.57 (2H, m), 3.18 (2H, t), 3.60 (2H, t), 4.38 (2H,
m/z = 368




pyridinylmethyl)-2-

t), 4.81 (2H, t), 7.34 (1H, d), 7.66 (1H, dd), 8.33
(M + H)




iminothiazolidine

(1H, d)



357
HOOC—CH2CH2-(2,3-
3-(2-chloro-5-
1, 2
2.77 (2H, t), 2.92 (2H, t), 3.12 (2H, t), 3.53 (2H,
m/z = 416



dihydrobenzo[b][1,4]dioxin
pyridinylmethyl)-2-

t), 4.22 (4H, s), 4.79 (2H, s), 6.69 (1H, dd), 6.73
(M + H)



6-yl)
iminothiazolidine

(1H, d), 6.76 (1H, d), 7.32 (1H, d), 7.62 (1H, dd),







8.32 (1H, d)



358
HOOC—CH2CH2-(3-
3-(2-chloro-5-
1, 2
2.84 (2H, t), 3.00 (2H, t), 3.53 (2H, t), 3.78 (3H,
m/z = 390



methoxyphenyl)
pyridinylmethyl)-2-

s), 4.78 (2H, s), 6.73 (1H, d), 6.78 (1H, d), 6.83
(M + H)




iminothiazolidine

(1H, d), 7.18 (1H, t), 7.30 (1H, d), 7.58 (1H, dd),







8.32 (1H, d)



359
HO—CH2CH2-(2-furanyl)
3-(2-chloro-5-
3, 4
3.07 (2H, t), 3.16 (2H, t), 3.57 (2H, t), 4.11 (2H,
m/z = 366




pyridinylmethyl)-2-

t), 4.80 (2H, s), 6.10 (1H, d), 6.29 (1H, d), 7.30
(M + H)




iminothiazolidine

(1H, d), 7.33 (1H, d), 7.63 (1H, dd), 8.30 (1H, d)



360
HO—CH2CH2-(3-furanyl)
3-(2-chloro-5-
3, 4
2.85 (2H, t), 3.16 (2H, t), 3.57 (2H, t), 4.31 (2H,
m/z = 366




pyridinylmethyl)-2-

t), 4.81 (2H, s), 6.33 (1H, s), 7.31 (1H, d), 7.33
(M + H)




iminothiazolidine

(1H, d), 7.36 (1H, d), 7.64 (1H, dd), 8.31 (1H, d)



366
HO—CH2-(2-thienyl)
3-(2-chloro-5-
3, 4
3.14 (2H, t), 3.53 (2H, t), 4.77 (2H, s), 5.34 (2H,





pyridinylmethyl)-2-

s), 6.95 (1H, dd), 7.13 (1H, dd), 7.30 (1H, d),





iminothiazolidine

7.62 (1H, dd), 8.28 (1H, d)



367
HO—CH2-(3-thienyl)
3-(2-chloro-5-
3, 4
3.15 (2H, t), 3.55 (2H, t), 4.78 (2H, s), 5.20 (2H,
1650, 1546,




pyridinylmethyl)-2-

s), 7.16 (1H, d), 7.27-7.35 (3H, m), 7.64 (1H,
1460, 1440,




iminothiazolidine

dd), 8.30 (1H, d)
1415


372
HOOC—CH═CHCF3
3-(2-chloro-5-
1, 2
3.19 (2H, t), 3.63 (2H, t), 4.88 (2H, s), 6.72 (1H,
1714, 1637,




pyridinylmethyl)-2-

d), 6.80 (1H, m), 7.34 (1H, d), 7.64 (1H, dd), 8.34
1616, 1540




iminothiazolidine

(1H, d)



373
HO—CH2CH2CN
3-(2-chloro-5-
3, 4
2.79 (2H, t), 3.20 (2H, t), 3.61 (2H, t), 4.37 (2H,
1671, 1549,




pyridinylmethyl)-2-

t), 4.81 (2H, s), 7.33 (1H, d), 7.67 (1H, dd), 8.32
1457, 1431




iminothiazolidine

(1H, d)



374
BrCOCH2Br,
3-(2-chloro-5-
7
2.44 (1H, t), 3.16 (2H, t), 3.58 (2H, t), 4.33 (2H,




HOOC—CH2OCH2C≡CH
pyridinylmethyl)-2-

s), 4.36 (2H, d), 4.81 (2H, s), 7.32 (1H, d), 7.65





iminothiazolidine

(1H, dd), 8.31 (1H, d)





















TABLE 19










IR (kBr,


Compound
Chemical
Chemical
Synthesis

v, cm−1)


No.
Precursor 1
Precursor 2
Example
NMR (CDCl3, δ, ppm)
or MS







429
BrCOCH2Br, HO—
3-(2-chloro-5-
7
1.85 (2H, m), 2.25 (2H, m),
1653, 1534,



CH2CH2CH2CF3
pyridinylmethyl)-2-

3.18 (2H, s), 3.54 (2H, t),
1461, 1414




iminothiazolidine

3.60 (2H, t), 4.18 (2H, s),







4.77 (2H, s), 7.29 (1H, d),







7.60 (1H, dd), 8.30 (1H, d)



430
BrCOCH2Br,
3-(2-chloro-5-
7
3.15 (2H, t), 3.57 (2H, t),




HO—CH2-(2-furanyl)
pyridinylmethyl)-2-

4.21 (2H, s), 4.65 (2H, s),





iminothiazolidine

4.80 (2H, s), 6.34 (2H, m),







7.31 (1H, d), 7.39 (1H, d),







7.64 (1H, dd), 8.32 (1H, d)



431
BrCOCH2Br,
3-(2-chloro-5-
7
3.16 (2H, t), 3.66 (2H, t),




HO—CH2-(3-furanyl)
pyridinylmethyl)-2-

4.22 (2H, s), 4.56 (2H, s),





iminothiazolidine

4.82 (2H, s), 6.45 (1H, d),







7.31 (1H, d), 7.39 (1H, d),







7.43 (1H, s), 7.65 (1H, dd),







8.35 (1H, d)



432
HOOC-(4-
3-(2-chloro-5-
1, 2
2.25 (1H, s), 3.21 (2H, t),
1617, 1527,



ethynylphenyl)
pyridinylmethyl)-2-

3.74 (2H, t), 5.00 (2H, s),
1462, 1419




iminothiazolidine

7.46 (1H, d), 7.52 (2H, d),







7.84 (1H, dd), 8.12 (2H, d),







8.46 (1H, d)



427
BrCH2COBr,
3-(2-chloro-5-
7
2.48 (2H, m), 3.16 (2H, t),
m/z = 382



HO—CH2CH2CF3
pyridinylmethyl)-2-

3.57 (2H, t), 3.82 (2H, t),
(M + H)




iminothiazolidine

4.23 (2H, s), 4.79 (2H, s),







7.32 (1H, d), 7.64 (1H, dd),







8.33 (1H, d)



428
HOOC—CH2OCH2CH2C≡CH
3-(2-chloro-5-
1, 2
1.97 (1H, t), 2.55 (2H, td),
m/z = 338




pyridinylmethyl)-2-

3.15 (2H, t), 3/57 (2H, t),
(M + H)




iminothiazolidine

3.73 (2H, t), 4.21 (2H, s),







4.80 (2H, s), 7.32 (1H, d),







7.63 (1H, dd), 8.33 (1H, d)



392
HOOC—CH2CH2CH2CF3
3-(2-chloro-5-
1, 2
1.93 (2H, m), 2.18 (2H, m),
m/z = 365




pyridinylmethyl)-2-

2.57 (2H, t), 3.13 (2H, t),
(M + H)




iminothiazolidine

3.56 (2H, t), 4.80 (2H, s),







7.31 (1H, d), 7.63 (1H, dd),







8.33 (1H, d)



433
HOOC—CH2OCH2CH2CH═CH2
3-(2-chloro-5-
1, 2
2.42 (2H, q), 3.14 (2H, t),
m/z = 340




pyridinylmethyl)-2-

3.56 (2H, t), 3.64 (2H, t),
(M + H)




iminothiazolidine

4.22 (2H, s), 4.80 (2H, s),







5.01 (1H, dd), 5.13 (1H, dd),







5.86 (1H, m), 7.31 (1H, d),







7.63 (1H, dd), 8.33 (1H, d)



434
HOOC—CH2OCH2CH═CH2
3-(2-chloro-5-
1, 2
3.13 (2H, t), 3.55 (2H, t),
m/z = 326




pyridinylmethyl)-2-

4.14 (2H, d), 4.21 (2H, t),
(M + H)




iminothiazolidine

4.79 (2H, d), 5.18 (1H, dd),







5.31 (1H, dd), 5.94 (1H, m),







7.32 (1H, d), 7.63 (1h, dd),







8.31 (1H, d)



435
HO—CH2CH2CH2-(2-
3-(2-chloro-
3, 4
2.03(2H, m), 2.72(2H, t),
m/z = 420



methoxyphenyl)
pyridinylmethyl)-2-

3.15(2H, t), 3.56(2H, t),
(M + H)




iminothiazolidine

3.81(3H, s), 4.20(2H, t),







4.82(2H, s), 6.84(1H, d),







6.87(1H, dt), 7.14(1H, dd),







7.18(1H, dd), 7.32(1H, dd),







7.66(1H, dd), 8.31(1H, d)









FORMULATION EXAMPLES
Formulation Example 1
Pellets

















Compound 6
 5% by weight



Bentonite
40% by weight



Talc
10% by weight



Clay
43% by weight



Calcium lignin sulfonate
 2% by weight









The above described ingredients were ground and mixed with each other uniformly. Then, water was added thereto, and the mixture was kneaded thoroughly, followed by pelletization and drying. Thus, pellets were obtained.


Formulation Example 2
Wettable Powder

















Compound 6
30% by weight



Clay
50% by weight



White carbon
 2% by weight



Diatomite
13% by weight



Calcium lignin sulfonate
 4% by weight



Sodium lauryl sulfate
 1% by weight









The above described ingredients were mixed with each other uniformly and ground. Thus, a wettable powder was obtained.


Formulation Example 3
Water Dispersible Granules

















Compound 6
30% by weight 



Clay
60% by weight 



Dextrin
5% by weight



Alkylmaleic acid copolymer
4% by weight



Sodium lauryl sulfate
1% by weight









The above described ingredients were ground and mixed with each other uniformly. Then, water was added thereto, and the mixture was kneaded thoroughly, followed by granulation and drying. Thus, water dispersible granules were obtained.


Formulation Example 4
Emulsion

















Compound 51
15% by weight



N,N-dimethylformamide
20% by weight



Solvesso 150
55% by weight



(ExxonMobil Yugen Kaisha)




Polyoxyethylene alkyl aryl ether
10% by weight









The above described ingredients were mixed with each other uniformly, and dissolved in each other. Thus, an emulsion was obtained.


Formulation Example 5
Powder

















Compound 51
 2% by weight



Clay
60% by weight



Talc
37% by weight



Calcium stearate
 1% by weight









The above described ingredients were mixed with each other uniformly. Thus, a powder was obtained.


Formulation Example 6
Liquefied Drops

















Compound 6
24% by weight



Ethanol
76% by weight









The above described ingredients were mixed with each other uniformly. Thus, liquefied drops were obtained.


Formulation Example 7
Liquefied Drops

















Compound 6
48% by weight



Ethanol
52% by weight









The above described ingredients were mixed with each other uniformly. Thus, liquefied drops were obtained.


TEST EXAMPLES
Test Example 1
Test on Control of Haemaphysalis longicornis

Into a 4-mL glass vial, 30 μl of an acetone solution containing a compound at 200 ppm, 10 ppm, or 1.7 ppm was introduced. This vial was placed on a shaker, and a dry film of the compound was formed on the inner wall of the vial. The vial was dried for 24 hours or more. Ten larvae of Haemaphysalis longicornis were introduced in the vial, and then the vial was capped. The vial was allowed to stand still in a thermostatic chamber under conditions of 25° C., a humidity of 85%, and total darkness. One day after the introduction, the larvae were observed for mortality, and the mortality ratio was calculated in accordance with the following formula. The test was duplicated.





Mortality ratio(%)=[Number of dead larvae/(Number of survived larvae+Number of dead larvae)]×100


As a result, each of the following compounds exhibited a mortality ratio on the dry film formed from the 200-ppm drug solution of 60% or higher.


2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 18, 21, 28, 29, 42, 43, 44, 45, 46, 47, 48, 51, 52, 53, 57, 58, 59, 61, 62, 64, 67, 70, 72, 73, 75, 76, 77, 78, 81, 83, 88, 89, 90, 93, 100, 104, 106, 107, 113, 114, 115, 117, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 131, 132, 133, 134, 135, 139, 140, 141, 142, 143, 144, 145, 147, 150, 151, 153, 154, 155, 156, 163, 167, 171, 173, 175, 176, 177, 179, 180, 182, 184, 185, 189, 190, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 239, 240, 241, 242, 243, 244, 247, 248, 249, 251, 252, 254, 255, 256, 258, 259, 260, 263, 264, 265, 267, 268, 270, 271, 273, 274, 277, 278, 279, 283, 284, 287, 289, 290, 291, 292, 299, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 326, 327, 328, 329, 330, 332, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 353, 354, 357, 358, 359, 360, 361, 362, 366, 367, 372, 373, 374, 427, 428, 429, 430, 431


Each of the following compounds exhibited a mortality ratio on the dry film formed from the 10-ppm drug solution of 60% higher.


2, 5, 6, 7, 8, 9, 10, 12, 18, 42, 43, 44, 45, 47, 51, 53, 57, 58, 59, 61, 70, 72, 75, 76, 81, 83, 88, 106, 107, 113, 114, 115, 122, 123, 124, 125, 126, 128, 129, 132, 134, 135, 139, 141, 142, 144, 145, 149, 155, 167, 171, 173, 184, 185, 189, 190, 197, 198, 199, 201, 203, 210, 211, 213, 214, 215, 216, 219, 220, 226, 227, 228, 229, 230, 233, 240, 241, 244, 246, 248, 249, 251, 254, 255, 256, 258, 259, 260, 267, 268, 283, 284, 292, 299, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310 311, 312, 313, 314, 315, 316, 318, 321, 322, 326, 328, 331, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 348, 349, 350, 354, 355, 356, 357, 358, 359, 361, 362, 366, 367, 373, 374, 427, 429, 430, 431


Each of the following compounds exhibited a mortality ratio on the dry film formed from the 1.7-ppm drug solution of 60% or higher.


6, 42, 43, 44, 45, 57, 61, 72, 76, 81, 83, 106, 107, 113, 114, 115, 122, 123, 124, 125, 128, 132, 134, 135, 139, 141, 144, 145, 155, 167, 171, 198, 211, 213, 216, 226, 227, 228, 230, 233, 240, 241, 244, 251, 255, 267, 268, 283, 292, 299, 302, 303, 308, 309, 313, 326, 328, 329, 336, 337, 338, 341, 343, 345, 349, 351, 352, 354, 355, 358, 359, 366, 374, 430, 431


Test Example 2
Test on Control of Haemaphysalis longicornis on Body Surface of Mouse

Hair on the back of a mouse (ICR, male, 5-weeks old) was shaved in a region having a diameter of approximately 2 cm, and a 15-mL polystyrene conical tube cut to have a height of approximately 1.5 cm was bonded to the region with an instant adhesive.


Then, 20 μl of a 1000-fold diluted liquid of a pest control agent prepared in the same manner as in Preparation Example 7 was added dropwise onto the body surface of the mouse within the bonded tube. After sufficient drying, or more larvae of Haemaphysalis longicornis were introduced, and the tube was capped. Three days after the introduction, the larvae of Haemaphysalis longicornis were observed for mortality, and the mortality rate was calculated in accordance with the following formula.





Mortality ratio(%)=[Number of dead larvae/(Number of survived larvae+Number of dead larvae)]×100


As a result, each of the following compounds exhibited a mortality ratio of 60% or higher.


81, 173, 283


Test Example 3
Test on Control of Tyrophagus putrescentiae

Into a 4-mL glass vial, 30 μl of an acetone solution containing a compound at 50 ppm was introduced. This vial was placed on a shaker, and a dry film of the compound was formed on the inner wall of the vial. After the vial was dried for 24 hours or more, five adults of Tyrophagus putrescentiae were introduced into the vial, and the vial was capped with absorbent cotton. The vial was allowed to stand in a thermostatic chamber under conditions of 25° C., a humidity of 85%, a 16-hour light period, and an 8-hour dark period. One day after the introduction, observation was made for mortality, and the mortality ratio was calculated in accordance with the following formula. The test was duplicated.





Mortality ratio(%)=[Number of dead mites/(Number of survived mites+Number of dead mites)]×100


As a result, each of the following compounds exhibited a mortality ratio on the dry film formed from the 50 ppm drug solution of 90% or higher.


2, 42


Test Example 4
Effects on Microfilariae of Dirofilaria immitis; In Vitro Test

Activities of compounds were evaluated on the basis of change in motility of microfilariae of D. immitis. Each compound of the present invention was dissolved in an RPMI 1640 liquid culture medium at a concentration of 12.5 ppm, 6.25 ppm, and 3.13 ppm. Then, approximately 20 microfilariae of D. immitis were introduced per culture liquid, and cultured at 37° C. Forty eight hours after the start of the culturing, the microfilariae of D. immitis were observed for motility. The compound was determined to be effective, when some influences were observed in 90% or more of the microfilariae, or when ⅓ or more of the microfilariae were dead.


As a result, the following compounds were effective at 12.5 ppm.


6, 28, 36, 48, 49, 52, 53, 57, 73, 75, 83, 111, 120, 154, 177, 196, 197, 198, 199, 201, 202, 203, 205, 226, 253, 254, 261, 262, 263, 267, 271, 299, 308, 309


The following compounds were effective at 6.25 ppm.


28, 48, 52, 53, 73, 75, 83, 84, 111, 120, 196, 198, 199, 202, 203, 205, 221, 226, 253, 261, 262, 263, 267, 271, 299, 308, 309, 357, 372


The following compounds were effective at 3.13 ppm.


52, 53, 73, 75, 83, 84, 111, 203, 226, 261, 262, 263, 267, 271, 299, 308, 309, 372


Test Example 5
Effects on Adults of Ascaridia galli (In Vitro Test)

Activities of compounds were evaluated on the basis of change in motility of adults of A. galli. Each compound of the present invention was dissolved in dimethyl sulfoxide, and then added to a culture liquid of A. galli dissolved in Ringer's solution, at a concentration of the compound of 50 ppm. Six adults of A. galli were introduced per culture liquid, and cultured at 41° C. Twenty four hours after the start of the culturing, the activity of the compound was evaluated by observing the motility of the adults of A. galli.


A compound was evaluated to be effective when 4 or more of the adults of A. galli stopped their active movement in the observation of the motility of adults of A. galli conducted 24 hours after the start of the culturing. As a result, the following compound was effective.


142


Test Example 6
Test on Control of Musca domestica

A drug solution was prepared by dissolving a compound in a 5% sucrose solution at 7.5 ppm. Five female adults of Musca domestica 24 hours after eclosion and absorbent cotton impregnated with 4 mL of the 5% sucrose solution containing the compound were placed in a 200-mL plastic cup in which a filter paper was laid. Then, the plastic cup was allowed to stand still under conditions of 25° C., a 16-hour light period, and an 8-hour dark period. One day after the placement, observation was made for mortality, and the mortality ratio was calculated in accordance with the following formula. The test was duplicated.





Mortality ratio(%)=[Number of dead insects/(Number of survived insects+Number of dead insects)]×100


As a result, the following compound exhibited a mortality ratio of 90% or higher.


42


Test Example 7
Test on Control of Musca domestica

One microliter of an acetone solution of a compound was locally administered to the back surfaces of thoraxes of female adults of Musca domestica within 24 hours after eclosion. The female adults of Musca domestica, and absorbent cotton impregnated with 4 mL of a 5% sucrose solution were placed in a 200-mL plastic cup in which a filter paper was laid. Then, the plastic cup was allowed to stand still under conditions of 25° C., a 16-hour light period, and an 8-hour dark period. One day after the placement, observation was made for mortality, and the mortality ratio was calculated in accordance with the following formula. The test was duplicated.





Mortality ratio(%)=[Number of dead insects/(Number of survived insects+Number of dead insects)]×100


As a result, the following compound exhibited a mortality ratio of 70% or higher, when administered at 0.1 μg/insect.


240


Test Example 8
Test on Control of Culex pipiens pallens

One milliliter of a 0.1% acetone solution containing a compound was prepared. To this solution, a small amount of a mixture of a dry yeast and a powdered solid feed for mice was added as a feed. Into this solution, 10 hatched larvae of Culex pipiens pallens were introduced. The solution was allowed to stand still under conditions of 25° C., a 16-hour light period, and an 8-hour dark period. One day after the placement, observation was made for mortality, and the mortality ratio was calculated in accordance with the following formula. The test was duplicated.





Mortality ratio(%)=[Number of dead larvae/(Number of survived larvae+Number of dead larvae)]×100


As a result, the following compound exhibited a mortality ratio of 60% or higher, when used at 1 ppm.


240


In Test Examples 1 to 8, the compounds of the present invention demonstrated excellent controlling effects against animal-parasitic pests and public health pests. The controlling effects were superior to those reported so far against pests in the agricultural field.


INDUSTRIAL APPLICABILITY

As described above, the present invention is capable of making a great contribution especially in the fields of controlling animal-parasitic pests and public health pests.

Claims
  • 1. A pest control agent comprising: one or more imino derivatives represented by the following chemical formula (I):
  • 2. A pest control agent according to claim 1, wherein Ar in the chemical formula (I) is represented by the following chemical formula (II) or (III):
  • 3. The pest control agent according to claim 1 or 2, wherein, in the chemical formula (I), X represents a sulfur atom, and Y represents COR1 or CO2R9,when Y is COR1, R1 represents a C1-C4 halogenated alkyl group, a C2-C6 alkenyl group, a C3-C6 alkynyl group, a substituted or unsubstituted phenyl(C1-C4)alkyl group, a substituted or unsubstituted phenyl(C2-C3)alkenyl group, a substituted or unsubstituted (C1-C4)alkoxy(C1-C3)alkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C1-C3)alkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C1-C3)alkenyl group, a substituted or unsubstituted heterocyclyl(C1-C3)alkyl group, or a substituted or unsubstituted heterocyclyl(C2-C3)alkenyl group, andwhen Y is CO2R9, R9 represents a C1-C6 halogenated alkyl group, a C3-C6 alkenyl group, a C3-C6 alkynyl group, a substituted or unsubstituted phenyl(C1-C4)alkyl group or a substituted or unsubstituted phenyl(C2-C4)alkenyl group, a methoxy(C3-C4)alkyl group; a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C1-C3)alkyl group, or a substituted or unsubstituted heterocyclyl(C2-C3)alkyl group.
  • 4. The pest control agent according to claim 1 or 2, wherein, in the chemical formula (I), X represents a sulfur atom, Y represents COR1 or CO2R9,when Y is COR1, R1 represents a C1-C3 halogenated alkyl group, a C4-C6 alkenyl group, a C4-C6 alkynyl group, a substituted phenyl(C2-C4)alkyl group, a substituted or unsubstituted phenyl(C2-C3)alkenyl group, a substituted or unsubstituted (C1-C4)alkoxymethyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkenyl group, a substituted or unsubstituted heterocyclyl(C2-C3)alkyl group, or a substituted or unsubstituted heterocyclyl(C2-C3)alkenyl group, andwhen Y is CO2R9, R9 represents a C3-C4 halogenated alkyl group, a C5-C6 alkenyl group, a C3-C4 alkynyl group, a substituted or unsubstituted phenyl(C2-C4)alkyl group, a substituted or unsubstituted phenyl(C2-C4)alkenyl group, a methoxy(C3-C4)alkyl group, a 3-membered to 7-membered substituted or unsubstituted heterocycloalkyl(C2-C3)alkyl group, or a substituted or unsubstituted heterocyclyl(C2-C3)alkyl group.
  • 5. The pest control agent according to claim 1, wherein the imino derivative represented by the chemical formula (I) is any one of the compounds shown in the following Table 1:
  • 6. A compound represented by the following chemical formula (Ia):
  • 7. The compound according to claim 6, wherein Ar′ in the chemical formula (Ia) is represented by the following chemical formula (II) or (III):
  • 8. The pest control agent according to claims 1 or 2, wherein the pest is an animal-parasitic pest.
  • 9. The pest control agent according to claims 1 or 2, wherein the pest is an animal-parasitic tick or mite.
  • 10. A method for controlling a pest, comprising: treating the pest with an effective amount of the pest control agent according to claims 1 or 2.
Priority Claims (2)
Number Date Country Kind
2010-154796 Jul 2010 JP national
2011-077912 Mar 2011 JP national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/JP2011/065285 7/4/2011 WO 00 1/4/2013